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ABSTRACT 
Designer nucleases permit the direction of DNA double-strand breaks and 
induction of DNA repair activities at virtually any genomic locus. The outcome of 
DNA repair is often non-random based on the structure of the double-strand DNA 
break and any homologies flanking the broken DNA ends. When an exogenous 
donor DNA molecule containing homology to a genomic DNA double-strand 
break site is supplied, DNA repair mechanisms can be hijacked to integrate the 
donor into the genome. However, to date rates of donor DNA integration are 
relatively low and recovery of precise gene targeting events is inefficient in vivo. 
Here, I demonstrate in zebrafish that liberating a donor cassette with 
CRISPR/Cas9 and the use of homologies as short as 12, 24, or 48 base pairs 
flanking double-stranded DNA donors can bias repair towards a Homology 
Directed Repair sub-pathway likely using strand annealing, herein called 
Homology-Mediated End Joining. This method, dubbed GeneWeld, drives 
precise integration in 50% of injected animals on average across 11 targeted loci 
and these events show low mosaicism in somatic tissue. GeneWeld events were 
recovered through the germline at an average rate of 50% across these loci. 
Southern blots demonstrate recovery of single copy, precise integration of donor 
cassettes at rates reasonable for average zebrafish labs, though some events 
are not precise. GeneWeld outperforms general Homologous Recombination 
(HR) in pig and human cells for integrating double-stranded DNA reporters. In 
addition, I apply an alternate, novel nuclease system from the CRISPR/Cas12a 
family, called CRISPR/Mad7, to GeneWeld in zebrafish and human cells, 
vii 
expanding genomic access and the genome editing toolbox. In the final part of 
this thesis, I describe genomic reporters that will be used to examine the genetic 
mechanisms of DNA repair using strand annealing in zebrafish. The work herein 
describes how short homologies can direct exogenous DNA integration 
effectively using the new method GeneWeld. GeneWeld increases accessibility 
and recovery of engineered genomes for functional genomics, agricultural 
engineering, therapeutic intervention, and addresses critical needs in the field of 
precision genome engineering. 
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CHAPTER 1.    INTRODUCTION 
Genome Engineering in the 21st Century 
For millennia, humans have relied on random mutagenesis to study 
developmental biology and the physical selection and breeding of traits to generate 
the wealth of agricultural products that feed our growing population. An ability to 
manipulate the genomes of living organisms at the molecular level allows humans to 
understand the fundamental mechanisms of life and could ultimately result in 
applications that confer crop resistance to a worldwide plague or cure human 
genetic disease. Since the 1944 discovery of DNA as the substance that carries 
genetic material, scientists have dreamed of having the ability to control its function 
at the molecular level (Avery, Macleod et al. 1944). In its infancy in zebrafish and 
other models, genome engineering was done through the simple introduction of DNA 
in cells in the hopes that randomly generated double-strand DNA breaks would 
sometimes assimilate the free-floating DNA (Lin, Sperle et al. 1984) (Thomas, Folger 
et al. 1986) (Wong and Capecchi 1986) (Grzesiuk and Carroll 1987). More efficient 
methods of genome engineering were applied to vertebrates using transposon 
systems (Ivics, Hackett et al. 1997) (Kawakami, Koga et al. 1998) (Cui, Geurts et al. 
2002) (Geurts, Yang et al. 2003) (Davidson, Balciunas et al. 2003) (Yant, Park et al. 
2004) (Zayed, Izsvak et al. 2004) (Baus, Liu et al. 2005) (Balciunas, Wangensteen et 
al. 2006). The development of transposon-based gene-trap lines for functional 
genomics was an invaluable contribution to the zebrafish field; however, these 
approaches still result in the random insertion of DNA, thus variables like genomic 
integration site and transgene copy number can affect the transgene expression 
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pattern (Dupuy, Akagi et al. 2005) (Copeland and Jenkins 2010) (Dupuy 2010) 
(Clark, Balciunas et al. 2011) (McGrail, Hatler et al. 2011).  
Designer nucleases, so dubbed because of their ease of reprogramming to 
target and hydrolyze DNA at virtually any genomic locus, allow researchers the 
ability to predictably control the integration site of exogenous DNA in cells in vitro or 
in whole organisms in vivo in just a single generation. Multiple platforms of designer 
nucleases have been developed and validated in organisms ranging from 
prokaryotic bacteria, plants, and eukaryotic vertebrates. Zinc Finger Nucleases 
(ZFN) and Transcription Activator Like Effector Nucleases (TALEN) are large, 
modular DNA proteins that need to be reengineered using complicated cloning 
efforts for each genomic target (Kim, Cha et al. 1996) (Christian, Cermak et al. 
2010). The democratization of genome engineering came in 2012 when Emmanuel 
Charpentier’s lab showed that an immune system from bacteria, CRISPR/Cas9, 
could be reprogrammed as a site-specific DNA targeting tool by simply changing an 
RNA cursor that directs the nuclease to its target site (Jinek, Chylinski et al. 2012). 
While designer nucleases have been used to alter the genomes of well over 100 
species to date, efficiencies are still low, off target effects are unappreciated, and 
complex genome edits are not well adopted across both model organisms and 
applied systems. In this thesis, I explore the use of zebrafish as an in vivo bioreactor 
to develop and validate methods for genome engineering and explore the DNA 
repair pathways at play, with the end goal of increasing efficiencies and precision in 
zebrafish for functional genomics, in agricultural systems, in large animal models, 
and in human health applications. 
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General DNA Repair Literature Review 
Cells have evolved elegant and highly conserved mechanisms to repair 
double-strand DNA breaks (DSB). DNA repair can be broadly categorized into four 
mechanistically distinct pathways: canonical non-homologous end joining (NHEJ), 
microhomology mediated end joining (MMEJ), single-strand annealing (SSA), and 
homologous recombination (HR). NHEJ is generally thought to be the quickest and 
most active repair pathway in mammalian cells (Mao, Bozzella et al. 2008). 
However, DNA repair pathway choice is dependent on many factors including the 
complexity of the DSB and the cell cycle (Her and Bunting 2018). MMEJ, SSA, and 
HR, collectively referred to as homology directed repair (HDR), all share an initial, 
committing step of DNA repair: 5’ to 3’ end resection to expose a 3’ tail that is the 
substrate for recombination (Lamarche, Orazio et al. 2010, Bhargava, Onyango et 
al. 2016) (Her and Bunting 2018). Additionally, though MMEJ and SSA use 
homology to repair the DSB, NHEJ, MMEJ, and SSA are considered error-prone 
DNA repair pathways as they most often result in the loss or disruption of genetic 
information. HR is considered to be error-free DNA repair as it uses genetic 
information encoded on a sister chromatid or homolog to complete repair. The 
mechanisms by which cells decide how to best repair DSBs is a subject of great 
interest and has increased with the application of designer nucleases; influencing a 
cell’s DNA repair pathway choice has applications in functional genomics, genome 
engineering, and gene therapy. Below these pathways and the critical proteins that 
aid cell’s DNA repair pathway choice are addressed in more detail, with a particular 
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focus on proteins of interest that may help bias DNA repair in order to enhance 
precision genome engineering. 
 
NHEJ 
NHEJ is active throughout the cell cycle and requires the protein heterodimer 
Ku70/Ku80 to bridge DNA ends and inhibit end resection (Rothkamm, Kruger et al. 
2003, Lieber 2010). This complex associates at the ends of DSBs within seconds of 
DNA damage (Chang, Pannunzio et al. 2017) (Mari, Florea et al. 2006). NHEJ uses 
no or limited homology (< 2 bp) surrounding a DSB to complete repair and most 
often results in short insertions or deletions (indels). Ku70/80 further functions as a 
“toolbelt protein” to recruit multiple factors important in processing the DNA ends for 
NHEJ. Importantly, DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) 
and Artemis are used to process complex DNA ends to blunt ends or short 3’ 
overhangs (Ma, Pannicke et al. 2002).  
The cell cycle plays an important role in whether or not DSBs are repaired 
with NHEJ or HDR (Branzei and Foiani 2008). MRE11 can promote long range end 
resection, a function critical to HDR, during G2 but not G1 (Biehs, Steinlage et al. 
2017). This likely further permits DNA-PKcs to associate with KU70/80 and DNA 
ends, enhancing NHEJ at the cost of HR. Finally, XRCC4 and LigIV operate to ligate 
DNA ends (Davis, Chen et al. 2014). While not required for NHEJ, another key factor 
that inhibits extended end resection and functions to shift the DNA repair balance 
towards NHEJ is 53BP1 (Panier and Boulton 2014). Indeed, it was recently shown 
that inhibition of 53BP1, a key regulator in the choice between NHEJ and HDR, can 
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enhance a cell’s ability to promote HDR and gene targeting as opposed to permit 
NHEJ mediated repair (Canny, Moatti et al. 2018). 
 
MMEJ 
MMEJ was first described in multicellular eukaryotes upon the observation in 
mice that p53-null, B cell lymphomas had recurrent microhomologies found at 
chromosome translocation junctions (Yan, Boboila et al. 2007) (Robert, Dantzer et 
al. 2009). MMEJ is characterized by the short homologies that are used to align and 
anneal broken DNA ends and are generally 5-25 bp long (McVey and Lee 2008) but 
in zebrafish, MMEJ events have shown to proceed with only 2-6 bp of homology 
(Ata, Ekstrom et al. 2018). Interestingly, some cell types allow mismatches in these 
short homologies (Lee and Lee 2007). Upon DSB, recruitment of the 
Mre11/Rad50/Nbs1 (MRN, MRX in yeast) complex generates a 3’ overhang and this 
activity is dependent on cyclin-dependent kinase (Cdk), linking up-regulation of 
MMEJ to S phase of the cell cycle (Lamarche, Orazio et al. 2010) (Truong, Li et al. 
2013). CtIP is another key protein that commits DSB repair to MMEJ or HR 
(Bennardo, Cheng et al. 2008, Rass, Grabarz et al. 2009).  Cdk2 mediated 
phosphorylation of C-terminal binding protein 1 interacting protein (CtIP) negatively 
impacts HR and MMEJ, indicating that resection activity promoted by CtIP is critical 
to the commitment steps of MMEJ (Truong, Li et al. 2013). However, Cdk2 
phosphorylates CtIP to increase its interaction with BRCA1, enhancing HR but not 
MMEJ, indicating context specificity and accessory protein requirements for each 
pathway (Yun and Hiom 2009). In addition, a critical need for MMEJ repair is the 
ability to trim 3’ flaps that result from aligning microhomologies distal to the DNA 
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ends. An evolutionarily conserved protein XPF/ERCC1 mediates this activity during 
MMEJ repair in mammalian cells (Ahmad, Robinson et al. 2008).  
Stability, or lack thereof, of the end resected ssDNA is also an important 
factor in promoting or inhibiting MMEJ. Upon DNA end resection, ssDNA ends are 
rapidly coated with RPA to remove secondary structure and promote stability of long 
ssDNA for eventual RAD51 nucleofilament production and HR (Sugawara, Wang et 
al. 2003). In yeast, a critical amino acid substitution in the homolog of mammalian 
RPA1 renders it unable to unwind and stabilize ssDNA secondary structure, 
enhancing MMEJ ~350x (Deng, Gibb et al. 2014). In addition to the decreased 
stability of ssDNA ends, this observation is also due to a decrease in recruitment of 
the Rad51 nucleofilament, which is required for strand invasion and commitment to 
HR (Holloman 2011). PARP is also critical to MMEJ repair, likely due to its role in 
end synapsis (Howard, Yanez et al. 2015) (Audebert, Salles et al. 2004). Finally, gap 
fill and ligation is needed to seal MMEJ events. In zebrafish, this activity is 
dependent on Pol-theta (Thyme and Schier 2016). Pol-theta also functions to 
promote MMEJ through its activity displacing RPA from ssDNA tails, limiting Rad51 
deposition, and promoting annealing and gap-filling (Mateos-Gomez, Kent et al. 
2017) (Ceccaldi, Rondinelli et al. 2016) (Ceccaldi, Liu et al. 2015). Further, MMEJ in 
zebrafish is dependent on Lig3 but not Lig4, indicating clear enzymatic differences 
between MMEJ and NHEJ in vertebrate cells in vivo (He, Li et al. 2007). 
 
SSA 
Single-strand annealing was first identified and described as a type of 
homologous recombination (Lin, Sperle et al. 1984). In these plasmid-based assays, 
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no protein requirements were determined but a model was described whereby DNA 
ends are resected to reveal direct repeats that are then annealed, deleting the 
intervening sequence. End resection for SSA can reach 2-4 kb, pending the 
recombination event (Chung, Zhu et al. 2010). MRX/MRN is only responsible for a 
fraction of that end resection activity and does not move from the periphery of DNA 
ends; yeast Sgs1-DNA2 (BLM/WRN in mammals) and/or ExoI are recruited in a 
manner that is enhanced, but not required, by MRX/MRN to promote further 
resection (Shroff, Arbel-Eden et al. 2004) (Zhu, Chung et al. 2008). Interestingly, 
ATM dependent phosphorylation of MRE11, a subunit of the MRN complex, acts to 
limit end resection through a negative feedback loop involving the phosphorylation of 
Exo1 (Kijas, Lim et al. 2015). Without MRE11 phosphorylation, Exo1 activity 
proceeds without control, increasing end resection and shunting DNA repair into 
SSA.  
Interestingly, 53BP1 plays a role in the choice between SSA and HR in 
addition to its role in promoting NHEJ repair, indicating the context specificity of its 
activity and accessory proteins involved in a cell’s DNA repair pathway choice 
(Ochs, Somyajit et al. 2016). When 53BP1 is depleted through generation of 
increasing levels of DSBs by infrared radiation, RAD52 recruitment on ssDNA is 
greater than RAD51 recruitment, suggesting extensively resected ends have lower 
affinity for RAD51 and increasing the fraction of DNA repair events completed 
through SSA rather than HR (Ochs, Somyajit et al. 2016). The ssDNA binding and 
annealing protein RAD52 is critical for SSA through its strand annealing activity 
(Ceccaldi, Rondinelli et al. 2016) (Mehta and Haber 2014).  This observation reflects 
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a potential paradigm shift in DNA repair pathway choice where a cell may favor one 
error-prone pathway over another; in the correct context, 53BP1 is required to 
promote NHEJ or HR in order to limit the highly mutagenic potential of SSA. Another 
recently identified strand annealing and exchange protein, FANCA, is also important 
for annealing of DNA ends in a RAD52 independent manner, however its interaction 
with other key SSA factors has yet to be elucidated (Benitez, Liu et al. 2018). Thus, 
while MMEJ and SSA share many common factors, they are separated by the extent 
of homology, end resection, and dependence on RAD52 for strand annealing, 
though other factors continue to be identified (Bhargava, Onyango et al. 2016). 
 
HR 
Homologous recombination can be defined as the reciprocal exchange of 
DNA from highly similar or identical chromosomes and is most well-known for its role 
in generating genetic diversity through crossover events during meiosis. However, 
HR serves an equally important role in somatic DNA repair and replication fork 
collapse. The mechanisms of HR were first hypothesized by Roy Holliday in 1964 
(Holliday 2007). The general temporal order to HR is as follows: First, as with MMEJ 
and SSA, end resection is a key committing step to HR repair. Second, RAD51 
replaces RPA coated ssDNA and this activity is mediated by BRCA2 and RAD52 
(New, Sugiyama et al. 1998). Third, RAD51 and RAD54 cooperate to find and 
initiate strand invasion, where the ssDNA tail penetrates a homologous DNA 
sequence (Ceballos and Heyer 2011). Fourth, the 3’ ends of the invading strand are 
elongated with the help of RAD54 branch migration (Mazin, Mazina et al. 2010). 
Finally, second end capture and Holliday junction resolution complete the 
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homologous exchange of genetic information (McIlwraith and West 2008, Nimonkar, 
Sica et al. 2009).  
While BLM and Exo1 are not required for MMEJ, they are critical in the shift 
from the short- to long-range end resection that SSA and HR necessitate (Truong, Li 
et al. 2013). However, short ssDNA tails are sufficient to initiate Rad51 mediated HR 
in yeast (Mimitou and Symington 2009). Along with the fact that 53BP1 acts to limit 
end resection to inhibit mutagenic SSA, under the proper cellular conditions limited 
resection can indeed promote HR based gene conversion and high-fidelity repair of 
DSBs. When 53BP1 is inhibited in BRCA1 deficient tumors partial rescue of HR is 
detected, indicating the interplay between BRCA1 and 53BP1 to promote, or inhibit, 
high-fidelity DNA repair (Bunting, Callen et al. 2010) (Bouwman, Aly et al. 2010). 
 
Zebrafish as a Model Organism 
The use of zebrafish as a model organism dates to the 1980s. Zebrafish are 
an attractive model organism due to their high fecundity, two-month generation time, 
transparent embryonic and larval development, relative low cost as opposed to 
mammalian models, and importantly, the ease with which the embryos can be 
manipulated through microinjection. Zebrafish are superior to mammalian models for 
a litany of reasons, most evident while studying developmental biology is the ability 
to observe organ development, cell lineage specification, and phenotypic effects of 
mutagenesis owed to the external fertilization and embryogenesis of zebrafish 
offspring (Kimmel and Warga 1987). In addition, 71% of human genes have an 
orthologue in zebrafish and 82% of known human disease-causing genes have a 
counterpart in zebrafish, showing the direct clinical relevance of using a model 
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organism such as zebrafish to study biology (Howe, Clark et al. 2013). Zebrafish 
contain 26,206 protein coding genes, more than any other known vertebrate, likely 
due to a teleost ancestor undergoing a whole genome duplication. Thus, a one-to-
one relationship of 47% of the genome relates human genes to fish genes. Indeed, 
studying human disease in zebrafish has shown translational promise (Golzio, Willer 
et al. 2012) (Panizzi, Becker-Heck et al. 2012) (Roscioli, Kamsteeg et al. 2012). 
Forward genetics, such as the use of mutagens like ENU or radiation, and 
insertional mutagenesis with transposons, have led to important discoveries in gene 
function. However, forward genetics is time consuming and limited by the ability to 
map the gene or genes that result in physical phenotypes. Further, forward genetics 
does not allow the preselection of genes that a given researcher is interested in 
unless a transgenic is used that drives expression of a transposase in a given tissue 
of interest or a mutant cDNA of interest in a null background. Designer nucleases, 
such as ZFN, TALEN, and CRISPR systems, ushered in the widespread adoption of 
reverse genetic approaches in zebrafish and are currently pushing the field from the 
study of disease, to functional genomics, to the genetic control of health. 
 
Genome Engineering Technology: Pre-Designer Nuclease Era 
DNA Injection 
In what could be deemed the original reports of genome engineering in 
vertebrates, circular or linear molecules of DNA were injected into either mammalian 
cells and xenopus embryos in order to study the effects of DNA recombination and 
to confer traits or genes in a transient manner (Capecchi 1980) (Lin, Sperle et al. 
1984) (Thomas, Folger et al. 1986) (Wong and Capecchi 1986) (Grzesiuk and 
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Carroll 1987). The first heritable DNA integration event in zebrafish was reported in 
1988 (Stuart, McMurray et al. 1988). In this study, a single founder transmitted the 
injected DNA and it segregated in a Mendelian fashion in F2, showing single site 
integration. While viable, this approach was limited in its ability to generate efficient 
germline heritable alleles, it was not effective enough for high-throughput generation 
of transgenic backgrounds or for insertional mutagenesis to study resulting mutant 
phenotypes. 
 
Transposons 
As explained above, DNA injection into vertebrate cells allows isolation of 
transgenic lines, however additional methods for introducing exogenous DNA in 
zebrafish were developed by hijacking the machinery of invertebrate transposable 
elements (Gibbs, Gray et al. 1994) (Raz, van Luenen et al. 1998) (Fadool, Hartl et 
al. 1998). Transposons have the potential to deliver genetic information in addition to 
the potential to be more effective insertional mutagens, while being more easily 
mapped than other random mutagenesis methods. While invertebrate transposases 
were active in zebrafish, transgenic lines were isolated at maximum germline 
transmission frequencies of 0.025% and random, non-transposase mediated 
integration of transposon vector DNA was detected at frequencies similar to DNA 
injection alone (Raz, van Luenen et al. 1998). A functional vertebrate transposase 
named Tol2, identified in medaka, was identified and shown to be active in a 
plasmid-based transposon excision assay in zebrafish (Kawakami, Koga et al. 
1998). In the first study to show germline transmission of transposed DNA in 
zebrafish using Tol2, 25% of founder animals transmitted at least 1 copy of the 
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transposed DNA, hinting at the utility of this system for insertional mutagenesis by 
multiple random, transposon mediated insertions.  
In 1997, Ivics et al., used phylogenetic analysis of the Tc1/mariner 
superfamily of vertebrate transposons to genetically re-engineer and demonstrate 
activity for a transposon dubbed Sleeping Beauty (SB) (Ivics, Hackett et al. 1997). 
SB achieved up to 31% germline transmission in the first report of its activity in 
zebrafish in vivo (Davidson, Balciunas et al. 2003). This publication furthered the 
work of Kawakami et al., 2000, demonstrating the utility of transposons in fish for the 
efficient delivery of promoter driven fluorescent proteins to follow tissue specific 
expression patterns as well as a “general utility transposon vector” where lines can 
be followed by a transgenic marker while a DNA of interest is expressed in cis with 
the transposed elements (Kawakami, Shima et al. 2000). Research and 
development using SB and Tol2 continued through the successive improvements of 
their activity through molecular engineering of inverted repeats and other alterations 
(Cui, Geurts et al. 2002) (Baus, Liu et al. 2005) (Geurts, Yang et al. 2003) (Yant, 
Park et al. 2004) (Zayed, Izsvak et al. 2004) (Balciunas, Wangensteen et al. 2006). 
While SB had been applied to insertional mutagenesis studies in mice 
models, successfully identifying novel drivers of cancer (Dupuy, Akagi et al. 2005) 
(Copeland and Jenkins 2010) (Dupuy 2010), reports in 2011 further validated the 
approach in zebrafish. Successful mobilization of a transgenic cassette by 
constitutive and RNA injected transposon allowed the identification of somatic 
drivers of cancer in zebrafish (McGrail, Hatler et al. 2011). In the same year, Clark et 
al., described the first report of in vivo protein trap lines in any vertebrate model 
13 
(Clark, Balciunas et al. 2011). This system effectively disrupts gene splicing and 
knock-down of endogenous expression levels >99% while providing a report of gene 
expression patterns. Thus, transposons provided an effective solution to 
mutagenesis and random delivery of genetic information. However, these forward 
genetic approaches still did not allow the direct manipulation of genes of interest. 
 
Genetic Engineering Technology in Zebrafish: Post-Designer Nuclease Era 
At the time, forward genetic screens using transposons allowed high-
throughput gene discovery by mobilizing high copy number transposons to randomly 
integrate throughout the genome. Interrogation of phenotypes and subsequent 
integration mapping allowed gene discovery by determining what genes were 
inactivated. However, the process to randomly discover genes based on selecting 
phenotypes of interest is time-consuming. Reverse genetics, pioneered in zebrafish 
through the application of morpholino technology, is a more targeted way of studying 
gene function, but comes with limitations (Blum, De Robertis et al. 2015). The 
development and application of designer nucleases promoted the realization of 
decades of hope – the ability to a priori disrupt gene function and permit efficient 
germline recovery of these mutations. Below are brief histories of select 
programmable nucleases and their first reports in zebrafish. 
 
ZFN 
C2H2 zinc fingers (ZF) are the DNA binding domains of abundantly found and 
expressed transcription factors in eukaryotic genomes (Diakun, Fairall et al. 1986). 
ZFs bind to tri-nucleotide DNA motifs and are modular in nature, a feature that 
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allows the re-engineering of DNA binding to re-target the protein to a site of interest, 
albeit with complicated cloning procedures (Kim, Cha et al. 1996). Fusion of the FokI 
endonuclease domain to the DNA binding domain created a readily engineered, 
“hybrid restriction enzyme”, that can target and cut DNA in a target specific manner 
(Kim, Cha et al. 1996). The first tractable nuclease used for precision gene targeting 
in zebrafish was the zinc finger nuclease (ZFN) (Doyon, McCammon et al. 2008) 
(Meng, Noyes et al. 2008). Optimization of ZFNs continued while demonstrations of 
their efficacy were shown in Arabidopsis (Lloyd, Plaisier et al. 2005), drosophila 
(Bibikova, Beumer et al. 2003), and human cultured cells (Porteus and Baltimore 
2003). However, ZFN technology was not widely adopted in zebrafish in part due to 
the complicated protein engineering required to reprogram the binding domains to 
any sequence of interest. 
 
TALEN 
In 2009, two groups “broke the code” of how Transcription Activator Like 
Effectors (TALEs), transcription factors from Xanthomonas spp., are able to bind to 
eukaryotic DNA (Moscou and Bogdanove 2009) (Boch, Scholze et al. 2009). TALEs 
use repeating alpha-helical domains of 34-35 amino acids, differing by only two 
amino acids dubbed the “repeat variable diresidue” (RVD) to specify a one to one 
relationship with DNA base pairs. In the same way that ZFs were turned to ZFNs, 
TALEs were quickly re-engineered to be TALE nucleases (TALEN) by addition of a 
FokI domain to the C terminus of the protein (Christian, Cermak et al. 2010). This 
system was quickly applied to zebrafish, showing both somatic knock-out 
percentages nearing 100% that are akin to morpholino based gene-disruption and 
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germline transmission of insertion/deletion alleles (Sander, Cade et al. 2011) (Cade, 
Reyon et al. 2012) (Dahlem, Hoshijima et al. 2012) (Bedell, Wang et al. 2012). 
Improvements in TALEN scaffolds and cloning strategies lead to wider adoption of 
this programmable nuclease in zebrafish than ZFN as new TALENs to target a locus 
of interest can be generated and sequence verified within ~5 days (Cermak, Doyle et 
al. 2011) (Bedell, Wang et al. 2012). 
 
CRISPR/Cas9 
TALEN’s time in the spotlight was cut short in 2012 when CRISPR/Cas9, an 
RNA-guided DNA interference mechanism from Staphylococcus aureus, was 
engineered to be a programmable nuclease system in vitro (Jinek, Chylinski et al. 
2012) and in vivo (Cong, Ran et al. 2013). CRISPR/Cas9 as it is applied today relies 
on just two components: 1) an RNA cursor molecule containing a programmable 20 
bp sequence that recognizes a 20 bp genomic DNA sequence linked with a constant 
secondary structure motif recognized by 2) the protein effector and nuclease Cas9 
(Mali, Yang et al. 2013). Cas9 searches the genome for a Protospacer Adjacent 
Motif (PAM) of the sequence NGG, where N is any nucleotide (Jinek, Chylinski et al. 
2012) (Mali, Yang et al. 2013). Upon recognition of a PAM, transient unwinding of 
the DNA helix allows the gRNA to search for a stable RNA-DNA match, at which 
point Cas9 catalyzes a double-strand break 3 base pairs 5’ of the PAM site (Jinek, 
Chylinski et al. 2012, Cong, Ran et al. 2013). In zebrafish, CRISPR/Cas9 was first 
applied to generate indel alleles at frequencies similar to reported levels of ZFN and 
TALEN (Hwang, Fu et al. 2013). Simultaneously, biallelic knock-out of CRISPR 
targeted loci in zebrafish and incorporation of loxp recombination sites using an 
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oligonucleotide donor was reported (Chang, Sun et al. 2013). CRISPR/Cas9 
application in zebrafish with a codon optimized, dual nuclear localization signal Cas9 
variant and multiplexed biallelic genome editing with increased efficiencies using an 
altered CRISPR gRNA secondary structure motif was thereafter reported (Jao, 
Wente et al. 2013). Additional reports using CRISPR/Cas9 mutants have expanded 
its utility. Disrupting the nuclease domains can generate a “dead Cas9” (dCas9), that 
can be used with accessory proteins for the targeted activation or silencing of target 
gene expression (Qi, Larson et al. 2013). Additionally, disrupting either/or of the two 
nuclease domains can result in a Cas9 “nickase” that cuts only a single strand of 
DNA (Ran, Hsu et al. 2013, Ran, Hsu et al. 2013). 
 
CRISPR/Cas12a 
It is estimated that 40% of bacteria and 90% of archaea contain CRISPR 
systems (Mojica, Diez-Villasenor et al. 2000). As such, the CRISPR toolbox 
continues to expand with new nucleases being discovered and reported. Recently, 
CRISPR/Cas12a (formerly CRISPR/Cpf1) was demonstrated to be active in 
mammalian cells and zebrafish (Zetsche, Gootenberg et al. 2015) (Moreno-Mateos, 
Vejnar et al. 2015) (Kim, Song et al. 2017). Cas12a activity is quite different in 
comparison to Cas9. First, the natural RNA molecule that directs Cas12a to its DNA 
target, called the crRNA, is a single RNA as opposed to two that form a 
heteroduplex to allow recognition by Cas9 (Zetsche, Gootenberg et al. 2015). 
Secondly, Cas12a uses a 5’-YTTN-3’ PAM that is directly upstream of the 
crRNA/DNA target. Finally, and perhaps most importantly, Cas12a leaves a 
staggered ~4-5 bp 5’ overhang. Indeed, Cas12a has increased efficiencies vs. Cas9 
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in zebrafish for targeting DNA with single-stranded DNA molecules to introduce SNP 
changes (Moreno-Mateos, Vejnar et al. 2015). This may be attributed to the fact that 
the 5’ overhang can stimulate end resection activity, shunting DNA repair from NHEJ 
into homology directed repair (Ran, Hsu et al. 2013). However, Cas12a activity in 
zebrafish is dependent on multiple experimental methods not required for Cas9. 
Cas12a requires either 1) a 34ºC heat shock, 2) protein injection (not mRNA 
injection), or 3) targeting the genomic region with dCas9 in order to relax chromatin 
(Moreno-Mateos, Vejnar et al. 2015). Thus, Cas12a does expand the CRISPR 
toolbox for specific applications in zebrafish however it may not be best in all 
situations. 
 
Precision Genome Engineering in Zebrafish with Designer Nucleases 
While the ability to precisely target and induce insertion/deletion mutagenesis 
in living organisms for creating putative “knock-out” alleles is an exciting advance in 
the field, designer nucleases also open the door to more complex genome edits. 
Pioneering work by Maria Jasin’s group showed that the ability to introduce 
exogenous DNA into genomes through homologous recombination is stimulated 
100-1000 fold when a DNA double strand break is targeted to the locus of interest 
(Rouet, Smih et al. 1994). However, in these experiments the locus of interest is a 
transgene containing I-SceI sites, creating an obvious limitation in targeting 
endogenous loci as I-SceI cannot be re-engineered to target outside of native 
recognition site. Designer nucleases allow researchers the opportunity to site 
specifically integrate exogenous DNA and/or create specific base pair changes by 
supplying a donor template at virtually any genomic locus.  
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Integrating exogenous DNA into specific genomic loci can aid researchers in: 
1) promotor tagging with an in-frame integration of a fluorescent reporter in order to 
visualize the spatiotemporal expression pattern of a gene product of interest 
2) protein tagging with an in-frame integration of a fluorescent reporter to visualize 
the cellular localization of the gene product of interest 
3) introduction of mutant cDNAs under the control of an endogenous promoter of 
interest to study cell biology 
4) humanizing loci for functional genomics and drug development  
5) gene therapy 
A plethora of methods for engineering the genome of zebrafish have been 
used in the designer nuclease era, each with advantages and shortfalls, based on 
the specific application a researcher needs. Below is a review of the techniques 
reported to date for exogenous DNA integration at designer nuclease cut sites in 
general and their application in zebrafish. The requirements for the key DNA repair 
pathway choice decision making proteins described above are not yet sufficiently 
explored in the context of precision genome engineering. For simplicity and for the 
fact that ZFN are not widely adopted in the zebrafish field, only TALEN and CRISPR 
based approaches to DNA integration will be discussed. 
 
NHEJ – Targeted Integration with Linear DNA 
In zebrafish embryos, non-homologous end joining is 10x more efficient than 
HR as demonstrated in an episomal plasmid ligation assay (Hagmann, Bruggmann 
et al. 1998) (Dai, Cui et al. 2010). Additionally, a report in 2012 demonstrated that 
only inhibition of the key ligase in NHEJ, Lig4, could decrease the efficiency of NHEJ 
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in a plasmid-based reporter assay (Liu, Gong et al. 2012). While these assays do 
not specifically address exogenous DNA integration into the genome, they indicate 
that NHEJ is a highly efficient pathway employed by zebrafish DNA repair 
machinery. By targeting both the genome and a donor plasmid with a designer 
nuclease, Auer et al., 2014 demonstrate up to 75% of injected animals display a 
broad report of targeted fluorescent protein expression (Auer, Duroure et al. 2014). 
Up to 40% of alleles transmitted to the germline were in frame, end to end NHEJ 
events. While this is powerful and efficient methodology for the targeted integration 
of exogenous DNA, there are limitations to this work; the donor molecule can 
integrate in either orientation, the frame cannot be implicitly specified, and 
concatemers of plasmid are sometimes integrated. These limitations are eliminated 
when utilizing homology mediated mechanisms to direct DNA integration. 
 
HR – Targeted Integration with Base Pair Precision using Long Homology 
Arms 
Designing donor vectors for homologous recombination mediated genome 
integration can eliminate the limitations of NHEJ based integration. General 
consensus for HR donor vectors requires long (>700 base pair) homology arms built 
flanking a donor cassette. In the first demonstration of HR based gene targeting, 
plasmid DNA was used to integrate sequence in the yeast genome (Orr-Weaver, 
Szostak et al. 1981). By introducing linear DNA with homologous ends to a target 
locus, integration was stimulated nearly 3000x over circular plasmid, and this 
integration activity was dependent on the homology to the genome. The general 
DSB repair model that came from these studies was elegantly described to be either 
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through a crossover or non-crossover model, pending how the Holliday junctions are 
resolved (Szostak, Orr-Weaver et al. 1983) (Holliday 2007).  
In the first report of TALEN mediated HR in zebrafish, 50% of injected 
animals contained a PCR product that indicated precise integration of the donor 
cassette, however no fluorescent report was detected (Zu, Tong et al. 2013). This 
publication also argued that injection of a linear plasmid increased knock-in 
efficiency. However, germline transmission of the targeted allele was recovered at 
1.5%, far lower than NHEJ mediated genome editing. Irion et al., 2014 demonstrated 
the first germline edit with a resulting phenotype using HR at 10% germline 
transmission rate (Irion, Krauss et al. 2014). Interestingly, this group found that in 
vivo liberation of their donor increased efficiencies of HR up to 10x. Following a 
similar strategy, Shin et al., 2014 demonstrated that homology arms up to 3.7 kb are 
required for optimal somatic circular plasmid knock-in; up to 80% of injected animals 
displayed sfGFP-tagged alleles (Shin, Chen et al. 2014). Germline transmission of 
these events was 32% at one locus and 16% at another, and concatemers were 
detected, demonstrating that injection of linear molecule in this experimental design 
is not the best approach for recovery of precise events. In addition to integration of 
reporter alleles, HR can also be used to incorporate epitope tags, SNP changes, and 
sequences for recombinase mediated cassette exchange like cre/lox, dre/rox, and 
flp/frt (Hoshijima, Jurynec et al. 2016). However, germline transmission of these 
events was reported to be only 5-15% based on the application, leaving room for 
improvement. While HR is reported to be an effective method of precision genome 
engineering, the field as a whole has not been able to replicate the results of the 
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above citations. Additionally, the design and cloning of HR based targeting vectors 
using long homology is cumbersome. Single base pair polymorphisms in long 
homology arms can reduce gene targeting efficiency in drosophila, and may be a 
limitation in zebrafish as well (Nassif and Engels 1993). 
 
MMEJ/SSA – Targeted Integration with Base Pair Precision using Short 
Homology Arms 
Alternative-NHEJ, also called MMEJ, is a pathway of DNA repair that 
generally uses short (5-25 base pair) homologies flanking DNA ends to bridge 
chromosomal repair (McVey and Lee 2008). In zebrafish, repair of CRISPR/Cas9 cut 
sites using MMEJ results in predominate DNA repair events that can be predicted in 
silico (Bae, Kweon et al. 2014) (Ata, Ekstrom et al. 2018). Further, MMEJ is required 
for survival of embryos following CRISPR/Cas9 targeted DNA double-strand break in 
zebrafish (Thyme and Schier 2016). These data demonstrate that MMEJ is more 
than a back-up repair pathway in vertebrate embryogenesis. Indeed, Hisano et al., 
2015 showed that using CRISPR/Cas9 to target the genome and a plasmid donor in 
vivo results in endogenous DNA integration at levels up to 86% using just 40 bp of 
homology flanking the integration cassette (Hisano, Sakuma et al. 2015). However, 
only 3% of events were categorized such that they show widespread somatic 
expression. Further, only 15% of adult fish transmitted the tagged allele to the next 
generation. While 40 bp of homology is far outside the “micro” requirement, the 
genetic mechanisms and base pair lengths that separate MMEJ and SSA in 
zebrafish are not yet fully resolved (Liu, Gong et al. 2012). Luo et al., 2018 also 
published using the same MMEJ approach employed by Hisano et al., 2015, and 
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reported 21-24% germline transmission based on the locus targeted, but again no 
molecular analysis of transmitted alleles was performed (Luo, Bian et al. 2018). 
These data indicate that MMEJ is a viable and more efficient approach than HR for 
generating efficient and precise somatic integrations and germline transmission 
alleles. Further, MMEJ based homology arms are easier to design and incorporate 
into a plasmid donor than long HR arms. However, questions remain about the 
efficiency of obtaining the predictable, precise events through the germline as no 
molecular analysis of germline events has been performed.  
 
GeneWeld: An Advanced Methodology for Genome Engineering 
While the above methods for precision genome engineering have been 
reported, widespread adoption of these methodologies is still lacking. Germline 
transmission of gene targeting events has been reported at efficiencies of 1.5%-
80%, displaying a broad range of activity that has not been realized by the majority 
of labs. Moreover, no thorough analysis of germline transmitted alleles has been 
performed with Southern blots. To date, there exists no publicly available suite of 
gene targeting donors with validated integration activities and efficiencies, and there 
are limited online web tools for homology arm design or genome editing protocol for 
troubleshooting and there are limited reports of alternate nucleases used reliably in 
zebrafish. Finally, the requirements for the key DNA repair pathway choice decision 
making proteins described above are not yet sufficiently explored in the context of 
precision genome engineering. 
In Chapter 2 of this dissertation, I develop a novel methodology dubbed 
GeneWeld whereby short homologies are used to direct exogenous DNA integration 
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at rates not reliably and reproducibly reported in the literature to date. This method 
relies upon simultaneous targeting of the genome and a donor molecule using highly 
efficient gRNAs that stimulate end resection in the genome and on the donor to 
reveal homology domains that are only 12, 24, or 48 bp in length. DNA repair using 
these short homologies proceeds through a pathway called Homology-Mediated End 
Joining (HMEJ). Using GeneWeld, 22 loci are targeted with integration activities in 
up to 100% of injected animals. Colleagues and I aimed to produce a suite of 
Golden Gate cloning compatible vectors, dubbed the pGTag Series, and a web tool 
with online protocol to aid researcher’s in designing homology arms to their locus of 
interest. The pGTag series allows researchers to target any site of interest using 
simple annealing of oligos and subsequent one-pot cloning reactions, decreasing the 
time from in silico design to in vivo experiments. Colleagues and I show that 
precision of gene targeting events is attainable as predicted and shows little somatic 
mosaicism, but that not all events are single copy, vector free integrations through 
the germline. We also demonstrate that genes can be simultaneously deleted and 
tagged using the GeneWeld strategy. Finally, GeneWeld is applied to exogenous 
DNA integration in pig and human cells in vitro. 
In Chapter 3 of this dissertation, I apply a novel CRISPR family nuclease, 
Mad7, to generating knock-outs in zebrafish. I further demonstrate Mad7 is an active 
nuclease that permits exogenous DNA integration using the GeneWeld strategy. 
Mad7 uses an alternate PAM sequence compared to Cas9, increasing genomic 
access to create alleles of interest. Mad7 is also applied to precision genome 
engineering in human cells.  
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In Chapter 4 of this dissertation, I describe the development of a genomic 
reporter to screen critical DNA repair pathway choice regulators in zebrafish strand 
annealing mediated DNA repair. We demonstrate that strand annealing mediated 
DNA repair activity in a genomic reporter is altered based on the chosen nuclease of 
interest, and propose overexpression of key proteins involved in differing steps of 
DNA repair will influence DNA repair pathway choice. 
The ability to predictably, reliably, and efficiently introduce new coding 
sequence at any locus of interest using only 48 bp of homology is a significant 
contribution to the field. The pGTag Vector Suite and GeneWeld strategy 
immediately allows researchers the ability to use short homology-based genome 
editing in their model system to create alleles in an efficient way. GeneWeld 
promotes recombination of exogenous DNA into pig and human chromosomes more 
efficiently than traditional HR approaches, opening the door to more complex edits 
like whole gene replacement using a “deletion-tagging” strategy. The work 
developed in this dissertation is poised for application to solve immediate problems 
in model organisms and gene therapy applications.  
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CHAPTER 2.    GENEWELD: A METHOD FOR EFFICIENT TARGETED 
INTEGRATION DIRECTED BY SHORT HOMOLOGY 
Modified from a paper submitted to the journal Developmental Cell 
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In Brief  
 Wierson et al. describe a targeted integration strategy, called 
GeneWeld, and a vector series for gene tagging, pGTag, which promote highly 
efficient and precise targeted integration in zebrafish, pig fibroblasts, and human 
cells. This approach establishes an effective genome engineering solution that is 
suitable for creating knock-in mutations for functional genomics and gene therapy 
applications. The authors describe high rates of germline transmission (50%) for 
targeted knock-ins at eight different zebrafish loci and efficient integration at safe 
harbor loci in porcine and human cells. 
 
Summary 
Choices for genome engineering and integration involve high efficiency with 
little or no target specificity or high specificity with low activity. Here, we describe a 
targeted integration strategy, called GeneWeld, and a vector series for gene tagging, 
pGTag (plasmids for Gene Tagging), which promote highly efficient and precise 
targeted integration in zebrafish embryos, pig fibroblasts, and human cells utilizing 
the CRISPR/Cas9 system. Our work demonstrates that in vivo targeting of a 
genomic locus of interest with CRISPR/Cas9 and a donor vector containing as little 
as 24 to 48 base pairs of homology directs precise and efficient knock-in when the 
homology arms are exposed with a double strand break in vivo. Given our results 
targeting multiple loci in different species, we expect the accompanying protocols, 
vectors, and web interface for homology arm design to help streamline gene 
targeting and applications in CRISPR compatible systems.  
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Introduction 
Designer nucleases have rapidly expanded the way in which researchers can 
utilize endogenous DNA repair mechanisms for creating gene knock-outs, reporter 
gene knock-ins, gene deletions, single nucleotide polymorphisms, and epitope 
tagged alleles in diverse species (Beumer, Trautman et al. 2008, Geurts, Cost et al. 
2009, Bedell, Wang et al. 2012, Carlson, Tan et al. 2012, Yang, Wang et al. 2013). A 
single dsDNA break in the genome results in increased frequencies of recombination 
and promotes integration of homologous recombination (HR)-based vectors (Orr-
Weaver, Szostak et al. 1981, Hasty, Rivera-Perez et al. 1991, Rong and Golic 2000, 
Zu, Tong et al. 2013, Shin, Chen et al. 2014, Hoshijima, Jurynec et al. 2016). 
Additionally, in vitro or in vivo linearization of targeting vectors stimulates homology-
directed repair (HDR) (Orr-Weaver, Szostak et al. 1981, Hasty, Rivera-Perez et al. 
1991, Rong and Golic 2000, Zu, Tong et al. 2013, Shin, Chen et al. 2014, Hoshijima, 
Jurynec et al. 2016). Utilizing HDR or HR at a targeted double-strand break (DSB) 
allows base-pair precision to directionally knock-in exogenous DNA, however, 
frequencies remain variable and engineering of targeting vectors is cumbersome.   
 Previous work has shown Xenopus oocytes have the ability to join or 
recombine linear DNA molecules that contain short regions of homology at their 
ends, and this activity is likely mediated by exonuclease activity allowing base 
pairing of the resected homology (Grzesiuk and Carroll 1987). More recently, it was 
shown in Xenopus, silkworm, zebrafish, and mouse cells that a plasmid donor 
containing short (≤40 bp) regions of homology to a genomic target site can promote 
precise integration at the genomic cut site when the donor plasmid is cut adjacent to 
the homology (Nakade, Tsubota et al. 2014, Hisano, Sakuma et al. 2015, Aida, 
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Nakade et al. 2016). Gene targeting is likely mediated by the alternative-end 
joining/microhomology-mediated end joining (MMEJ) pathway or by a single strand 
annealing (SSA) mechanism (Ceccaldi, Rondinelli et al. 2016). In contrast, in human 
cell culture, linear donors with homologous ends have been reported to show 
inefficient integration until homology domains reach ~600 bp (Zhang, Li et al. 2017), 
suggesting that different repair pathways may predominate depending on cell type. 
In the initial reports using short regions of homology for in vivo gene targeting in 
zebrafish, the level of mosaicism in F0 injected animals was high, resulting in 
inefficient recovery of targeted alleles through the germline (Nakade, Tsubota et al. 
2014, Hisano, Sakuma et al. 2015, Aida, Nakade et al. 2016). 
Here, we present GeneWeld, a strategy for targeted integration directed by 
short homology, and demonstrate increased germline transmission rates for 
recovery of targeted alleles. We provide a detailed protocol and a suite of donor 
vectors, called pGTag, that can be easily engineered with homologous sequences 
(hereafter called homology arms) to a gene of interest, and a web interface for 
designing homology arms (www.genesculpt.org/gtaghd/). We demonstrate that 24 or 
48 base pairs of homology directly flanking cargo DNA promotes efficient gene 
targeting in zebrafish, pig, and human cells with frequencies up to 10-fold higher 
than other HR strategies. Using short homology-arm mediated end joining, we can 
achieve germline transmission rates averaging approximately 50% across several 
zebrafish loci. Southern blot analysis in the F1 generation reveals that the 
GeneWeld strategy can yield alleles with precise integration at both 5’ and 3’ ends, 
as well as alleles that are precise on just one end. Finally, we present a strategy to 
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delete and replace up to 48kb of genomic DNA with a donor containing homology 
arms flanking two distal CRISPR/Cas9 sites in a gene. These tools and methodology 
provide a tractable solution to creating precise targeted integrations and open the 
door for other genome editing strategies using short homology. 
 
Design 
The GeneWeld strategy takes advantage of two simultaneous actions to 
initiate targeted integration directed by short homology (Fig. 1a). First, a high 
efficiency nuclease introduces a DSB in the chromosomal target. Simultaneously, 
a second nuclease makes a DSB in the pGTag vector integration cassette exposing 
the short homology arms. The complementarity between the chromosomal DSB and 
the donor homology arms activates a MMEJ/SSA or other non-NHEJ DNA repair 
mechanism, referred to as homology-mediated end joining (HMEJ). The reagents 
needed for this gene targeting strategy include Cas9 mRNA to express the Cas9 
nuclease, a guide RNA targeting the genomic sequence of interest, a universal 
gRNA (UgRNA) that targets two sites in the pGTag series donor vectors to expose 
the homology arms, and a pGTag/donor vector with gene specific homology arms 
(Fig. 1a). The universal gRNA (UgRNA) has no predicted sites in zebrafish, pig, or 
human genomes. Alternatively, a gene specific guide RNA can be used to expose 
homology arms in the donor vector. For simplicity we will refer to this set of reagents 
as ‘GeneWeld reagents’. Using GeneWeld reagents to target various loci, we 
demonstrate widespread reporter gene expression in injected F0 zebrafish embryos, 
porcine fibroblasts, and human K-562 cells, indicating efficient and precise in-frame 
integration in multiple species and cell systems.    
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Results 
A single homology domain of up to 48 bp drives efficient integration of RFP 
into noto 
To develop baseline gene targeting data, we engineered variable length 
homology domains to target noto. These lengths were based on observations that 
DNA repair enzymes bind DNA and search for homology in 3 or 4 base pair lengths 
(Supplementary Fig. 1a)  (Singleton, Wentzell et al. 2002, Conway, Lynch et al. 
2004). Upon injection of a noto sgRNA to target both the genome and one homology 
domain of a 2A-TagRFP-CAAX-SV40 donor vector, efficient integration was 
observed as notochord-specific RFP (Supplementary Fig. 1b, c, Supplementary 
Table 1-3). The frequency of RFP expression increased as the homology domain 
was expanded up to 48 bp (Supplementary Fig. 1b), while 192 bp of homology 
displayed reduced integration activity (data not shown). Somatic junction fragment 
analysis showed precise integration efficiencies reaching 95% of sequenced alleles 
(Supplementary Fig. 1d). Following these initial experiments, a 3 bp spacer 
sequence was included in all homology arm designs to separate the donor 
CRISPR/Cas9 target PAM and the homology domain and prevent arbitrarily 
increasing the length of the targeting domain, as single base pair alterations in the 
homology region can affect knock-in efficiency up to 2-fold (Supplementary Fig. 2).  
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Using the UgRNA to Liberate Donor Homology 
To simplify donor design and liberate donor cargo in vivo with reproducible 
efficiency, a UgRNA sequence, with no predicted targets in zebrafish, pig, or human 
cells, was designed based on optimal base composition (Supplementary Fig. 3a) 
(Moreno-Mateos, Vejnar et al. 2015). The target sequence for the UgRNA with a 
PAM sequence was cloned 5’ adjacent to the homology arm in a donor vector to 
direct a DSB for homology exposure. Experiments targeting noto with this UgRNA 
a c
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Figure 1. GeneWeld strategy and pGTag vector series (a) GeneWeld reagent components 
are designed for simultaneous genome and donor nuclease targeting to reveal short regions 
of homology. Red arrowheads represent in vivo designer nuclease DSBs. Components 
include: 1 - Designer nuclease mRNA, either Cas9 to target both the genome and donor, or 
Cas9 to target the donor and TALEN to cut the genome; 2 - sgRNA for targeting Cas9 to 
genome; 3 - Universal sgRNA to liberate donor cargo and homologous ends; and 4 - pGTag 
donor of interest with short homology arms. (b) Type IIs restriction endonucleases BfuAI and 
BspQI create incompatible ends outside of their recognition sequence, allowing digestion and 
ligation of both homology arms into the vector in a single reaction. Homology arm fragments 
are formed by annealing complementary oligonucleotides to form dsDNA with sticky ends for 
directional cloning into the vector. XFP = Green or Red Fluorescent Protein. pA = SV40 or β-
actin 3’ untranslated region. Red and green fluorescent proteins were cloned into the pGTag 
vectors, and for each color, subcellular localization sequences for either nuclear localization 
(NLSs) and membrane localization (CAAX) are provided (c) Schematic of GeneWeld 
targeting in vivo. After designer nuclease creates targeted double-strand breaks in the 
genome and donor, end resection likely precedes homology recognition and strand 
annealing, leading to integration of the donor without vector backbone. Red arrowheads 
represent in vivo designer nuclease DSBs.  
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donor plasmid resulted in RFP expression in the notochord in 21% of injected 
embryos, indicating correct targeting of noto and demonstrating the efficacy of 
Cas9/UgRNA to expose the single 5’ homology arm in the donor and drive precise 
Figure 2. HMEJ strategy promotes efficient somatic targeting of knock-in cassettes at 
different zebrafish loci. (a-d) Live confocal images of F0 injected embryos showing fluorescent 
reporter expression of noto-2A-eGFP-SV40 at mid somite stage (a, a’), cx43.4-2A-tagRFP-CAAX-
SV40 at 31 hours post fertilization (b, b’). Expression from UAS-RFP Tg(UAS:mRFP)tpl2 after 
injection with tyr-2A-Gal4VP16-β-actin at 5 days post fertilization (dpf) (c, c’), or esama-2A-
Gal4VP16-β-actin at 2 dpf (d) and 3 dpf (d’). (e) Reporter gene expression following targeting with 
HMEJ at noto, cx43.4, tyr, and esama results in a high proportion of injected F0 embryos 
displaying widespread signals. Homology lengths flanking donor cargos indicated by 24/24 or 
48/48, in base pairs. Data represents mean +/- s.e.m. of 3 independent targeting experiments. 
Scale bars, 100 µm. 
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integration (Supplementary Fig. 2b, 3c). The high frequency of RFP+ cells following 
injection of GeneWeld reagents suggests that repair of the DSB preferentially utilizes 
the homology in the targeting construct over the NHEJ pathway. 
 
Liberating Short Homology by Dual Targeting of Donor Vectors and Genomic 
Loci Directs Precise Integration in Somatic Tissue 
 We leveraged the activity of the UgRNA in the design of the pGTag 
vector series by including UgRNA target sites on both ends of the cargo (Fig. 1b). 
Homology arms can be simply added to the vectors using Golden Gate cloning. 
Cleavage by Cas9 at the UgRNA sites in the embryo or cell liberates the DNA cargo 
from the plasmid backbone and exposes both 5’ and 3’ homology arms for 
interaction with DNA on either side of the genomic DSB (Fig. 1c). Injection of 
GeneWeld reagents containing either 2A-TagRFP-CAAX-SV40 or 2A-eGFP-SV40 
donors targeting noto resulted in 24% of embryos showing extensive notochord 
expression of the reporter, indicating a similar targeting efficiency compared to 
targeting with 5’ homology alone (Fig. 2a, e; Supplementary Fig. 1, Table 1-3).  
To extend our results to other loci in zebrafish, we targeted different genes 
with 2A-TagRFP-CAAX-SV40 and varying homologies (Fig. 2, Supplementary Table 
1-4). GeneWeld reagents targeting connexin43.4 (cx43.4) with 24 and 48 bp of 
homology resulted in broad RFP expression throughout the nervous system and 
vasculature in 38 to 50% of the injected embryos (Fig. 2b, e). Together, these results 
suggest that 24 bp of homology directs targeted integration as efficiently as 48 bp.   
Targeting exon 4 of tyrosinase (tyr) with GeneWeld reagents did not result in 
detectable RFP signal, similar to previous reports (Hisano, Sakuma et al. 2015). 
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However, PCR junction fragments from injected larvae showed the 2A-TagRFP-
CAAX-SV40 donor was precisely integrated in frame into tyr exon 4 (Supplementary 
Fig. 5), suggesting RFP expression was below the threshold of detection. To amplify 
the fluorescent signal, we injected homology directed pGTag-2A-Gal4VP16-b�actin 
to integrate the transactivator Gal4VP16 into the tyr exon 4 target site in transgenic 
zebrafish embryos carrying a 14xUAS-RFP reporter, Tg(UAS:mRFP)tpl2 
(Balciuniene, Nagelberg et al. 2013). This resulted in strong RFP signal in 64% of 
injected animals; however, the embryos were highly mosaic compared to targeting 
2A-TagRFP-CAAX-SV40 into noto and cx43.4, with only 9% of RFP embryos 
displaying extensive expression throughout pigmented cells (Fig. 2c, e).  
Similar to tyr, GeneWeld reagents used for targeting 2A-TagRFP-CAAX-SV40 
into exon 2 of the esama gene did not result in detectable RFP expression, however, 
targeting pGTag-2A-Gal4VP16 in the Tg(UAS:mRFP)tpl2 transgenic background 
resulted in 21% of embryos displaying extensive RFP expression specifically in the 
vasculature (Fig. 2d, e). This approach was further extended to five additional loci, 
targeting 2A-Gal4VP16 to filamin a (flna), moesin a (msna), aquaporin 1a1 (aqp1a1), 
aquaporin 8a1 (aqp8a1), and annexin a2a (anxa2a). At these loci, transient 
expression of RFP was observed following injection in 4-55% of Tg(UAS:mRFP)tpl2 
embryos (Supplementary Table 1 and 2). Taken together, these results show that 
the application of GeneWeld reagents promotes high efficiency somatic integration 
following injection into zebrafish embryos.  
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Figure 3. Live confocal images of F1 zebrafish with inherited germline alleles of integrated 
GTag reporters.  (a, a’) Tg(noto-2A-TagRFP-CAAX-SV40) embryo at mid somite stage showing 
expression in the notochord and floor plate. (b, b’) Tg(tyr-2A-Gal4Vp16-β-actin) displaying expression 
in the melanocytes in a 5 dpf larva. (c, c’) Tg(esama-2A-Gal4Vp16- β-actin) larva showing expression 
in the vascular system at 4 dpf. (d, d’) Tg(flna-2A-Gal4VP16- β-actin) embryo at 1 dpf showing 
widespread expression. (e, e’ and f, f’) Tg(msna-2A-Gal4VP16- β-actin) targeted to either exon 2 or 
exon 6 showed expression in the central nervous system and vasculature at 2 dpf. (g, g’ and h, h’) 
Tg(aqp1a1-2A-Gal4VP16- β-actin) and Tg(aqp8a1-2A-Gal4VP16- β-actin) display expression in the 
trunk and tail vasculature at 2 dpf. All images are lateral views, and the Gal4VP16 integrations have 
Tg(UAS:mRFP)tpl2 in the background for visualization of expression. Scale bars are 100 µm.  
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Efficient germline transmission 
Three out of five (60%) noto-2A-TagRFP-CAAX-SV40 injected founder fish 
raised to adulthood transmitted noto-2A-TagRFP-CAAX-SV40 tagged alleles 
through the germline (Figure 3, Table 1, Supplementary Tables 3 and 4). For tyr-2A-
Gal4VP16-b�actin injections, 8 embryos with expression in the retinal pigmented 
epithelia were raised to adulthood and outcrossed. Of those, three founder animals 
transmitted tagged alleles to the next generation (37.5%) (Figure 3, Table 1 and 
Supplementary Table 3 and 4). Likewise, for esama-2A-Gal4VP16-β-actin, 18 F0s 
displaying widespread vasculature RFP expression were raised to adulthood, and 12 
(66.7%) transmitted esama-2A-Gal4VP16-β-actin alleles to the F1 generation. We 
have extended these results to flna, two different target sites in msna (exon 2 and 6), 
aqp1a1, aqp8a1, and anxa2a with a combined F0 transmission rate of 49% across 
all loci (Figure 3, Table 1, Supplementary Tables 3 and 4). Taken together, these 
results indicate GeneWeld reagents which efficiently promote targeted integration in 
zebrafish F0s based on reporter expression are also efficiently transmitted through 
the germline.  
 
Precise 5’ and 3’ junctions and single copy integration in F1s 
Given that homology was present on both sides of the pGTag constructs used 
for targeting, it was expected that precise integration would occur at both 5’ and 3’ of 
the genomic cut site. Genomic Southern blot analyses of four F1s from two of the 
noto-2A-TagRFP-CAAX-SV40 founders confirmed a single copy integration in noto 
exon 1 (Fig. 4, a-c). Progeny from the first founder had precise integrations at the 5’  
49 
 
F1-4F1-3F1-2F1-1WIK10 1
F1-4F1-3F1-2F1-1WIK
tyr F0 #1
Ex Exon 5
BglIBglI
on 42A-GAL4/VP16-pAExon 3Exon 2
tyr probe
7400 
1740 
GAL4/VP16 
probe
4899 bp
6106 bp
7427 bp
4899 bp
6106 bp
7427 bp
G
al
4/
VP
16
 p
ro
be
tyr
 p
ro
be
* * * *
d
e
 10    1  WIK  1     2     3    4    5     6     7     8
3639 bp
2799 bp
1953 bp
1482 bp
 10     1    WIK   1     2      3     4     5      6      7    8
3639 bp
2799 bp
1953 bp
1482 bp
noto F0 #1         noto F0 #2
RF
P 
pr
ob
e
b
c
a  noto
no
to
 p
ro
be
noto F0 #1           noto F0 #2
tyr F0 #1
Figure 4
f
Exon 1 Exon 2 Exon 3
SpeIEcoRV
1342 bp
noto probe
Ex Exon 2 Exon 3
SpeIEcoRV
2524 bp
on 12A-RFP-pA
Ex Exon 2 Exon 3on 12A-RFP-pA
SV40f
flhSBr
Ex Exon 32A-RFP-pA
SV40f
~271 bp
Expected integration before Southern Blot
Predicted integration from noto F1s from F0 #1
2
Ex Exon 2 Exon 3on 12A-RFP-pA
SV40f
flhjxnr
~2000 bp of vector bacbone
Predicted integration from noto F1s from F0 #2
noto probeRFP probe
tyr
Figure 4. Molecular analysis of F1 embryos from gene targeting experiments at noto and 
tyr. (a-c) Tg(noto-2A-RFP) F1 targeted integration alleles from 2 independent F0 founders. (a) 
noto gene model with location of restriction enzymes used for genomic Southern blot analysis. 
Location of the 513 bp noto probe is indicated (dark lines). The predicted and recovered alleles 
are shown. (b) Southern blots of F1 Tg(noto-2A-RFP) individuals hybridized with RFP probe. F1 
from founder F0#1 contain a ~2100 bp band corresponding to integration plus deletion of ~400 bp 
in noto. F1 progeny from founder F0#2 show two bands: a ~3700 bp band corresponding to 
integration of the reporter plus 2000 bp of vector backbone, and a ~1500 bp band which may 
represent an off-target integration. Loading controls (10, 1) correspond to 10 copies or 1 copy of 
RFP containing plasmid. WIK, wild type control DNA. 
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end of the target site but contained an ~400 bp deletion downstream extending into 
exon 2. The second founder produced offspring with an allele with precise 5’  
integration and also included an insertion at the 3’ end, likely to be a segment of the 
vector backbone based on the size of the insert on Southern blot. Sequencing of 
junction fragments from the first founder confirmed that NHEJ drove integration at 
the 3’ end rather than a homology-based mechanism which was not expected (Fig. 
4, Supplementary Fig. 4). In contrast, Southern blot analysis and sequencing of tyr-
2A-Gal4VP16-b-actin F1 progeny demonstrated a single copy integration of the 
Gal4VP16 cassette with precise integration at both 5’ and 3’ ends (Fig. 4, d-f, 
Supplementary Fig. 4, 5).  
Junction fragment analysis of F1s from each of seven transmitting loci 
indicated precise events were primarily recovered at the 5’ for all the genes 
examined (30/31 or 97% across seven genes) (Supplementary Fig. 4). This result is 
expected as precise 5’ integrations are selected for by screening for expression of 
the report from the donor cassette.  For esama, the 3’ junctions were also precise in 
9/10 of the F1s examined from 6 different F0s, and both aqp1a1 and app8a1 had 
precise 3’ junctions. This is compared to msna E2 targeting with 2A-Gal4VP16-b-
actin, where only one out of the 12 F1s examined had a precise 3’ junction. 
Figure 4. Molecular analysis of F1 embryos from gene targeting experiments at noto and 
tyr continued.  (c) Southern blot in (b) stripped and re-hybridized with the noto-specific probe. A 
1342 bp band representing the wild type allele was detected in all individuals. The integration 
allele in F1s from F0 #1 was not detected due to deletion of the region containing the probe. F1s 
from F0 #2 contain the ~3700 bp band corresponding to the noto-2A-RFP integration allele. (d, e) 
Molecular analysis of Tg(tyr-2A-GAL4/VP16) F1 offspring from a single targeted F0 founder. (d) 
Schematic of expected integration pattern for tyr targeted with pGTag-2A-GAL4/VP16. 148 bp tyr 
probe in Exon 3 and 583bp probe in GAL4/VP16 are indicated. (e) GAL4/VP16 and (f) tyr probed 
Southern blots of genomic DNA from wild type (WIK) and 4 individual GAL4/VP16 positive F1s. 
The expected 7400 bp band is detected with both probes, suggesting a single copy integration. 
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Together, these results indicate that GeneWeld reagents can promote precise single 
copy integration at a genomic cut site without vector sequences, although events 
involving NHEJ at the at the 3’ end are also recovered. 
 
Homology Engineered to Distal Genomic gRNA Sites Seeds Deletion Tagging 
in Somatic Tissue  
To further demonstrate the utility of GeneWeld reagents, we tested whether 
the pGTag donors could function to bridge two CRISPR/Cas9 genomic cuts, 
resulting in simultaneous deletion of endogenous sequences and integration of 
exogenous DNA to create a “deletion tagged” allele. The pGTag-2A-Gal4VP16 
donor was cloned with homology arms to two gRNA target sites in the zebrafish 
retinoblastoma1 (rb1) gene. The two gRNA sites were located in exons 2 and 4, 
which are located 394 bp apart, or in exons 2 and 25 which are separated by ~48.4 
kb (Fig. 5a). The 5’ homology arm contained sequence upstream of the cut site in 
exon 2, while the 3’ homology arm contained sequence downstream of the cut site in 
either exon 4 or exon 25. Injection of GeneWeld reagents with the corresponding 
exon 2-exon 4 or exon 2-exon 25 pGTag-2A-Gal4VP16-β-actin donor into 
Tg(UAS:mRFP)tpl2 embryos resulted in 59% and 60%, respectively, of injected 
embryos showing broad and ubiquitous RFP expression (Fig. 5b-c, f, Supplementary 
Table 1,2). Somatic junction fragment analysis showed precise integration at both 
the 5’ (29/30 or 97% of the fragments analyzed) and 3’ ends (20/30 or 67%) of rb1 
(Supplementary Fig. 6). Increasing the size of the deleted region from 394 bp to 48.4 
Kb did not affect the frequency of reporter integration. One out of 16 F0 founders 
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screened (6%) transmitted a precise 5’ junction through the germline, but the 3’ 
junction could not be amplified by PCR (Supplementary Table 3, 4).  
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Figure 5. Deletion tagged alleles created with the HMEJ strategy during zebrafish 
embryogenesis. (a) Schematic for Gal4VP16 reporter integration to tag a deletion allele of rb1 
exons 2-4 (top) and rb1 exons 2-25 (bottom). Arrowheads designate CRISPR/Cas9 DSBs. 
CRISPR gRNAs in two exons are expected to liberate the intervening genomic DNA. The 
targeting vector to replace the liberated genomic sequence, contains a 5’ homology arm to the 
upstream exon and a 3’ homology arm to the downstream exon inside of uGuide sites. (b, b’) Live 
confocal image of F0 Tg(UAS:mRFP)tpl2 embryo deletion tagged at rb1 exons 2-4, and (c, c’) 
deletion tagged at rb1 exons 2-25 by integration of 2A-Gal4VP16-β-actin . (d) Schematic for 
Gal4VP16 deletion tagging of msna exons 2-6. (e, e’) Live confocal image of F0 
Tg(UAS:mRFP)tpl2 embryo deletion tagged at msna exons 2-6 with 2A-Gal4VP16-β-actin. (f) 
Somatic reporter efficiency of targeted deletion tagging using 48 bp homology arms for rb1 exons 
2-4, rb1, exons 2-25 and msna exons 2-6. Data represents mean +/- s.e.m. of 4 (rb1) and 5 
(msna) independent targeting experiments. Scale bars in b, c, c’, e are 200 µm and  b’, e’ are 100 
µm. 
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Using the same approach, we targeted the zebrafish gene moesina (msna) at 
exons 2 and 6, located 7.8 kb apart, with 2A-Gal4VP16-b�actin using 48 bp of 
homology. This resulted in 63% of embryos displaying RFP in a pattern consistent 
with the expression of msna (Fig. 5d-f, Supplementary Table 1,2). Somatic junction 
fragment analysis showed precise integration at both the 5’ (11/13 or 85% of the 
fragments analyzed) and 3’ ends (9/20 or 45%) of msna (Supplementary Fig. 6). Of 
the 10 F0 zebrafish raised to adulthood, none transmitted a deletion tagged allele to 
the next generation. In contrast, targeting 2A-Gal4VP16-b�actin to exon 2 or 6 alone 
resulted in 2 out of 7 F0s transmitting a targeted allele to the next generation 
(Supplementary Table 3, 4).  
Together, these results demonstrate simultaneous targeting of two distal 
genomic cut sites can create integration at both ends of a pGTag reporter cassette 
by HMEJ in somatic tissue, but these events are not easily passed through the 
germline. This was reinforced by attempting deletion tagging at additional loci, 
including kdrl, s1pr1, and vegfaa, which showed 32-81% expression in F0s, but no 
germline transmission to F1s (Supplementary Table 2).  
 
Integration of Exogenous DNA Using HMEJ in Porcine and Human Cells is 
More Efficient than HR 
To determine if HMEJ integration directed by short homology functions 
efficiently in large animal systems, we tested the GeneWeld targeting strategy in S. 
scrofa fibroblasts. The ROSA26 safe harbor locus was targeted with a cassette that 
drives ubiquitous eGFP expression from the UbC promoter (Fig. 6a-c). GeneWeld 
reagents, where the genomic sgRNA was replaced with mRNAs encoding a TALEN  
54 
 
Figure 6. HMEJ-based targeted integration with UgRNA-based vectors promotes efficient 
knock-in in porcine fibroblasts and human K-562 cells. (a) Strategy for integration using 
HMEJ and HR donors into intron 1 of S. scrofa ROSA26 locus. Arrow heads CRISPR/Cas9 (for 
HMEJ donor) and TALEN (genome) DSBs. (b) Targeting efficiency of the HMEJ donor vs the 
HR donor as reported by GFP positive colonies out of total colonies. (c) Percent of GFP positive 
colonies analyzed containing properly sized junction fragments, comparing HMEJ and HR 
donors. Data are from three independently targeted cell populations. Data represents mean +/- 
s.e.m. of 3 independent targeting experiments. (d) Diagram of HR and HMEJ strategies for 
targeted integration of a MND:GFP reporter cassette into the human AAVS1 locus. (e) Flow 
cytometry analysis of GFP expression 14 days post-electroporation for each targeting modality: 
HR (left), HMEJ without universal sgRNA (middle), and HMEJ with universal sgRNA (right). 
Stable gate was drawn to measure the uniformly expressing population formed by targeted 
integration and was set based on episome only controls. (f) Quantitation of stable GFP 
expressing population as measured by flow cytometry at day 14. Data are from three 
independently targeted cell populations. Data represents mean +/- s.e.m. of 3 independent 
targeting experiments. p values calculated using two-tailed unpaired t-test. 
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pair to generate a genomic DSB in the first intron of ROSA26, were delivered to pig 
fibroblasts by electroporation. This strategy was compared to cells electroporated 
with just the TALEN pair and a HR donor containing approximately 750 bp of 
homology flanking the genomic target site. GFP expression was observed in 23% of 
colonies using GeneWeld reagents, compared to 2% of colonies using the HR donor 
with ~750 bp homology arms. Co-occurring precise 5’ and 3’ junctions were 
observed in over 50% of the GFP+, GeneWeld engineered colonies while none of 
the GFP+, HR colonies contained both junctions. Sequencing of junctions from 8 
GFP+, GeneWeld engineered colonies that were positive for both junctions showed 
precise integration in 7/8 colonies at the 5’ junction and 8/8 colonies at the 3’ 
junction.  
The GeneWeld strategy was also used to target integration of a MND:GFP 
reporter (Halene, Wang et al. 1999) into the AAVS1 safe harbor locus in human K-
562 cells (Fig. 6d-f). Integrations were attempted with either GeneWeld reagents or 
an HR donor targeting the AAVS1 cut site by electroporation of K-562 cells. Cells 
were FACs sorted by GFP at day 14 following electroporation. With GeneWeld 
reagents over 50% of cells were GFP positive, compared to only 6% of cells 
electroporated with the HR donor. This suggests the GeneWeld strategy promoted 
efficient integration and stable expression of the MND:GFP cassette at the AAVS1 
locus (Supplementary Fig. 7).  Expression was maintained over 50 days, and 5’ 
precise junction fragments were observed following PCR amplification in bulk cell 
populations (Supplementary Fig. 8). The results above demonstrate that the 
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GeneWeld strategy outperforms traditional HR techniques in mammalian cell 
systems and is effective without antibiotic selection. 
 
Discussion 
 The results described here demonstrate the utility of short homology-
based gene targeting for engineering precise integration of exogenous DNA and 
expand the potential of efficient tagging to diverse loci with differing endogenous 
expression levels. We show that using short homology to bridge distal ends together 
simultaneously creates a deletion and a reporter integration, however, these events 
are not easily passed through the germline.  We demonstrate efficient integration of 
cargos up to approximately 2 kb in length in zebrafish, pig fibroblasts, and human 
cells. Both CRISPR/Cas9 and TALENs are effective as GeneWeld genomic editors, 
providing flexibility in deployment and genome-wide accessibility. 
Several components of the GeneWeld strategy may lead to enhanced 
somatic and germline targeting efficiencies in zebrafish as compared to previous 
reports (Hisano et al., 2015). Canonical NHEJ is highly active during rapid cell 
divisions in early zebrafish embryogenesis (Bedell, Wang et al. 2012). However, 
given the correct sequence context surrounding the dsDNA break, MMEJ is the 
preferred method of non-conservative repair (He, Zhang et al. 2015, Kent, 
Chandramouly et al. 2015, Ata, Ekstrom et al. 2018). GeneWeld homology arms are 
rationally designed based on the known homology searching activity of RAD51 and 
strand annealing activity of RAD52 (Singleton, Wentzell et al. 2002, Conway, Lynch 
et al. 2004). In our experiments at noto, gene targeting is significantly reduced when 
48 bp homology arms are altered by 1 bp to 47 or 49 bp (Supplementary Fig. 3). 
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This suggests that optimal short homology arms should be designed in groups of 3 
and/or 4 bp increments. We are currently testing this hypothesis further. Additionally, 
Shin et al., 2014 showed the highest rates of somatic targeting when their donor was 
linearized in vitro inside a ~1 kb 5’ homology arm, leaving 238 bp of homology 
flanking the knock-in cargo. Thus, it is tempting to speculate that gene targeting in 
these experiments proceeded not through HR, but through other related HMEJ DNA 
repair pathway more similar to the findings presented here.  
The dramatic shift of DNA repair at genomic DSBs from cis-NHEJ to trans-
HMEJ using GeneWeld donors likely also influences enhanced editing of the 
germline. Across all zebrafish experiments with germline transmission, 49% of 
founders transmitted tagged alleles, with 17.4% of gametes carrying the edited allele 
of interest (Supplementary Table 3, 4), demonstrating decreased germline 
mosaicism and increased germline transmission from previous reports. Given that 
our somatic knock-in and germline transmission rates are higher than published 
reports, we conclude that GeneWeld is a more effective homology-based method for 
generating precisely targeted knock-in alleles in zebrafish. 
 While targeting noto with 5’ only homology shows an increase in 
targeting efficiency with longer homology, increasing homologies on both ends of the 
cargo DNA did not increase targeting efficiency (Fig. 2e). Positive events are 
selected only by fluorescently tagged alleles, indicating precise 5’ integration 
patterns. We speculate that inclusion of homology at the 3’ end of our cargo creates 
competition for the donor DNA ends, as not all editing events are precise at both 5’ 
and 3’ junctions (Fig. 4 and Supplementary Fig. 4). Thus, it is conceivable that 
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precise events at the 3’ end could preclude precise integration at the 5’ end during 
some editing events, and vice versa. It is tempting to speculate that this data hints at 
synthesis dependent strand annealing (SDSA) as a possible DNA repair mechanism 
for pGTag donor integration (Ceccaldi, Rondinelli et al. 2016). After strand invasion 
using either of the homology domains and replication through the reporter, second 
DNA end capture may abort before or after replication through the opposing 
homology domain, resulting in imprecision, as greater than or equal to 150 bp is 
required for proper second end capture in yeast (Mehta, Beach et al. 2017). 
Experiments to address this hypothesis by varying homology arm lengths flanking 
the donor cassettes and including negative selection markers are of note for future 
work in determining the genetic mechanisms that promote efficient integration. 
Timing and turnover of Cas9 during the genomic editing event can influence 
cut efficiency and somatic mosaicism/germline transmission rates (Clarke, Heler et 
al. 2018, Zhang, Zhang et al. 2018), increasing the interest of using RNP during all 
precision gene editing applications. However, we were unable to observe 
fluorescence following injection of GeneWeld components with RNPs or detect 
targeted integrations at a high frequency (unpublished data). We hypothesize this is 
due to Cas9 and UgRNA locating and binding to the UgRNA sites on the pGTag 
donors during dilution of the injection mixture. This heteroduplex either activates 
DSBs on the donor in vitro, or directly after injection, before the genomic gRNA can 
locate and cut the genome. Thus, the stochastics of DNA end availability are altered 
using RNPs and integration activity is greatly reduced. Injection of the GeneWeld 
plasmid donor and RNPs in separate injection mixtures does not produce integration 
59 
in zebrafish embryos (unpublished data).  Further experiments could address these 
limitations through the use of inducible nuclease systems.  
Targeting genes with lethal phenotypes, such as tumor suppressors or other 
genes required for embryogenesis, is of interest to the zebrafish community. 
However, using fluorescence to screen for targeted events can be misleading. For 
example, the RFP signal is dramatically reduced or lost upon biallelic inactivation of 
noto, likely when notochord cells transfate to muscle cells (Talbot, Trevarrow et al. 
1995, Melby, Warga et al. 1996). Additionally, though deletion tagging using two 
target sites in the genome seems to be robust in somatic tissue, germline 
transmission of deletion tags is rare. This suggests that edited germ cells may be 
lost to apoptosis due to the additional cut in the genome, or that heterozygous 
deletion tagged alleles are recognized during homologous chromosome pairing and 
are repaired or lost as germ cells mature. Similar susceptibility of stem cells to 
apoptosis following gene editing has been previously observed (Ihry, Worringer et al. 
2018, Li, Li et al. 2018). In both of these cases, it may be necessary to modulate 
GeneWeld reagent concentrations in order to avoid biallelic inactivation of the 
genomic target, or to ensure homozygous deletion tagging.  
Amplification of the fluorescence signal using GAL4/VP16 allowed us to target 
several genes for which we did not observe a fluorescence report from integration of 
a fluorescent protein directly. While this approach is advantageous for selecting 
correctly targeted embryos to examine for germline integration, GAL4/VP16 may 
have toxic effects as reported previously (Ogura, Okuda et al. 2009). For example, 
we found dominant phenotypes in the F1 generation for both msna and flna which 
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could reflect toxicity from high levels of expression of GAL4/VP16. Alternatively, 
these gene could also display haploinsufficiency or express a partial protein product 
that functions in a dominant manner. Heterozygous msna mutants targeting exon 5 
in the F1 generation display phenotypes similar to morpholino targeting of this gene 
(Wang, Kaiser et al. 2010) (data not shown), suggesting haploinsufficiency or a 
dominant negative peptide is a likely explanation.  
GeneWeld is also an effective strategy to precisely control exogenous DNA 
integration in mammalian cell lines. While our data shows an approximate 10-fold 
increase in targeted integration using 48 bp of homology to drive HMEJ versus HR, 
Zhang et al. (2017) concluded that targeted integration did not appreciably increase 
until homology arms of ~600 bp were used (Zhang, Li et al. 2017). However, this 
could reflect differences in the experimental design or cell types used and suggest 
different DNA repair pathways may be more prevalent in certain conditions. 
Deciphering the DNA repair pathway used for HMEJ in zebrafish and mammalian 
cells is paramount to increasing editing efficiencies in basic research and for gene 
therapy.  
Given the high efficiency and precision of GeneWeld, additional applications 
to efficiently introduce other gene modifications, such as single or multiple nucleotide 
polymorphisms, by exon or gene replacement is possible using the deletion tagging 
method. Further, GeneWeld could be used to create conditional alleles by targeting 
conditional gene break systems into introns (Clark, Balciunas et al. 2011). In 
conclusion, our suite of donor vectors with validated integration efficiencies, 
methods, and web interface for pGTag donor engineering will serve to streamline 
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experimental design and broaden the use of designer nucleases for homology-
based gene editing at CRISPR/Cas9 and TALEN cut sites in zebrafish. We also 
demonstrate an advanced strategy for homology-based gene editing at 
CRISPR/Cas9 and TALEN cut sites in mammalian cell lines. Our results open the 
door for more advanced genome edits in animal agriculture and human therapeutics. 
 
Methods 
Contact for reagent and resource sharing 
Further information and requests for resources and reagents should be 
directed to and will be fulfilled by the Lead Contact, Jeffrey Essner 
(jessner@iastate.edu). 
 
Experimental model and subject details 
Zebrafish were maintained in Aquatic Habitats (Pentair) housing 
on a 14 hour light/10 hour dark cycle. Wild-type WIK were obtained from the 
Zebrafish International Resource 
Center. The Tg(miniTol2/14XUAS:mRFP, γCry:GFP)tpl2, shortened 
to Tg(UAS:mRFP)tpl2, was previously described (Balciuniene, Nagelberg et al. 
2013). All experiments were carried out under approved protocols from Iowa State 
University IACUC.   
The human K-562 chronic myelogenous leukemia cell line (ATCC CCL-243) 
used in gene targeting experiments was cultured at 37oC in 5% CO2 in RPMI-1640 
(Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS) and 
Penicillin/Streptomycin.  Electroporation was conducted with 1.5 x 105 cells in a 10 µl 
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tip using the Neon electroporation device (Thermo Fisher Scientific) with the 
following conditions: 1450V, 10ms, 3x pulse. Nucleic acid dosages were as follows: 
1.5 �g Cas9 mRNA (Trilink Biotechnologies), 1 �g each chemically modified sgRNA 
(Synthego), and 1 �g donor plasmid. 
 Fibroblasts were cultured in DMEM (high glucose) supplemented to 
10% vol/vol FBS, 20 mM L-glutamine and 1X Pen/ Strep solution and transfected 
using the NeonTM system (Invitrogen).  Briefly, 1 x 106 fibroblasts were transfected 
with 1 ug of polyadenylated ROSA TALEN mRNA, 1 �g of universal gRNA mRNA, 1 
�g of polyadenylated Cas9 mRNA and 1 �g of donor plasmid.  Transfected cells 
were cultured for 3 days at 30oC before low density plating, extended culture (10 
days) and colony isolation.  Individual colonies were aspirated under 
gentle trypsanization, replated into 96- well plates and cultured for 3-4 days.  
 
pGTag series vectors   
To build the pGTag vector series, 2A-TagRFP, 2A-eGFP, and 2A-Gal4/VP16 
cassettes were assembled from a 2A-TagRFP-CAAX construct, p494. To clone 
the eGFP cassette, the plasmid p494 was amplified with primers F-p494-XhoI and 
R-p494-SpeI to generate unique enzyme sites in the backbone. The eGFP coding 
sequence (Clontech Inc.) was amplified with the primers F-eGFP-SpeI and R-eGFP-
XhoI to generate the corresponding enzyme sites on the eGFP coding 
sequence. Fragments were digested with SpeI-HF 
and XhoI (NEB) and following column purification with the Qiagen miniprep protocol, 
were ligated to the plasmid backbone with T4 ligase (Fisher).     
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The Gal4/VP16 coding sequence and zebrafish b-actin 3’ untranslated 
region was amplified from vector pDB783 (Balciuniene, Nagelberg et al. 2013) with 
primers F-2A-Gal4-BamHI and R-Gal4-NcoI to add a 2A peptide to the 5’ end of 
the Gav4Vp16 cDNA. The resulting PCR product was then cloned into the 
intermediate Topo Zero Blunt vector (Invitrogen) and used for mutagenesis PCR 
with primers F and R ‘-gal4-Ecofix’ to disrupt the internal EcoRI restriction site. The 
resulting Gal4/VP16 sequence was cloned into the BamHI and NcoI sites in the 
p494 backbone.   
The 5’ universal/optimal guide site and lacZ cassette were added to pC-2A-
TagRFP-CAAX-SV40, pC-2A-eGFP-SV40, and pC-2A-Gal4VP16-b-actin with the 
following steps. The lacZ was first amplified with primers F-lacZ and R-lacZ, which 
add the type IIS enzyme sites to either end of the lacZ. The resulting PCR product 
was then cloned into an intermediate vector with the Zero Blunt® TOPO® PCR 
Cloning Kit (Invitrogen). This intermediate was used as a template in a nested PCR 
to add the Universal guide sequence GGGAGGCGTTCGGGCCACAGCGG 
to the end of the lacZ sequence. The nested PCR used primers F-lacZ-universal-
1 and R-lacZ-universal-BamHI to add the first part of the universal guide to one end 
and a BamHI site to the other.  This was used as template for PCR with the 
primers F-lacZ-universal-EcoRI and R-lacZ-universal-BamHI to add the remainder of 
the universal guide and an EcoRI site. The fragment was column purified as above, 
digested with EcoRI-HF and BamHI-HF and cloned into the appropriate sites in the 
three vectors.   
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The 3’ universal guide and type 2 restriction enzyme sites were cloned into 
each vector in two steps. A segment from a Carp beta-actin intron containing a 99 
bp spacer flanked by two BspQI sites was amplified using the primers F-3’-uni-1 and 
R-3’-uni-1 to add the universal site to one side of the spacer. This product was 
column purified as above and used as template for the second amplification with 
primers F-3’-uniNco1 and R-3’-uniEagI to add cloning sites. This product was 
column purified and cloned using the Topo zero blunt kit. This intermediate was 
digested with NcoI-HF and EagI, and the BspQI fragment purified and cloned into 
the three vectors as above.  Ligations were grown at 30oC to reduce the possibility 
of recombination between the two universal guide sites.   
Correct clones for pU-2A-TagRFP-CAAX-U, pU-2A-eGFP-U, and pU-2A-
Gal4/VP16-U were selected and used as template for mutagenesis PCR with 
KOD to remove extra BspQI sites from the backbone with primers F/R-BBfix, 
digested with DpnI (NEB), and ligated with T4 ligase. A correct pU-2A-TagRFP-
CAAX-U clone was used as template for PCR with F/R-TagRFPfix to interrupt 
the BspQI site in the TagRFP coding sequence as above. A correct clone of pU-2A-
Gal4/VP16-U was selected and used as template with primers F/R-Bactfix to remove 
the BspQI site in the Beta-actin terminator, the product was re-cloned as above. All 
constructs were sequence verified.   
 
Homology arm design and donor vector construction   
For detailed methods, see Supplementary gene targeting protocol. In brief, 
homology arms of specified length directly flanking a genomic targeted double 
strand break were cloned into the pGTag vector, in between the UgRNA sequence 
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and the cargo. A three nucleotide buffer sequence lacking homology to the genomic 
target site was engineered between the donor UgRNA PAM and the homology arms, 
in order to maintain the specified homology arm length. See Supplementary Table 4 
for all homology arms, gRNA target sites, and spacers.   
  
Zebrafish embryo injection  
pT3TS-nCas9n was a gift from Wenbiao Chen (Addgene plasmid # 
46757). XbaI linearized pT3TS-nCas9n was purified under RNase-free conditions 
with the Promega PureYield Plasmid Miniprep System. Linear, purified pT3TS-
nCas9n was used as template for in vitro transcription of capped, polyadenylated 
mRNA with the Ambion T3TS mMessage mMachine Kit. mRNA was purified using 
Qiagen miRNeasy Kit. The genomic and universal sgRNAs were generated using 
cloning free sgRNA synthesis as described in (Varshney, Pei et al. 
2015) and purified using Qiagen miRNeasy Kit. Donor vector plasmid DNA was 
purified with the Promega PureYield Plasmid Miniprep System. noto, cx43.4, 
tyrosinase, and moesina, were targeted by co-injection of 150 pg of nCas9n mRNA, 
25 pg of genomic sgRNA, 25 pg of UgRNA (when utilized), and 10 pg of donor DNA 
diluted in RNAse free ddH2O. The rb1 targeting mixture contained 300 pg nCas9n 
mRNA. 2 nl was delivered to each embryo.   
  
Recovery of zebrafish germline knock-in alleles  
Injected animals were screened for fluorescence reporter expression on a 
Zeiss Discovery dissection microscope and live images captured on a Zeiss LSM 
700 laser scanning confocal microscope. RFP/GFP positive embryos were raised to 
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adulthood and outcrossed to wildtype WIK adults to test for germline transmission of 
fluorescence in F1 progeny. tyr, esama, rb1 and msna embryos targeted with 
Gal4VP16 were crossed to Tg(UAS:mRFP)tpl2.   
  
DNA isolation and PCR genotyping  
Genomic DNA for PCR was extracted by digestion of single embryos in 
50mM NaOH at 95oC for 30 minutes and neutralized by addition of  1/10th volume 
1M Tris-HCl pH 8.0. Junction fragments were PCR-amplified with primers listed 
in Supplementary Table X and the products TOPO-TA cloned before sequencing.  
  
Southern blot analysis  
Genomic Southern blot and copy number analysis was performed 
as described previously (McGrail, Hatler et al. 2011). PCR primers used for genomic 
and donor specific probes are listed in Supplementary Table 6.  
  
Junction fragment analysis in pig fibroblasts  
Individual colonies were scored for GFP expression and prepared for PCR by 
washing with 1X PBS and resuspension in PCR-safe lysis buffer (10 mM Tris-Cl, pH 
8.0; 2 mM EDTA; 2.5% (vol/vol) Tween-20; 2.5% (vol/vol) Triton-X 100; 100 μg/mL 
Proteinase K followed by incubation at 50oC for 60 min and 95oC for 15 min.  PCR 
was performed using 1X Accustart Supermix (Quanta) with the primers: 5’ junction 
F-5’ TAGAGTCACCCAAGTCCCGT-3’, R-5’- ACTGATTGGCCGCTTCTCCT-3’; 3’ 
junction F-5’- GGAGGTGTGGGAGGTTTTT-3’, R-5’- 
TGATTTCATGACTTGCTGGCT-3’. ROSA TALEN sequences are:  TAL FNG 
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NI NI HD HD NG NN NI NG NG HD NG NG NN NN; TAL RHD NN NG NI HD NI 
HD HD NG NN HD NG HD NI NI NG.  
  
K-592 Flow Cytometry  
K-562 cells were assessed for GFP expression every 7 days for 28 days 
following electroporation. Flow cytometry was conducted on an LSRII instrument 
(Becton Dickinson) and data was analyzed using FlowJo software v10 (Becton 
Dickinson). Dead cells were excluded from analysis by abnormal scatter profile and 
exclusion based on Sytox Blue viability dye (Thermo Fisher Scientific).   
Junction PCR to detect targeted integration was conducted using external 
genomic primers outside of the 48bp homology region and internal 
primers complementary to the expression cassette. PCR was conducted 
using Accuprime HIFI Taq (Thermo Fisher Scientific). PCR products from bulk 
population were sequenced directly.   
 
Quantification and statistical analysis 
Statistical analysis was performed using GraphPad Prism software. Data 
plots represent mean +/- s.e.m. of n independent experiments, indicated in the text. 
p values were calculated with two-tailed unpaired t-test. Statistical parameters are 
included in the figure legends. 
 
Data and software availability  
The webtool GTagHD  was developed to assist users in designing 
oligonucleotides for targeted integration using the pGTag vector 
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suite. GTagHD guides users through entering: 1) the guide RNA for cutting their 
cargo-containing plasmid; 2) the guide RNA for cutting their genomic DNA 
sequence; (3) the genomic DNA sequence, in the form of 
a GenBank accession number or copy/pasted DNA sequence; and 4) the length of 
microhomology to be used in integrating the plasmid cargo. If the user is utilizing one 
of the pGTag series plasmids, GTagHD can also generate a 
GenBank/ApE formatted file for that plasmid, which includes the user's incorporated 
oligonucleotide sequences. GTagHD is freely available online 
at http://genesculpt.org/gtaghd/ and for download at https://github.com/Dobbs-
Lab/GTagHD.  
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Supplementary Figure 1. Short homology to the noto gene from a single homology arm 5’ 
to the gRNA target site targets integration in zebrafish embryos. (a) Schematic for noto 
homology arm and donor vector design. gRNA is the noto non-coding template strand. Black 
bars represent 12, 24, and 48 bp homology arms. PAM sequences are underlined. (b) Targeting 
efficiency of 12, 24, and 48 bp noto 5’ only donors. Data represents mean +/- s.e.m. of 3 
independent targeting experiments. p values calculated using two-tailed unpaired t-test. (c) Live 
confocal image of noto-2A-TagRFP-CAAX-SV40 targeted embryo showing specific RFP 
expression in the notochord. Scale bar is 100 µm. (d) Sanger sequencing of cloned 5’ junction 
fragments from RFP positive F0 embryos, aligned to the expected sequence from a precise 
integration event. 
 
12 base pair homology arm
                    noto  <  12 bp  > 2A
Precise junction – ACCAACCAAACGCCTGTCGGATCC
Emb. 1 allele 1  - ACCAACCAAACGCCTGTCGGATCC  1/5 clones 
Emb. 1 allele 2  - ACCAACCAAACGCCTGTCAGGATCC 4/5 clones
Emb. 2 allele 1  - ACCAACCAAACGCCTGTCGGATCC  4/4 clones
                                       Total 5/9 clones
24 base pair homology arm
                    noto <---      24 bp    ---> 2A
Precise junction – TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
Emb. 1 allele 1  - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC 10/10 clones                          
Emb. 2 allele 1  - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC 9/10 clones
Emb. 2 allele 2  - TACCGGAGCATAACCAACCAAACGCCTGTCTAGGAGCATAACCAACCAAACGCCTGTCGGATCC 1/10 clones
                                                                             Total 19/20 clones
48 base pair homology arm
                    noto <-------------        48 bp      -------------> 2A
Precise junction – GAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
Emb. 1 allele 1  - GAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATCC  5/9 clones
Emb. 1 allele 2  - GAGATGAGAGAAGAGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATCC 4/9 clones
Emb. 2 allele 1  - GAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATCC  9/10 clones
Emb. 2 allele 2  - GAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATTC  1/10 clones
                                                                           Total 15/19 clones
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5’-AGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCTCCAGCTCTGCGCTCCC-3’
3’-TCTCTTGCTTGTTTGCGCATGGCCTCGTATTGGTTGGTTTGCGGACAGAGGTCGAGACGCGAGGG-5’
2 3noto
Supplementary figure 1
2A tagRFP-CAAX pAgRNA
5’-GGGAGCGCAGAGCTGGAGACAGGaaaAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTC-3’
3’-CCCTCGCGTCTCGACCTCTGTCCtttTCTCTTGCTTGTTTGCGCATGGCCTCGTATTGGTTGGTTTGCGGACAG-5’
12,24,48
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a b
noto
Supplementary figure 2
2A tagRFP-CAAX pAgRNA 47, 48, 49
Supplementary Figure 2. Single base pair differences in homology arm length 5’ to 
the Cas9/gRNA cut site influence integration frequencies in zebrafish embryos. (a) 
Schematic for targeting 2A-TagRFP-CAAX-SV40 into noto exon 1 with 5’ homology to the 
Cas9/gRNA cut site containing 47, 48, or 49 bp of homology. (b) The frequency of injected 
zebrafish embryos displaying notochord RFP expression after targeting noto exon 1 with 
donors containing 47, 48, or 49 bp of 5’ homology. Data represents mean +/- s.e.m. of 3 
(47 bp, 49 bp) or 7(48 bp) independent targeting experiments. p values calculated using 
two-tailed unpaired t-test. 
 
 
 
5’-GGGAGGCGTTCGGGCCACAGCGGACGGATCGGATCTGAGTCGGGATA-3’
3’-CCCTCCGCAAGCCCGGTGTCGCCTGCCTAGCCTAGACTCAGCCCTAT-5’
5’-ACGGATCGGATCTGAGTCGGGATAGCTTGGATTGCTAC-3’
3’-TGCCTAGCCTAGACTCAGCCCTATCGAACCTAACGATG-5’
Exon 1 Exon 2 Exon 3
5’- GGGAGGCGUUCGGGCCACAGCGG -‘3
b
a c
Supplementary figure 3
Supplementary Figure 3. The Universal gRNA (UgRNA) promotes high efficiency targeted 
integration. (a) Universal gRNA (UgRNA) sequence. Cas9 PAM underlined. (b) Schematic 
showing the sequence of UgRNA in the targeting domain of the knock-in cassette. Sequence in 
green from the noto gene is the engineered homology in the donor vector for HMEJ. The Cas9 
PAM is underlined. (b) Frequency of injected embryos displaying RFP expression in the notochord 
compared to total injected embryos following noto targeting using UgRNA to liberate the homology 
in the donor. 
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noto F1 junction fragments from DNA represented on 
Southern Blot
24 base pair homology arms -
5’ F1 junctions from F0 #1 
                    noto  <---  24 bp domain  --->Vector
Precise junction – TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
F1 #1            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
F1 #2            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
F1 #3            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
F1 #4            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
3’ F1 junctions from F0 #1
                     --24bp homology domain--      Alternate  homology
Knock-in alignment - TCCAGCTCTGCGCTCCCGCTTATT------ATCTGCTCTCCAACTCACT
F1 #1 no sequencing performed
F1 #2              - TCCAGCTCTGCGCTCCCGCTTATTCCGCTTATCTGCTCTCCAACTCACT
F1 #3              - TCCAGCTCTGCGCTCCCGCTTATTCCGCTTATCTGCTCTCCAACTCACT
F1 #4              - TCCAGCTCTGCGCTCCCGCTTATTCCGCTTATCTGCTCTCCAACTCACT
5’ F1 junctions from F0 #2
                    noto  <---  24 bp domain  --->Vector
Precise junction – TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
F1 #5            - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
F1 #6            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
F1 #7            - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
F1 #8            - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
3’ F1 junctions from F0 #2
No junctions obtained
tyr F1 junction fragments - DNA from single F1
24 base pair homology arms -
5’ F1 junction  
                     Tyr <---  24 bp domain  --->  Vector
Precise junction – ACAACGACGGATACTTCATGGTGCCCTTCAttGGATCC
F1               - ACAACGACGGATACTTCATGGTGCCCTTCAttGGATCC
3’ F1 junction
                   Vector<---  24 bp domain  ---> Tyr
Precise junction - CCATGGTCCCTCTCTACAGGAACGGAGACTATTTTC
F1               - CCATGGTCCCTCTCTACAGGAACGGAGACTATTTTC
Supplementary figure 4
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esama F1 junction fragments
24 base pair homology arm - 
5’ F1 junctions
                   esama <---  24 bp domain  --->  Vector
Precise junction – CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#4, F1#1       - CTTATGAAAATGTGGTTGTGATCCAAGGGAttGGATCC
F0#4, F1#2       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#5, F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#5, F1#2       - GATAAGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#6, F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#6, F1#2       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#7, F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#7, F1#2       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#9, F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#11,F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
3’F1 junctions
                   Vector<---  24 bp domain  —>  esama
Precise junction - CCATGGAGATGGTGGTGCTGCAGGCGTCATATTCGA
F0#4, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#4, F1#2       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#5, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#5, F1#2       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#6, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#6, F1#2       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#7, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATGAAGGTGCTGCAGGCTTCATATTCGA
F0#7, F1#2       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#9, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#11, F1#1      - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
flna F1 junction fragments
48 base pair homology arm -
5’ F1 junctions
                    flna <---              48 bp domain              --->Vector
Precise junction – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
F1#1             – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
F1#2             – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
F1#3             – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
F1#4             – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
3’ F1 junctions
not determined 
msna F1 junctions for exon 2 integration
48 base pair homology arm -
5’ F1 junctions
                    msna <---              48 bp domain              --->  Vector
Precise junction – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#1             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#2             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#3             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#4             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#5             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#6             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#7             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#8             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#9             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#10            – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#11            – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#12            – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
3’ F1 junction
                   Vector<---              48 bp domain              ---> msna
Precise junction – AGGAAGCAGCACCACAGGGAAACAGTTATTTGACCAGGTTTGTGTGTGGCCTCTTTTTTT
F1               – AGGAAGCAGCACCACAGGGAAACAGTTATTTGACCAGGTTTGTGTGTGGCCTCTTTTTTT
Supplementary figure 4 continued
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aqp1a1 F1 junction fragments
5’ F1 junction
                   aqpa1a<---              48 bp domain              --->  Vector
Precise junction – CCGTCAGTCAGTCAGTCATGAACGAGCTGAAGAGCAAGGCTTTCTGGCGGGCCGccGGATCC
F2 line 1        – CCGTCAGTCAGTCAGTCATGAACGAGCTGAAGAGCAAGGCTTTCTGGCGGGCCGccGGATCC
3’ F1 junction
                   Vector<---              48 bp domain              --->aqpa1a
Precise junction – AGGAAGTCCTGGCCGAGCTGCTGGGAATGACCCTGTTCATCTTCCTCAGCATTACAGCAG
F2 line 1        – AGGAAGTCCTGGCCGAGCTGCTGGGAATGACCCTGTTCATCTTCCTCAGCATTACAGCAG
aqp8a1 F1 junction fragments
5’ F1 junction 
                   aqp1a1<---              48 bp domain              --->  Vector
Precise junction – GAGTCGTCGGCTCTTTCCTCTTCATGTTTGTGGGCTGCGTGTCCGTCATGGGCAttGGATCC
F1#1             – GAGTCGTCGGCTCTTTCCTCTTCATGTTTGTGGGCTGCGTGTCCGTCATGGGCAttGGATCC
3’ F1 junction
                   Vector<---              48 bp domain              --->aqpa1a
Precise junction – AGGAAGACGTGGGCATCAGCGGGAGCATCCAGCCCGCCCTGGCACACGGACTAGCACTGG
F1#1             – AGGAAGACGTGGGCATCAGCGGGAGCATCCAGCCCGCCCTGGCACACGGACTAGCACTGG
Supplementary figure 4 continued
Supplementary Figure 4. Sequence of PCR junction fragments amplified from F1 
genomic DNA show precise integrations at the 5’ and 3’ ends of most F1s. 
Lowercase letters represent “padding” nucleotides used to bring homology in 
frame of the coding region based on Cas9 cut site. Red letters represent 
mismatches unless otherwise noted below. Underline represents the up- and 
downstream sequence after homology arms and precise integration confirmation. 
Cross through is an imprecise insertion. esama F1 3’ junctions – Red T in all 
samples was included in homology arms as an annotated synonymous variant per 
Ensembl. 
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24 base pair homology arm
                    Tyr  <---  24 bp homology  --->   2a
Precise junction – ACAACGACGGATACTTCATGGTGCCCTTCATTGGATCC
Emb. 1 allele 1  - ACAACGACGGATACTTCATGGTGCCCTTCATTGGATCC 3/4 clones
Emb. 1 allele 2  - ACAACGACGGATACTTCATGGTGCCCTTCATTGGACCC 1/4 clones
Emb. 2 allele 1  - ACAACGACGGATACTTCATGGTGCCCTTCATTGGATCC 3/3 clones
                                                    Total 7/7 clones precise integration
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Supplementary figure 5
Supplementary Figure 5. Integration of Gal4/VP16 amplifies signal of targeted 
tyr. (a) PCR of 5’ junction fragments and sequencing results from junction fragments 
between the pGTag vector and the tyr locus amplified from randomly selected RFP 
negative embryos after injection with GeneWeld reagents for targeting tyr with 2A-
tagRFP-CAAX-SV40pA. Most F0 injected zebrafish contain the expected 5’ junction 
fragment (marked with an ‘*’). The junction fragments from F0-1 and -2 were isolated 
for sequencing, and precise integrations were observed (b) Efficiency of 5’ homology 
integration to target RFP or GAL4/VP16 into tyr and detect RFP expression. Data 
represents mean +/- s.e.m. of 3 independent targeting experiments. p values 
calculated using two-tailed unpaired t-test. 
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rb1 e2-e4 deletion tagging
5’ junction
                   rb1 e2<---             48 bp domain             --->                        Vector
Precise junction – CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC
Embryo 1         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise
Embryo 2         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAGAGGGAAATTAGGAGCATGGacGGATCC 4/5 clones precise
Embryo 3         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise
3’ junction
                   Vector                     <---                48 bp domain            --->rb1 e4
Precise junction - AGGAAGCCTAAGGTCAATAGCGCCGTCACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGATTTGTA
Embryo 1         - AGGAAGCCTAAGGTCAATAGCGCCGTCACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGATTTGTA 1/5 clones precise
Embryo 2         - AGGAAGCCTAAGGTCAATAGCGCCGTCACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGATTTGTA 2/5 clones precise
Embryo 3         - AGGAAGCCTAAGGTCAATAGCGCCGTCACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGATTTGTA 5/5 clones precise
rb1 e2-e25 deletion tagging
5’ junction
                   rb1 e2<---             48 bp domain             --->                        Vector
Precise junction - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC  
Embryo 1         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise 
Embryo 2         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise 
Embryo 3         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise 
3’ junction 
                   Vector                       <---                48 bp domain            --->rb1 e25 
Precise junction - AGGAAGCCCTCAAAAGACTCAGATTCGATATGGACGGACAAGATGAAGCAGACGGAAGGTGGGAGTCATGATCAGTTTACTCT 
Embryo 1         - AGGAAGCCCTCAAAAGACTCAGATTCGATATGGACGGACAAGATGAAGCAGACGGAAGGTGGGAGTCATGATCAGTTTACTCT 5/5 clones precise 
Embryo 2         - AGGAAGCCCTCAAAAGACTCAGATTCGATATGGACGGACAAGATGAAGCAGACGGAAGGTGGGAGTCATGATCAGTTTACTCT 4/5 clones precise 
Embryo 3         - AGGAAGCCCTCAAAAGACTCAGATTCGATATGGACGGACAAGATGAAGCAGACGGAAGGTGGGAGTCATGATCAGTTTACTCT 3/5 clones precise 
msna e2-6 deletion tagging
5’ junction
                    msna <----               48 bp domain             --->Vector
Precise junction – GATCAGTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATCC
Embryo 1         - GATCAGTGTTCGTGTGACTACGATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATCC 4/4 clones single SNP
Embryo 2         - GATCAGTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATCC 4/5 clones precise
Embryo 3         - GATCAGTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATCC 3/4 clones precise
3’ junction
                   vector<----              48 bp domain             ---> msna
Precise junction - AGGAAGCAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTTCTGTTT
Embryo 1         - No junction obtained
Embryo 2         - AGGAAGCAAGGGCATGTTGAGGTACAGACAATGAAATGTGCTCTTGCTATTTTTCTGTTT 1/5 clones single SNP
                   AGGAAGCAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTTCTGTTT 2/5 clones precise
                   AGGAAGCAAGGGCATGTTGAGGTACAGACAATGGAATGGGCTCTTGCTATTTTTCTGTTT 2/5 clones single SNP
Embryo 3         - AGGAAGCAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTTCTGTTT 4/5 clones precise
Supplementary figure 6
Supplementary Figure 6. Sequences of 5’ and 3’ junction fragments from rb1 exon 2-4, 
rb1 exon 2-25, and msna exon 2-6 deletion tagged alleles in F0 injected embryos. 
Primarily precise junction fragments at the 5’ and 3’ ends are recovered in somatic tissue of 
F0 targeted embryos. Cloned PCR amplicons were sequenced from 3 individual embryos for 
each targeted deletion tagging experiment. 
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Supplementary Figure 7
Supplementary Figure 7. HMEJ-mediated targeted integration of an 
MND:GFP reporter at the AAVS1 locus in human K-562 cells. FACs sorted 
percent of GFP+ cells out of total K-562 cells at day 7, 21, 28, and 50. (b) 
Summary data for percent of stable GFP+ K-562 cells from day 7, 14, 21, and 28. 
(b’) Summary data for percent of total cells GFP+ from day 7, 14, 21, 28, and 50. 
Data represents mean +/- s.e.m. of 3 independent targeting experiments. p values 
calculated using two-tailed unpaired t-test. 
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AAVS1 5’ junction
                     AAVS1 <---              48 bp domain              --->Vector
Predicted junction – GCTCTGGTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTACGATCG
Repetition 1       - GCTCTGGTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTACGATCG
Repetition 2       - GCTCTGGTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTACGATCG
Repetition 3       - GCTCTGGTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTACGATCG
Supplementary figure 8
Supplementary Figure 8. Direct sequencing of 5’ junction PCR products 
derived from three independently targeted bulk cell populations. (a) 
Direct sequencing of 5’ junction PCR products derived from three 
independently targeted bulk cell populations. 48 bp HMEJ homology region 
and remainder of genomic AAVS1 gRNA are indicated. Genomic sequence is 
directly left of the 48 bp HMEJ region and vector sequence is directly to the 
right of the AAVS1 gRNA cut site. 
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Supplementary Table 1 - Gene targeting experiments and knock-in averages. 
Genomic target Donor vector
Donor 
sgRNA  
target 
(genomic 
or 
UgRNA)
Homolog
y length 
(5'/3')
Experime
nt 
number
Reporter 
positive 
embryos
Total 
embryos 
Percent 
with 
positive 
report
Standard 
Error
noto  E1 2A-TagRFP-CAAX-SV40
genomic 
sgRNA 12/x Average 22 178 12.4% 0.55%
noto  E1 2A-TagRFP-CAAX-SV40
genomic 
sgRNA 24/x Average 30 131 22.9% 0.74%
noto  E1 2A-TagRFP-CAAX-SV40
genomic 
sgRNA 48/x Average 40 114 35.1% 1.01%
noto  E2 2A-TagRFP-CAAX-SV40 UgRNA 24/x Average 32 150 21.3% 0.66%
noto  E1 pGTag-2A-eGFP-SV40 UgRNA 24/24 Average 45 185 24.3% 0.90%
noto  E1 pGTag-2A-eGFP-SV40 UgRNA 48/48 Average 44 172 25.6% 0.82%
tyr  E4 pGTag-2A-Gal4VP16-bactin UgRNA 24/24 Average 84 132 63.6% 1.44%
cx43.4  E2
pGTag-2A-
TagRFP-CAAX-
SV40
UgRNA 24/24 Average 42 84 50.0% 4.39%
cx43.4  E2
pGTag-2A-
TagRFP-CAAX-
SV40
UgRNA 48/48 Average 31 81 38.3% 4.15%
esama E2 ag-2A-Gal4VP16-ba UgRNA 48/48 Average 34 162 21.0% 0.59%
msna E2 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 102 185 55.1% 9.87%
msna E6 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 25 96 26.0%
anxa2a E3 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 12 34 35.3%
flna  E4 pGTag-2A-Gal4VP16-bactin UgRNA 48/42 Average 9 9 100.0%
aqp1a1 E1 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 1 25 4.0%
aqp8a1 E1 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 3 21 14.3%
rb1  E2-E4 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 273 463 59.0% 6.44%
rb1  E2-E25 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 292 486 60.1% 3.78%
msna  E2-E6 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 91 151 60.3% 5.92%
kdrl E3-E30 pGTag-2A-Gal4VP16-bactin UgRNA 42/48 Average 8 23 34.8%
s1pr1 E2-E2 pGTag-2A-Gal4VP16-bactin UgRNA 48/27 Average 76 94 80.9%
vegfaa E3-E7 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 Average 29 92 31.5%
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Supplementary Table 2 - Gene targeting experiments and knock-in percentages. 
Genomic target Donor vector
Donor sgRNA  
target (genomic 
or UgRNA)
Homology 
length (5'/3')
Experiment 
number
Reporter positive 
embryos Total embryos 
Percent 
with 
positive 
report
Standard Error
noto  E1 2A-TagRFP-CAAX-SV40 genomic sgRNA 12/x 1 4 32 12.5%
2A-TagRFP-CAAX-SV40 genomic sgRNA 12/x 2 12 91 13.2%
2A-TagRFP-CAAX-SV40 genomic sgRNA 12/x 3 6 55 10.9%
Average 22 178 12.4% 0.55%
noto  E1 2A-TagRFP-CAAX-SV40 genomic sgRNA 24/x 1 10 47 21.3%
2A-TagRFP-CAAX-SV40 genomic sgRNA 24/x 2 10 41 24.4%
2A-TagRFP-CAAX-SV40 genomic sgRNA 24/x 3 10 43 23.3%
Average 30 131 22.9% 0.74%
noto  E1 2A-TagRFP-CAAX-SV40 genomic sgRNA 48/x 1 10 29 34.5%
2A-TagRFP-CAAX-SV40 genomic sgRNA 48/x 2 15 40 37.5%
2A-TagRFP-CAAX-SV40 genomic sgRNA 48/x 3 15 45 33.3%
Average 40 114 35.1% 1.01%
noto  E2 2A-TagRFP-CAAX-SV40 UgRNA 24/x 1 13 62 21.0%
2A-TagRFP-CAAX-SV40  UgRNA 24/x 2 10 49 20.4%
2A-TagRFP-CAAX-SV40 UgRNA 24/x 3 9 39 23.1%
Average 32 150 21.3% 0.66%
noto E1 pGTag-2A-TagRFP-CAAX-SV40 UgRNA 24/24 1 18 68 26.5%
pGTag-2A-TagRFP-CAAX-SV40 UgRNA 24/24 2 9 38 23.7%
pGTag-2A-TagRFP-CAAX-SV40 UgRNA 24/24 3 6 28 21.4%
pGTag-2A-TagRFP-CAAX-SV40 UgRNA 24/24 4 12 51 23.5%
Average 45 185 24.3% 0.90%
noto  E1 pGTag-2A-eGFP-SV40 UgRNA 48/48 1 9 33 27.3%
pGTag-2A-eGFP-SV40 UgRNA 48/48 2 17 71 23.9%
pGTag-2A-eGFP-SV40 UgRNA 48/48 3 18 68 26.5%
Average 44 172 25.6% 0.82%
tyr E4 pGTag-2A-Gal4VP16-bactin UgRNA 24/24 1 21 31 67.7%
pGTag-2A-Gal4VP16-bactin UgRNA 24/24 2 21 33 63.6%
pGTag-2A-Gal4VP16-bactin UgRNA 24/24 3 42 68 61.8%
Average 84 132 63.6% 1.44%
2A-TagRFP-CAAX-SV40 genomic sgRNA 24/x 1 0 41 0.0%
2A-TagRFP-CAAX-SV40 genomic sgRNA 24/x 2 0 22 0.0%
Average 0 63 0.0% 0.00%
cx43.4 E2 pGTag-2A-TagRFP-CAAX-SV40 UgRNA 24/24 1 8 21 38.1%
pGTag-2A-TagRFP-CAAX-SV40 UgRNA 24/24 2 15 29 51.7%
pGTag-2A-TagRFP-CAAX-SV40 UgRNA 24/24 3 19 34 55.9%
Average 42 84 50.0% 4.39%
cx43.4 E2 pGTag-2A-TagRFP-CAAX-SV40 UgRNA 48/48 1 10 34 29.4%
pGTag-2A-TagRFP-CAAX-SV40 UgRNA 48/48 2 15 32 46.9%
pGTag-2A-TagRFP-CAAX-SV40 UgRNA 48/48 3 6 15 40.0%
Average 31 81 38.3% 4.15%
esama E2 pGTag-2A-Gal4VP16-bactin UgRNA 24/24 1 9 40 22.5%
pGTag-2A-Gal4VP16-bactin UgRNA 24/24 2 13 65 20.0%
pGTag-2A-Gal4VP16-bactin UgRNA 24/24 3 12 57 21.1%
Average 34 162 21.0% 0.59%
msna E2 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 11 34 32.4%
48/48 2 91 151 60.3%
Average 102 185 55.1% 9.87%
msna E6 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 25 96 26.0%
Average 25 96 26.0%
anxa2a E3 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 12 34 35.3%
Average 12 34 35.3%
flna  E4 pGTag-2A-Gal4VP16-bactin UgRNA 48/42 1 9 9 100.0%
Average 9 9 100.0%
aqp1a1 E1 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 1 25 4.0%
2 n/a n/a n/a
Average 1 25 4.0%
aqp8a1 E1 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 3 21 14.3%
Average 3 21 14.3%
rb1  E2-4 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 48 108 44.0%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 2 56 111 50.0%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 3 53 96 55.0%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 4 116 148 78.0%
Average 273 463 59.0% 6.44%
rb1  E2-25 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 47 76 62.0%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 2 58 119 49.0%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 3 87 149 58.0%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 4 100 142 70.0%
Average 292 486 60.1% 3.78%
msna E2-E6 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 8 13 61.5%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 2 29 34 85.3%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 3 17 34 50.0%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 4 26 48 54.2%
pGTag-2A-Gal4VP16-bactin UgRNA 48/48 5 11 22 50.0%
Average 91 151 60.3% 5.92%
kdrl E3-E30 pGTag-2A-Gal4VP16-bactin UgRNA 42/48 1 8 23 34.8%
Average 8 23 34.8%
s1pr1 E2-E2 pGTag-2A-Gal4VP16-bactin UgRNA 48/27 1 76 94 80.9%
Average 76 94 80.9%
vegfaa E3-E7 pGTag-2A-Gal4VP16-bactin UgRNA 48/48 1 29 92 31.5%
Average 29 92 31.5%
81 
 
Supplementary table 3 - 
Germline Transmission 
Genomic target F0s outcrossed F0s transmitting
Germline 
transmission 
percentage
noto  E1 24/24 5 3 60.0%
tyr  E4 48/48 8 3 37.5%
cx43.4  24/24 1 0 0.0%
cx43.3  48/48 4 0 0.0%
esama E2 48/48 18 12 66.7%
msna  E2 48/48 4 1 25.0%
msna  E6 48/48 3 1 33.3%
anxa2a  E3 48/48 4 4 100.0%
flna  E4 48/42 3 3 100.0%
aqp1a1  E1 48/48 9 2 22.2%
aqp8a1 E1 48/48 1 1 100.0%
rb1 E2-E4 48/48 10 0 0.0%
rb1 E2-E25 48/48 16 1 6.3%
msna  E2-E6 48/48 8 0 0.0%
kdrl E3-E30 44/48 3 0 0.0%
s1pr1 E2-E2 48/48 24 0 0.0%
vegfaa E3-E7 48/48 16 0 0.0%
mmp14a E1-E10 48/48 4 0 0.0%
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Primer name Sequence Purpose
notoSBf CAGATGCCACACTTCGCGT Southern blot analysis
notoSBr CGATGTTATACTTGCTTCTTTTTAGTTTTGTACATAT Southern blot analysis
tyrSBe3f GTTTTGCTAATCCTGAGACGGGTTTG Southern blot analysis
tyrSBe3r CTGTCAATAAAAGCATGATGTATGATGAAAATGG Southern blot analysis
esamaSBe3f ATCATCTCATTCGTCAATGGAGACTTCAG Southern blot analysis
esamaSBi4r CACAGTGTGGCAGTGAGCATTC Southern blot analysis
gal4SBr CTGAAGAACAACTGGGAGTGTCGC Southern blot analysis
gal4SBf TTACATATCCAGAGCGCCGTAGGG Southern blot analysis
rfpSBf ATGGTGTCTAAGGGCGAAGAGC Southern blot analysis
rfpSBr AGCTTCAGGGCCATGTCGC Southern blot analysis
Supplementary table 6 - Primes and oligos
Primer name Sequence Purpose
notojxn5'f GCTTTTTGGACTAAACAGACGCCATG Junction fragment analysis
notojxn3'r CTTGTGCGTACACAGCTCCACG Junction fragment analysis
notojxn3'delr CGATGTTATACTTGCTTCTTTTTAGTTTTGTACATAT Junction fragment analysis
tyrjxn5'f CATCTTTGAGCAGTGGTTGAGGAGA Junction fragment analysis
tyrjxn3'r CACCTGGATCCTGTAAATATGCATATTCATATC Junction fragment analysis
esamajxn5'f GGTCTTTCAGTCAGCGAGTTTAATGTC Junction fragment analysis
esamajxn3'r CATTTCAGTGCTGGTAGCAGACTG Junction fragment analysis
cx43.4jxn5'f GCAGGACTGAGACGGTGGTA Junction fragment analysis
cx43.4fxn3'r CAAATGCATCGTAGCAAACG Junction fragment analysis
Rb2jF AAGGACAAGGATCCTGAGTTTG Junction fragment analysis
galjf GCAAACGGCCTTAACTTTCC Junction fragment analysis
GaljR GCCTTGATTCCACTTCTGTCA Junction fragment analysis
Rb4jR GCTTTGCATCACAACCTCAA Junction fragment analysis
Rb25jR AGCCAGCTTCTGGATCAGTG Junction fragment analysis
RFP5'jxnr CCTTAATCAGTTCCTCGCCCTTAGA Junction fragment analysis
sv403'jxnf GGGGAGGTGTGGGAGGTTTT Junction fragment analysis
gfp5'R GCTGAACTTGTGGCCGTTTA Junction fragment analysis
GFP3'F ACATGGTCCTGCTGGAGTTC Junction fragment analysis
F-msna-exon2 TTCCTTCATTCATTCATTGACA Junction fragment analysis
R-msna-exon2 GGGCACGGCTACAAAGAAG Junction fragment analysis
R-msna-exon6 CGTGTGATTGACAGGGTCAC Junction fragment analysis
F-msna-exon6 GTTCTGGAGCAGCACAAGC Junction fragment analysis
anxa2a5'Cut3'JxnPrR CTTCCAGACAGGACGAGTGA Junction fragment analysis
anxa2a5'Cut5'JxnPrF TTTCCTCATTGTTTGGCTGT Junction fragment analysis
F-1a1junc AGATTAGAGGCGTCAGTCCG Junction fragment analysis
R-1a1junc GCTGAGGAAGATGAACAGGG Junction fragment analysis
KDRLEx3JxnF TTGTTTTTGTTGTGACTTCCAAT Junction fragment analysis
KDRLEx30JxnR GGGTGGTGTGGAGTAACGAA Junction fragment analysis
S1PR1.5'JxnF ACAAGGACCCGGGACTCA Junction fragment analysis
S1PR1.3'JxnR CGAGACGAAAAAGTTCACGA Junction fragment analysis
vegfaaEx3.5'JxnF AACACTCTCGCTTTGCTTCC Junction fragment analysis
vegfaaEx7.3'JxnR TGCTGTGCCGTTTAAAAAGTT Junction fragment analysis
R-8a1-exon1_junc TGATTTCCCCAAAAATTGCT Junction fragment analysis
F-8a1-exon1_junc GCCCTTCTTCGAGCACTACA Junction fragment analysis
F-mmp14a-junc ? Junction fragment analysis
R-mmp14a-junc ? Junction fragment analysis
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Abstract 
Clustered Regularly Interspaced Palindromic Repeats (CRISPR) RNA cursors 
and CRISPR associated (Cas) effector proteins enable the direction of DNA double-
strand breaks to defined loci based on a variable length RNA cursor specific to each 
effector. The cursors are generally similar in size and form, consisting of a ~20 base 
pair sequence specifying the DNA target and a secondary structure used by the 
effector for cursor/DNA recognition. However, the effector proteins vary in size, 
target DNA binding kinetics, nucleic acid hydrolyzing activities, and Protospacer 
Adjacent Motif (PAM) requirements. Recently, a Cas12a family member protein 
named Mad7 was identified that is most similar to Cas12a from Acidaminococcus 
sp. Here, we demonstrate for the first time its activity in zebrafish and human cells. 
We predict Mad7 hydrolyzes DNA ~14 and ~20 bp 3’ of the PAM, leaving a 
staggered 5’ overhang. We utilize a genomic reporter to demonstrate CRISPR/Mad7 
elicits strand annealing DNA repair more efficiently than CRISPR/Cas9. Finally, we 
use CRISPR/Mad7 with our previously reported gene targeting method GeneWeld in 
order to integrate reporter alleles in both zebrafish and human cells. Together, this 
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work provides methods for deploying an additional CRISPR/Cas system, increasing 
the flexibility researchers have in applying genome engineering technologies. 
 
Introduction 
CRISPR systems have been widely adopted in zebrafish due to high efficacy 
and the ease of reprogramming DNA cursor activity mediated by a chimeric, single 
guide RNA (sgRNA or gRNA) molecule (Jinek, Chylinski et al. 2012) (Cong, Ran et 
al. 2013) (Jao, Wente et al. 2013). The CRISPR toolbox continues to expand with 
the identification of systems that display varying PAM requirements, differing 
nuclease size, and DSB architecture (Adli 2018). While Cas9 generally hydrolyzes 
DNA leaving a blunt ended cut three bp 5’ of the PAM sequence, Cas12a proteins 
from Acidaminococcus sp and Lachnospiraceae hydrolyze DNA in a staggered 
fashion 3’ of their PAM and leave four base pair 5’ overhangs (Zetsche, Gootenberg 
et al. 2015). As DSB architecture and subsequent end resection is a critical 
determinant in DNA repair pathway choice, there is increased demand for CRISPR 
variants that elicit more predictable repair outcomes for precision genome 
engineering (Truong, Li et al. 2013). Indeed, it has been shown that programming 
DNA overhangs with CRISPR/Cas9 nickases can stimulate precision genome 
engineering using oligonucleotides (Ran, Hsu et al. 2013), increasing the interest for 
identifying CRISPR systems that show altered DSB architectures so as to avoid 
using multiple Cas9 targeting events. 
CRISPR/Cas12a activity has been reported in zebrafish (Moreno-Mateos, 
Fernandez et al. 2017) (Fernandez, Vejnar et al. 2018). In these studies, Cas12a 
activity is enhanced by the injection of ribonucleoprotein (RNP) complexes due to 
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pre-crRNA and crRNA instability. Further, Cas12a mediated DNA cleavage required 
either a 34º heat shock or the co-targeting of nuclease dead Cas9 to the region 
where Cas12a cleavage was desired. Cas12a mediates enhanced oligonucleotide 
incorporation as compared to Cas9, perhaps indicating mechanistically distinct 
enzymatic activities and resulting genomic DNA end availability. Recently, a distantly 
related CRISPR/Cas12a family member was described called Mad7 (Inscripta 
2018). Mad7 is a 1262 amino acid protein that recognizes a 5’-YTTN PAM and uses 
a 42 or 56 bp RNA cursor to recognize and catalyze site-specific DNA cleavage 
(Kelley 2018). While CRISPR/Mad7 is active in human cells (Inscripta 2018), the cut 
site has not been reported and its application in gene targeting has not been 
described. 
In the early zebrafish embryo, MMEJ is a highly active DNA repair pathway 
that can generate predictable alleles after nuclease targeting (Thyme and Schier 
2016) (He, Zhang et al. 2015) (Ata, Ekstrom et al. 2018). MMEJ based gene 
targeting has been described in zebrafish and mammalian cells, though the 
homology arms used for these events may be more similar to the lengths employed 
by SSA (Aida, Nakade et al. 2016) (Hisano, Sakuma et al. 2015) (Nakade, Tsubota 
et al. 2014) (Bhargava, Onyango et al. 2016). In this method, nuclease targeting of a 
donor plasmid in vivo liberates a donor cassette, exposing homology arms that are 
used to direct integration. A more general term for using this method for gene 
targeting has been called Homology Mediated End Joining (HMEJ) (Yao, Wang et 
al. 2017). 
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We recently reported an advanced methodology with high efficiency zebrafish 
somatic gene targeting and germline transmission using HMEJ methodology, though 
with shorter homologies (Wierson et al., submitted, Chapter 2). This method, dubbed 
GeneWeld, is similar to previous reports and involves the simultaneous in vivo 
targeting of a genomic target and a donor plasmid with designer nucleases to reveal 
24 or 48 bp homology arms to be used with MMEJ or SSA machinery. GeneWeld 
works with both TALEN and CRISPR/Cas9 mediated genomic targeting events, but 
other nucleases have not yet been tested.  
Here, we describe the activity of Mad7 in a vertebrate model organism and its 
application for gene targeting in human cells for the first time, to our knowledge. 
Consistent with its relation to Cas12a, Mad7 activity requires a 34ºC heat shock in 
zebrafish. However, injection of mRNA encoding Mad7 is effective for DSB activity, 
and pre-crRNA is an effective RNA guide for Mad7 activity, in contrast to previous 
reports (Moreno-Mateos, Fernandez et al. 2017). We predict Mad7 hydrolyzes DNA 
~14 bp (non-target strand) and ~20 bp (target strand) 3’ from the PAM generating a 
staggered cut with a ~6 bp 5’ overhang. Mad7 potently induces Strand Annealing 
Mediated Repair (SAMR) in a genomic reporter at efficiencies greater than 
CRISPR/Cas9 and elicits gene targeting activity on par with GeneWeld reports using 
CRISPR/Cas9. Finally, we demonstrate Mad7 activity at the human safe harbor 
locus AAVS1 and apply GeneWeld with Mad7 in human cells. 
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Results 
Mad7 activity in zebrafish embryos  
To gain a rapid phenotypic read-out of Mad7 activity in zebrafish, the 
notochord specific transcription factor noto was chosen. Three pre-crRNAs were 
designed in exon 1 of noto (Figure 1a). Injection of mRNA encoding zebrafish codon 
optimized, dual NLS-Mad7 (nMad7n) with noto-pre-crRNA1 and incubation as 
normal at 28º C after injection did not elicit any activity (data not shown). However, 
injection of nMad7n mRNA with noto-pre-crRNA1 or noto-pre-crRNA3 and a 4-hour 
34º C heat shock elicits phenotypes characteristic of biallelic loss of noto at 
efficiencies ranging from 7-61% that are dependent on pre-crRNA concentration 
(Fig. 1b) (Talbot, Trevarrow et al. 1995). PCR across these individual target sites 
and subsequent heteroduplex mobility shift assays show the presence of indels 
compared to uninjected WT DNA, characteristics of NHEJ (Figure 1c, Figure 1d). 
noto-pre-crRNA2 does not elicit a phenotype and a heteroduplex mobility shift assay 
across this locus indicates it is an inactive gRNA (data not shown). However, 
efficiencies of biallelic noto inactivation at the same target varied considerably from 
injection to injection (Figure 1b), consistent with previous reports in human cells and 
zebrafish using CRISPR/Cas12a (Kim, Kim et al. 2016) (Kim, Song et al. 2017) 
(Moreno-Mateos, Fernandez et al. 2017). To confirm our results are not locus 
specific, we injected nMad7n mRNA and pre-crRNA targeting two independent loci 
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at cx43.4 (Figure 1e). PCR across the individual target sites and subsequent RFLP 
analysis demonstrates that cx43.4-pre-crRNA2 is active (Figure 1f).  
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Figure 1 – CRISPR/Mad7 induces mutations in zebrafish. (a) Schematic and sequences 
of pre-crRNA used to target noto. (b) Data plots showing ratio of injected animals displaying 
somatic noto phenotype. Whiskers represent mean ± s.d. p values calculated with one-tailed 
Student’s t-test. (c, d) Gel showing heteroduplex mobility shift of injected animals vs wild type 
(WIK) for pre-crRNA1 and pre-crRNA3 at noto. (e) Schematic and sequences of pre-crRNA 
used to target cx43.4. (f) RFLP analysis showing pre-crRNA2 is active at cx43.4. 
109 
In order to gain a better understanding of the true nature of Mad7 indel 
events, we used next generation sequencing to analyze the efficiencies of mutation 
at the active noto and cx43.4 target sites. DNA from 5 noto mutant embryos at each 
target site and 5 cx43.4 randomly chosen embryos were pooled, amplified over the 
target locus, and sequenced. As expected from biallelic inactivation at noto, ~61% of 
alleles at target site 1 show insertions/deletions (indels), characteristic of NHEJ 
and/or MMEJ after nuclease targeting (Table 1). The phenotypically more efficient 
noto target site 3 showed ~90% of alleles containing indels (Table 1). However, in 
agreement with RFLP analysis, the vast majority of alleles sequenced at cx43.4, 
~74%, are wild type, indicating not all targeting events with Mad7 are efficient 
Target Sequence Indel Length
Microhomology 
Signature
% of Total 
Read Count
noto target 1 WT: TTTACTCGCAGATGCCACACTTCGCGTACAGCCAAAGCATCATGCAAACTCAG N/A N/A 38.85
Allele 1:         TTTACTCGCAGATGCCACA-----------GCCAAAGCATCATGCAAACTCAG -11 ACA 9.85
Allele 2:         TTTACTCGCAGATGCCACAC---------AGCCAAAGCATCATGCAAACTCAG -9 AC 7.84
Allele 3: TTTACTCGCAGATGCCA-----------------AAGCATCATGCAAACTCAG -17 GCCA 5.23
Allele 4: TTTACTCGCAGATGCCACA-----------------GCATCATGCAAACTCAG -17 GCCACA 1.75
Allele 5:         TTTACTCGCAGATGCCACAC------------CAAAGCATCATGCAAACTCAG -12 N/A 1.35
noto target 3 WT: CCAGGCGGAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAA N/A N/A 10.47
Allele 1: CCAGGCGGAGATGAGAGAACGAACAA------------GCATAACCAACCAAA -12 N/A 12.13
Allele 2:         CCAGGCGGAGATGAGAGAACGAACA----------------TAACCAACCAAA -16 CA 7.67
Allele 3: CCAGGCGGAGATGAGAGAACGA----------------GCATAACCAACCAAA -16 GA 6.12
Allele 4: CCAGGCGGAGATGAGAGAACGAACAA----------TAGCATAACCAACCAAA -10 N/A 3.38
Allele 5:         CCAGGCGGAGATGAGAGAACGAAC------------GAGCATAACCAACCAAA -12 N/A 2.06
cx43.4 target 2 WT: TTTGACTGTTGTGGGGGGAGAATCGATATACTACGATGAACAGAGCAAATTTG N/A N/A 73.68
Allele 1: TTTGACTGTTGTGGGGGGA---------TACTACGATGAACAGAGCAAATTTG -9 N/A 1.01
Allele 2:         TTTGACTGTTGTGGGGGGAGA---------------TGAACAGAGCAAATTTG -15 GA 0.65
Allele 3: TTTGACTGTTGTGGGGGGAG--------TACTACGATGAACAGAGCAAATTTG -8 N/A 0.48
Allele 4: TTTGACTGTTGTGGGGGGAGA-------TACTACGATGAACAGAGCAAATTTG -7 N/A 0.42
Allele 5:         TTTGACTGTTGTGGGGGGAG-TTC---ATACTACGATGAACAGAGCAAATTTG -4 N/A 0.34
noto target 1
noto target 3
cx43.4 target 2
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enough for biallelic 
mutation of the target 
locus (Table 1). As a 
whole, over 1/3 of mutation 
events at cx43.4 and over 
half of mutation events at 
both noto target sites are out of frame mutations (Table 2). Taken together, these 
data indicate CRISPR/Mad7 is active in zebrafish dependent on a 34ºC heat shock, 
consistent with its relation to Cpf1, and pre-crRNA is an active RNA guide for 
directing Mad7 activity to genomic target sites.  
 
Mad7 elicits SSA more efficiently than Cas9 in a genomic reporter system 
We next employed a stably integrated red fluorescent protein (RFP) reporter 
system to visually assay the efficiencies with which CRISPR/Cas9 and 
CRISPR/Mad7 elicit nuclease-specific outcomes DNA repair using SAMR (Figure 
2a, described in detail in Chapter 4). Injection into the one-cell stage of noto:RFP-
DR48 transgenic embryos with Cas9 mRNA and UgRNA results in RFP expression in 
the notochord, indicative of SAMR after CRISPR/Cas9 targeting (Figure 2b). Locus 
specific PCR across RFP(+) animals showed the expected deletion pattern 
dependent on SAMR of the locus, however RFP(-) embryos also display this 
deletion pattern, indicating that the spatiotemporal activity of the Cas9/UgRNA 
complex was active in cell lineages outside the mesoderm (Figure 2c, Figure 2d). 
Consistent with this, repair events are highly mosaic and were qualitatively sorted 
Target Mutation % % of mutants out of frame Total Read Count
noto  target 1 61.15 54.88 85513
noto target 3 89.53 53.3 49347
cx43.4  target 2 26.32 34.65 144387
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into three classes of notochord expression pattern: broad, intermediate, and narrow 
(Figure 2e-i). We next tested whether CRISPR/Mad7 promotes SAMR in the 
noto:RFP-DR48  assay. As expected, injection of nMad7n and U-pre-crRNA results in 
RFP expression in the notochord (Figure 2b). As a percentage of injected animals 
with RFP+ notochords, Mad7 elicits SAMR statistically greater than Cas9 (Figure 
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Figure 2 – Using noto:RFP-DR48 to assay the propensity of Mad7 and Cas9 to elicit 
strand annealing. (a) Schematic of noto:RFP-DR48 showing the location of the 48 bp direct 
repeats flanking both the Cas9 and Mad7 universal RNA cursor sites (underline) and PAM 
sites (red text). (b) Data plot showing the ratio of injected animals displaying RFP in the 
notochord out of total carrying the transgene. Whiskers represent mean ± s.d. p values 
calculated with one-tailed Student’s t-test. (c,d) Gel showing expected shift as a result of the 
target and one direct repeat being lost after strand annealing repair compared to uninjected 
animal. 
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2b). However, these repair events are equally mosaic (Figure 2f). These results 
indicate that noto:RFP-DR48  is a viable assay for screening the propensity of 
designer nucleases to elicit SAMR and that the enzymatic activity of Mad7 enhances 
activation of SAMR in vivo. 
 
Figure 2 continued  – Using noto:RFP-DR48 to assay the propensity of Mad7 and Cas9 in 
eliciting strand annealing. (e, f) Mosaicism of RFP expression in the notochord after targeting 
noto:RFP-DR48 with Cas9 or Mad7. (g, g’) Example of a broadly expressing embryo after 
targeting noto:RFP-DR48. (h, h’) Example of an intermediately expressing embryo after 
targeting noto:RFP-DR48. (i, i’) Example of a narrowly expressing embryo after targeting 
noto:RFP-DR48. Scale bars are 100 um. 
e f
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Figure 2 continued
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Exon 1 
5’-CCGCTTATTTACTCGCAGATGCCACACTTCGC-3’
3’-GGCGAATAAATGAGCGTCTACGGTGTGAAGCG-5’
5’-TTTAGGGGAGGCGTTCGGGCCACAGgagCCGCTTATTTACTCGCAGATGCCA-3’
3’-AAATCCCCTCCGCAAGCCCGGTGTCctcGGCGAATAAATGAGCGTCTACGGT-5’
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noto bait 5’ junction fragment
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                        noto <---  24 bp domain  --->Vector
Precise junction     – GCGCTCCCGCTTATTTACTCGCAGATGCCAGGATCC
Junction             – GCGCTCCCGCTTATTTACTCGCAGATGCCAGGATCC
b’
Figure 3 – Targeting noto with GeneWeld using only a 5’ homology domain. (a) 
Schematic showing designed homology for precise 5’ integration using Mad7. Green is 
designed homology. The PAM for Mad7 targeting in the genome and donor is underlined. (b, 
b’) Representative confocal Z-stack image showing mosaic GFP expression in the embryo. 
Scale bar is 100 um. (c) Data plot showing the ratio of embryos with GFP expression in the 
notochord out of total injected embryos. Whiskers represent mean ± s.d. (d) Gel showing 
junction fragment expected after precise integration using GeneWeld. (e) Gel showing no 
junction, indicating there is no integration without the genomic pre-crRNA. (f) DNA sequencing 
of Lane 5 in (d) showing a precise integration using the programmed homology.  
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Figure 4 – Targeting noto with GeneWeld. (a) Schematic of noto showing designed 
homology for precise integration using Mad7. Green is designed 5’ homology. Blue is 
designed 3’ homology. The PAM for Mad7 targeting in the genome and donor is underlined. 
(b, b’) Confocal Z-stack image showing broad GFP expression in the embryo. Scale bar is 
100 um. (c) Data plot showing the ratio of embryos with GFP expression in the notochord out 
of total injected embryos. Whiskers represent mean ± s.d. (d) Gel showing 5’ junction 
fragment expected after precise integration using GeneWeld. (e) Gel showing 3’ junction 
fragment expected after precise integration using GeneWeld. (f) DNA sequencing of Lane 5 
in (d) and (e) showing a precise integration using the programmed homology.  
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GeneWeld with Mad7 
We leveraged the activity of the U-pre-crRNA to determine whether 
CRISPR/Mad7 would permit HMEJ based integration of fluorescent reporters using 
our previously described system GeneWeld (Wierson et al., submitted). First, we 
injected nMad7n, noto-pre-crRNA1, U-pre-crRNA, and a GFP reporter plasmid 
programmed with the U-pre-crRNA site and 24 bp of homology 5’ to noto-crRNA1 
genomic site to elicit gene targeting at noto (Figure 3a, Table 5). Indeed, fluorescent 
positive notochord cells were observed at the 18-somite stage, indicating in frame 
integration of the GFP cassette at noto (Figure 3b, b’). On average, 24% of embryos 
injected display targeted noto integrations (Figure 3c, Table 6). However, notochords 
were highly mosaic, indicating a low efficiency of somatic integration activity (Figure 
3b, b’). GFP was often observed outside of the notochord, as expected with biallelic 
disruption of noto (Talbot, Trevarrow et al. 1995). Junction fragment PCR was 
performed on GFP+ embryos to confirm integration using the programmed 
homology. As expected, a PCR band was recovered in GFP+ embryos, while no 
PCR band is detected in the same experiment performed without the genomic pre-
crRNA (Figure 3d, 3e). DNA sequencing confirmed precise junctions at the 5’ end of 
the integration (Figure 3f).  
We next designed a GeneWeld donor with both 5’ and 3’ homology domains 
in order to integrate a DNA cassette without the vector backbone (Figure 4a, Table 
4, Table 5). Indeed, targeting noto using pre-crRNA3 with GeneWeld resulted in an 
average of 31% of embryos with GFP+ notochords (Figure 4b, 4b’, Figure 4c, Table 
6). While most notochords were highly mosaic and displayed GFP expression 
indicative of lost cell fate, as with noto target 1 targeting (Figure 3b), some events 
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are recovered where the vast majority of the notochord is expressing GFP (Figure 
4b). PCR confirmed the expected 5’ and 3’ junction fragments in GFP+ embryos 
(Figure 4d, 4e). Junction fragment sequencing from a single embryo confirmed 
precise integration at both ends of the integration (Figure 4f). These data indicate 
that Mad7 is an effective editor for generating precise GeneWeld integrations, but 
show that optimization is needed to enhance targeting frequency and somatic 
integration efficiency. 
 
Mad7 activity in human cells 
 To confirm previous reports of Mad7 activity in human cells, we targeted the 
therapeutically relevant AAVS1 locus (Figure 5a). An expression vector to drive 
Mad7 and AAVS1 pre-crRNA1 (pMad7-AAVS1) was transfected into HEK293 cells. 
Without selection, genomic DNA from whole cell populations of transfected and 
control experiments was PCR amplified at the Mad7 target site. In order to assess 
the in vitro cleavage activity of Mad7, we utilized the T7 endonuclease assay to 
qualitatively determine if indels were present. As expected, cleaved bands were 
detected in transfected cell DNA, but not control cell DNA, suggesting Mad7 activity 
at the target locus (Figure 5b). To gain a more quantitative understanding of the 
cleavage activity of Mad7 in vitro, PCR amplicons of Mad7 transfected cells targeting 
AAVS1 were submitted for Sanger sequencing. ICE analysis suggests that targeting 
AAVS1 with Mad7 and pre-crRNA1 creates indels in 67% of sequenced amplicons, 
and 56% of these mutations at this site resulted in out-of-frame knock-out. ICE 
analysis shows the most prevalent indel is a 5-base pair deletion, in contrast to the 
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longer deletions in zebrafish (Figure 5c, Table 1). Taken together, these data 
demonstrate that Mad7 is active in human cells at AAVS1. 
We next wanted to determine if Mad7 would mediate GeneWeld integrations 
at the AAVS1 pre-crRNA1 site. We designed a GeneWeld donor with 48 bp 
homology arms flanking a CMV:GFP::Zeocin fusion cassette (pGFP::Zeo-48) to be 
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Figure 5 – Mad7 activity and GeneWeld in human cells. (a) Schematic showing AAVS1 
target site and pre-crRNA. (b) T7E1 assay displaying cleaved amplicon, indicative of indels 
after Mad7 targeting. No amplicon cleavage is detected in the control. (c) ICE analysis 
showing percentage of PCR products sequenced with a given indel size. (d) Schematic of 
AAVS1 showing designed homology for precise integration using Mad7. Green is designed 
5’ homology. Blue is designed 3’ homology. The PAM for Mad7 targeting in the genome and 
donor is underlined. (e) Gel showing 5’ junction fragment expected after precise integration 
using GeneWeld in both HT1080 and HEK293 cells. No junction is obtained when 
transfecting cells with just the donor. (f) DNA sequencing of 5’ junctions showing precise 
integration using the programmed homology. 
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liberated by the AAVS1 pre-crRNA1 (Figure 5d, Table 4, Table 5). The pGFP::Zeo-
48 and pMad7-AAVS1 were doubly-transfected into both HEK293 and HT1080 cells. 
Two days post transfection, DNA from whole cell populations was harvested and 
screened for insertion of the cassette by junction fragment PCR. Indeed, in both cell 
types, a 5’ junction fragment was observed, while cells transfected with the donor 
but no Mad7/pre-crRNA did not display a PCR product (Figure 5e). We sequenced 
these junction fragments and confirmed precise targeting in both cell types (Figure 
5f). These data demonstrate that Mad7 is a viable nuclease for mediating GeneWeld 
integrations in human cells.  
 
Discussion 
In this report, we demonstrate for the first time CRISPR/Mad7’s activity in 
zebrafish and its application as an efficient alternative nuclease for generating 
HMEJ-based gene targeting events in vivo and in human cells in vitro. We employed 
nMad7n mRNA injection using pre-crRNAs to create frame shift knock-out alleles in 
noto and cx43.4 at ~54% and ~35%, respectively based on next generation 
sequencing analysis. Mad7 activity is temperature dependent and requires a 34º 
heat shock for activity in zebrafish. We demonstrate that Mad7 elicits SAMR in a 
genomic reporter assay at levels nearly 2-fold greater than Cas9. We also 
demonstrate that Mad7 is a viable nuclease for mediating gene targeting using the 
GeneWeld strategy in zebrafish. In addition, we demonstrate effective chromosome 
disruption and GeneWeld integrations in human cells at AAVS1. 
In the only report of Cas12a family CRISPR system activity in zebrafish, 
appreciable nuclease activity was only observed after RNP delivery and heat shock, 
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“proxy-CRISPR” to relax chromatin structure, or targeting a gene with multiple 
crRNAs at once (Moreno-Mateos, Fernandez et al. 2017). Nuclease activity was 
shown to be dependent on the stability of the pre-crRNA or crRNA complexing with 
Cas12a, protecting it from degradation. While pre-crRNA was ineffective for 
nuclease activity under normal conditions with Cas12a, longer heat shocks rescued 
activity, indicating a kinetics issue with the use of pre-crRNA. It is interesting to note 
that in our experiments, pre-crRNA injection with nMad7n mRNA permitted activity 
while crRNA was less effective, displaying a stark contrast between Cas12a and 
Mad7 in either their ability to complex with the RNA guide and access DNA or the 
stability of the differing pre-crRNA structures. Further, the use of multiple crRNAs 
per target a gene in tandem, dramatically increasing the possibility of off target 
effects, while our study displays sufficient knock-out activity with only a single crRNA 
per target gene.  
Levels of mosaicism in gene targeting using HMEJ in zebrafish vary greatly in 
the reported literature (Hisano, Sakuma et al. 2015) Wierson et al., 2018 submitted. 
Consistent with the observation that SAMR in noto:RFP-DR48 is mosaic, it was 
recently reported that translation of Cas9 mRNA and subsequent gene editing after 
one-cell stage injection is not complete until the 16 or 32 cell stage while RNP 
injections however result in appreciable nuclease activity by the 2-4 cell stage 
(Zhang, Zhang et al. 2018). noto:RFP-DR48 thus represents an assay system where 
injection conditions can be optimized to enhance somatic gene targeting and 
decrease mosaicism in cell types that arise from the mesoderm.  
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While noto:RFP-DR48 showed enhanced activity for SAMR vs Cas9, our gene 
targeting experiments with Mad7 in zebrafish displayed no difference compared to 
our previous reports (Wierson et al., submitted, Chapter 2). It could be predicted that 
repair of DNA in cis is more efficient than in trans, and thus the outcome of strand 
annealing in a genomic reporter will not translate to targeted integrations. 
Additionally, while Mad7 is an effective editor for GeneWeld integrations, mosaicism 
is greater than when using Cas9 as the GeneWeld editor (Wierson et al., 2018 
submitted, Chapter 2). Still, optimization of PAM orientation, RNA cursor kinetics, 
and homology arm choice and size may lead to enhanced rates with Mad7. Indeed, 
it was recently reported that the addition of tracts of uridine at the 3’ end of Cas12a 
crRNAs enhances nuclease activity (Bin Moon, Lee et al. 2018). It will be interesting 
to test different modifications of crRNAs both their effect on mutagenesis and gene 
targeting. 
 
Future work 
While the data presented here is compelling evidence that Mad7 is a 
functional nuclease in zebrafish and human cells, optimization is needed. Only one 
experimental condition for heat shock has been analyzed to date: a 34º heat shock 
for 4 hours following injection. It is possible that altering the heat shock length may 
promote enhanced activities, though Cas12a activity is optimal using the conditions 
described here. Additionally, a thorough comparison using more pre-crRNAs at 
additional target sites and genes in both zebrafish and human cells may uncover the 
rules for how PAM specificity and GC content of individual RNA cursors mediates 
Mad7 activity. 
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Sequencing of more target sites will also allow a better analysis of the 
potential cut site and any preferential repair of Mad7 events using MMEJ. 
Sequencing of noto:RFP-DR48 is needed to determine if the difference in the 
percentage of injected GFP+ animals using Cas9 and Mad7 is a result of enhanced 
SAMR in the mesoderm or the embryo as a whole. Additionally, the use of pre-
crRNA or crRNA is a factor that alters Cpf1 activity in zebrafish (Moreno-Mateos, 
Fernandez et al. 2017). Interestingly, we compared noto-pre-crRNA1 to noto-
crRNA1 and found crRNA less effective for biallelic inactivation of noto at target 1, 
indicating a difference between the secondary structures between LbCpf1 and Mad7 
RNA cursors, but a more thorough analysis of these experiments is needed. 
Additionally, more analysis of Mad7 targeting at AAVS1 in human cells is needed in 
order to determine the repair outcomes from using Mad7 to generate indels. 
A more thorough dissection of conditions that may enhance GeneWeld 
activity is also needed. The experiments outlined above may also shed light on a 
more rationale design of homology arms for GeneWeld experiments, including 
where homology should be designed for optimal integration activities. While raw 
percentages of integration positive events per injected animal is on par with 
GeneWeld using Cas9, somatic mosaicism using GeneWeld with Mad7 is at levels 
that likely preclude efficient recovery of germline transmission events. However, only 
one locus has been tested in zebrafish, noto, and it is possible that other loci will be 
more efficient. Further analysis of GeneWeld events in human cells includes FACs 
sorting GFP+ cells in order to determine the efficiencies of targeted integration. 
Potential experimental conditions that may enhance activity are: properly designed 
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homology arms based on cut site and overhang analysis of Mad7 nuclease activity, 
longer homology arms, varying concentrations of Mad7 mRNA and RNA cursor 
levels, and shorter or longer heat shocks for optimal Mad7 activity. Additionally, 
experiments testing HDR mediated SNP generation with oligonucleotides is of 
interest to the field. 
 
Conclusions 
Here, we demonstrate effective chromosome editing in a vertebrate model in 
vivo and human cells in vitro using the newly described CRISPR/Mad7 system. 
CRISPR/Mad7 is active in zebrafish and promotes efficient somatic mutation and 
HMEJ-mediated integration. Integration of donor cassettes is achieved at levels up 
to 44% in zebrafish, immediately demonstrating the utility of this system alternate 
nuclease system to generate precision genome modifications. In human cells, Mad7 
represents an additional tool to target the therapeutically relevant AAVS1 locus. 
Alternate nuclease systems are of interest to the field of precision therapeutics in 
order to expand the available toolbox for creating a desired genome editing 
outcome. Mad7 increases the flexibility that researchers have in generating gene 
targeting events beyond the canonical CRISPR/Cas9 PAM site. Following 
optimization, our data indicate that the use of Mad7 may enhance gene targeting 
activity. 
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gBlock name Sequence
Fragment 1
CCATGGCTTCTCCACCTAAGAAGAAGAGAAAGGTGAACAACGGAACTAATAATTTTC 
AAAACTTCATTGGGATTAGTTCTCTGCAGAAGACCCTTCGGAATGCCCTCATTCCCACTGAGACGACTCAACAGTTTATCGTAAAAAATGGAATTATTAAGGAGGATG 
AGTTGCGGGGGGAGAATAGGCAGATTTTGAAAGACATCATGGATGACTATTACCGGGGTTTTATCTCCGAGACCCTGTCCTCTATCGATGATATTGATTGGACGTCTC 
TTTTTGAGAAGATGGAGATTCAGCTGAAAAATGGTGATAACAAAGATACCCTCATTAAGGAGCAAACCGAGTACCGGAAGGCGATCCACAAGAAGTTCGCCAACG 
ATGATCGTTTTAAGAATATGTTCTCAGCCAAACTCATCAGTGACATCCTTCCAGAATTTGTAATTCATAATAATAACTACTCTGCGTCTGAGAAAGAAGAAAAAACTCA 
AGTCATCAAGCTCTTTTCACGGTTTGCAACGAGCTTTAAGGATTACTTTAAAAACCGCGCTAATTGTTTTTCTGCGGACGACATCAGCTCATCCAGCTGCCACAGAATC 
GTCAATGACAATGCGGAGATCTTCTTCTCCAATGCTCTGGTATATAGGCGCATTGTAAAGTCCTTGTCCAATGACGATATTAATAAGATAAGTGGTGATATGAAGGA 
TTCTCTCAAGGAAATGTCATTGGAGGAGATCTACAGCTATGAGAAATACGGTGAATTTATTACACAAGAAGGAATATCCTTTTATAATGACATCTGTGGGAAGGTGA 
ATTC 
Fragment 2
GAATTCTTTCATGAATTTGTACTGTCAAAAAAACAAGGAGAACAAAAACCTCTACAAATTGCAAAAACTGCATAAGCAAATTCTTTGTATAGCGGACACTAGCTATGATCC
TCGACAACATTTCCAGTAAGCATATCGTGGAACGGCTCAGGAAGATAGGG 
GATAACTATAATGGCTATAACCTTGACAAGATCTATATCGTGAGTAAATTCTATGAAAGTGTATCTCAAAAGACCTATCGAGATTGGGAAACCATAAACACAGCTCTT 
GAGATTCATTACAATAATATTCTTCCTGGTAACGGGAAAAGTAAAGCCGATAAAGTGAAGAAGGCCGTCAAAAACGACCTGCAGAAGAGCATAACGGAAATCAATG 
AATTGGTGTCTAACTACAAGCTGTGCTCAGATGACAACATAAAAGCTGAGACATATATCCATGAGATCAGCCACATACTGAATAACTTTGAGGCGCAAGAGCTGAAAT 
ATAATCCTGAGATCCACCTTGTAGAGTCTGAACTCAAGGCTTCCGAACTGAAAAATGTACTTGACGTAATCATGAATGCTTTTCACTGGTGTAGTGTATTCATGACTGA 
GGAACTGGTTGATAAGGATAATAATTTTTATGCGGAACTTGAAGAAATATACGATGAGATTTATCCCGTTATCTCACTCTATAATTTGGTCCGAAATTATGTAACTCA 
AAAACCATACTCCACAAAGAAAATCAAGCTCAATTTCGGTATCCCGACCTTGGCTGACGGATGGTCTAAAAGCAAGGAGTACTCCAATAACGCGATAATCTTGATGC 
GAGATAATCTTTACTATCTCGGAATTTTTAATGCTAAAAATAAGCCCGATAAAAAGATTATTGAAGGAAACACATCTGAGAACAAAGGCGATTATAAAAAGATGATT 
TATAATTTGCTCCCTGGACCAAACAAAATGATCCCTAAAGTTTTCCTCAGTTCCAAGACCGGGGTTGAGACGTACAAGCCTAGTGCATATATCTTGGAAGGTTATAAG 
CAAAACAAGCACATCAAAAGTTCTAAGGACTTTGACATCACTTTTTGTCATGATTTGATTGACTATTTTAAAAACTGTATTGCAATTCACCCAGAGTGGAAGAATTTTG 
GATTTGACTTCTCAGACACGTCTACCTATGAAGATATATCAGGATTTTATCGCGAGGTTGAGCTCCAGGGTTACAAGATTGATTGGACTTATATCAGCGAGAAGGATA 
TTGATCTTTTGCAGGAAAAAGGCCAACTTTATTTGTTCCAAATCTACAACAAGGACTTTTCTAAGAAATCAACTGGCAACGATAACCTTCATACTATGTACCTCAAAAA 
TCTCTTTTCCGAAGAGAATCTTAAGGATATCGTGCTCAAGCTGAACGGTGAGGCAGAGATATTTTTCCGAAAGAGTTCTATCAAAAACCCAATTATCCACAAAAAAGG 
CAGCATCCTGGTTAACAGGACGTACGGGTGCCGTATAAATTTGAGTCAGATGAGGAGGTCTACCAAAGCGTAAACGGCT 
Fragment 3
CGTACGAGGCCGAAGAGAAAGATCAGTTCGGCAACATACAGATAGTGCGGAA 
GAATATACCAGAGAATATCTACCAAGAGCTTTATAAGTATTTTAATGATAAGTCTGAGCTACGGTTTTAAAAAAGGGAGGTTCAAGGTGGAGCGACAGGTGTACCA 
AAAGTTTGAAACGATGCTTATTAATAAACTCAATTACCTCGTGTTCAAGGATATAAGCATAACAGAAAATGGAGGGCTCCTTAAGGGATACCAGCTCACATACATAC 
CGGACAAGCTTAAAAACGTGGGACACCAGTGCGGGTGTATATTTTACGTTCCTGCCGCGTATACATCAAAGATAGACCCCACCACAGGGTTCGTGAATATCTTCAAG 
TTTAAGGACTTGACAGTCGATGCAAAACGTGAGTTCATCAAGAAATTCGATTCAATCCGGTACGATTCAGAAAAGAATCTGTTCTGTTTTACGTTCGATTATAACAACT 
TTATTACGCAAAATACAGTGATGTCAAAGAGCTCATGGAGTGTCTACACATACGGGGTTAGGATAAAGCGCAGGTTCGTTAACGGTCGGTTCTCAAACGAATCAGAC 
ACGATTGACATTACGAAGGATATGGAAAAGACTCTGGAGATGACCGACATAAATTGGCGAGACGGCCACGACCTCCGACAAGATATCATTGACTACGAGATCGTCC 
AACACATTTTTGAAATCTTCCGGTTGACCGTCCAGATGCGAAACAGTCTTTCTGAATTGGAAGACCGGGATTACGACAGATTGATCAGTCCTGTATTGAACGAAAACA 
ACATATTCTATGATTCCGCCAAAGCTGGCGATGCTTTGCCAAAAGACGCCGACGCGAATGGAGCATATTGTATCGCCCTTAAAGGCCTTTACGAAATCAAACAAATAA 
CAGAGAACTGGAAAGAGGATGGGAAATTTAGCCGAGATAAGCTCAAGATCAGCAACAAAGACTGGTTTGACTTTATTCAAAACAAACGGTACTTGCCGAAAAAGAA 
ACGCAAAGTATAACCGCGGAGACAAAGAGCTTTCAGACGAGGCGGCGAAGTTGAAAAATGTAGTGGGACAT 
CACGAAGCCGCCACAAACATCGTGAAGGACTATCGGTATACCTATGATAAGTACTTCCTTCACATGCCAATCACGATCAATTTTAAAGCGAATAAGACCGGGTTCAT 
AAATGACCGGATTCTGCAGTACATAGCAAAGGAGAAAGATCTTCATGTTATAGGCATTGATCGCGGCGAAAGAAACCTTATTTATGTCTCCGTTATAGACACATGTG 
GGAACATCGTTGAACAAAAATCCTTTAATATCGTTAATGGATACGACTATCAGATAAAGCTCAAACAACAGGAGGGGGCGCGCCAGATTGCTCGTAAAGAATGGAA 
GGAAATAGGAAAAATAAAAGAAATCAAGGAGGGTTACCTGAGCCTTGTAATTCATGAAATCTCCAAAATGGTTATAAAGTACAACGCGATTATTGTCATGGAAGATT 
Mad7 cloning primers
mad7f1 ATGCCCATGGCTTCTCCACC
mad7r1 GCATGAATTCACCTTCCCACAGATG
mad7f2 ATGCGAATTCTTTCATGAATTTGTACTGTC
mad7r2 GCATCGTACGTCCTGTTAACCAG
mad7f3 ATGCCGTACGAGGCCGAAG
mad7r3 GCATCCGCGGTTATACTTTGCG
Mad7 cloning for human expression
Mad7 AgeI Fw ACCGGTTTCTTTTTGCAGAAGCTCAG
Mad7 BamHIRev GGATCCTACTTTGCGTTTCTTTTTCGG
mad7 sgRNA AAVS1 top CACCGTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATGGACGGTGCGATCCCACCCCTTTTTT
mad7 sgRNA AAVS1 bottom GGCCAAAAAAGGGGTGGGATCGCACCGTCCATCTACAAGAGTAGAAATTAAAAAGGTCTTTTGAC
Table 3 - Mad7 cloning
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Primer name Sequence Purpose
notojxnf ATAGACGCTCTGCTCGCGAG Indel and junction fragment analysis
notojxnr CTTGTGCGTACACAGCTCCAC Indel and junction fragment analysis
cx43.4jxnf1 CCTTCGTGGGCAAGATATGGCTC Indel and junction fragment analysis
cx43.4jxnf1r TCTCACAACCAGGTTGCTGGG Indel and junction fragment analysis
cx43.3jxnf2f ATGGAAGAGATCGTGCCTGAGAAA Indel and junction fragment analysis
cx43.4jxnf2r AATCCTCGACAGAAGCTGCAGG Indel and junction fragment analysis
SSA f CGACATCCTGGCTACCAGCTTC Indel and junction fragment analysis
SSA R TGTCGCTTCTGCCTTCCAGG Indel and junction fragment analysis
gfp5'R GCTGAACTTGTGGCCGTTTA Indel and junction fragment analysis
GFP3'F ACATGGTCCTGCTGGAGTTC Indel and junction fragment analysis
cxm7gRNA2fEZ ATGCATGCCCTTCGTGGGCAAGATATGGCTC Indel and junction fragment analysis
cxm7gRNA2rEZ ATGCATGCTCTCACAACCAGGTTGCTGGG Indel and junction fragment analysis
mad7noto1fEZ CGTACGTAATAGACGCTCTGCTCGCGAG Indel and junction fragment analysis
mad7noto1rEZ CGTACGTACTTGTGCGTACACAGCTCCAC Indel and junction fragment analysis
mad7noto3fEZ TCGATCGAATAGACGCTCTGCTCGCGAG Indel and junction fragment analysis
mad7noto3rEZ TCGATCGACTTGTGCGTACACAGCTCCAC Indel and junction fragment analysis
AAVS1Target1FW CCCATTGAACCCCCGTCTAC Indel and junction fragment analysis
AAVS1Target1Rev TGCCCCTACTCACGAATCTC Indel and junction fragment analysis
AAVS1ExonTargetFwTGCAGCTTCGGAACCAAAAAG Indel and junction fragment analysis
AAVSIExonTargetReGGGGCAGTTCCCTCGACTG Indel and junction fragment analysis
CMVUnivRev CCCGTGAGTCAAACCGCTAT Indel and junction fragment analysis
noto site 1 pre-
crRNA GTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATCTCGCAGATGCCACACTTCGC Synthego custom RNA
noto site 2 pre-
crRNA GTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATCATGATGCTTTGGCTGTACGC Synthego custom RNA
noto site 3 pre-
crRNA GTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATGTTGGTTATGCTCCGGTACGC Synthego custom RNA
cx43.4 site 1 
pre-crRNA GTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATTTCTCCGCCGGCCGTCATGTT Synthego custom RNA
cx43.4 site 2 
pre-crRNA GTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATACTGTTGTGGGGGGAGAATCG Synthego custom RNA
noto site 1 
crRNA GGAATTTCTACTCTTGTAGATCTCGCAGATGCCACACTTCGC Synthego custom RNA
UgRNA pre-crRNA GTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATGGGGAGGCGTTCGGGCCACAG Synthego custom RNA
Human
AAVSI Target 1 GTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATGGACGGTGCGATCCCACCCCT IDT Oligos
AAVSI Exon 
Target GTCAAAAGACCTTTTTAATTTCTACTCTTGTAGATCCTCCAGGACTTGTCCAAGGA IDT Oligos
noto site 1 5' 
arm A 24 AATTCTTTAGGGGAGGCGTTCGGGCCACAGGAGCCGCTTATTTACTCGCAGATGCCAG Homology arm oligo
noto site 1 5' 
arm B 24 GATCCTGGCATCTGCGAGTAAATAAGCGGCTCCTGTGGCCCGAACGCCTCCCCTAAAG Homology arm oligo
noto site 3 5' 
arm A 24 AATTCTTTAGGGGAGGCGTTCGGGCCACAGTTTGCGGAGATGAGAGAACGAACAAACG Homology arm oligo
noto site 3 5' 
arm  B 24 GATCCGTTTGTTCGTTCTCTCATCTCCGCAAACTGTGGCCCGAACGCCTCCCCTAAAG Homology arm oligo
noto site 3 3' 
arm  A 24 CATGGGAGCATAACCAACCAAACGCCTGTAAACTGTGGCCCGAACGCCTCCCCTAAAC Homology arm oligo
noto site 3 3' 
arm  B 24 GGCCGTTTAGGGGAGGCGTTCGGGCCACAGTTTACAGGCGTTTGGTTGGTTATGCTCC Homology arm oligo
AAVSI T1 L48HA CTTTAGGACGGTGCGATCCCACCCCTCTGAGCCAGAATCGGAAGAGCCAGACGGAGGCTTTAGGACGGTGCGATCCTGCAGGCGTTACATAACTT Homology arm oligo
AAVS1 T1 R48HA CTTTAGGACGGTGCGATCCCACCCCTGGGAAGCCAGGAAGCTGGGCACCCAGCAGGCAAAGCCCCGACGGAGGGTTACGGTTCCTGGCCTTTTGCTG Homology arm oligo
AAVS1 T1 L24HA CTTTAGGACGGTGCGATCCCACCCCTCGGAGGCTTTAGGACGGTGCGATCCCTGCAGGCGTTACATAACTT Homology arm oligo
AAVS1 T1 R24HA CTTTAGGACGGTGCGATCCCACCCCTACCCAGCAGGCAAAGCCCCGACGGTTACGGTTCCTGGCCTTTTGCTG Homology arm oligo
Table 4 - Primers and oligos
Genomic target Donor vector Donor sgRNA  target (genomic or UgRNA)
Homology 
length 
(5'/3')
Experiment 
number
Reporter 
positive 
embryos
Total 
embryos 
Percent 
with 
positive 
report
Standard 
Error
noto site 1 p494-2a:eGFP-pA UgRNA 24/x 1 21 80 26.3%
p494-2a:eGFP-pA UgRNA 24/x 2 18 84 21.4%
p494-2a:eGFP-pA UgRNA 24/x 3 17 73 23.3%
Average 56 237 23.6% 0.01146295
noto site 3 p494-2a:eGFP-pA UgRNA 24/24 1 33 74 44.6%
p494-2a:eGFP-pA UgRNA 24/24 2 9 50 18.0%
p494-2a:eGFP-pA UgRNA 24/24 3 14 57 24.6%
Average 56 181 30.9% 0.06530989
Table 6 - Gene targeting experiments, knock-in repetitions 
Genomic target Donor vector Genomic target sequence Donor target sequence 5' spacer 5' homology arm 3' spacer 3' homology arm 
Zebrafish
noto site 1 p494-2a:eGFP-pA TTTACTCGCAGATGCCACACTTCGC TTTAGGGGAGGCGTTCGGGCCACAG gag CCGCTTATTTACTCGCAGATGCCA N/A N/A
noto site 3 p494-2a:eGFP-pA AAACGCGTACCGGAGCATAACCAAC TTTAGGGGAGGCGTTCGGGCCACAG ttt GCGGAGATGAGAGAACGAACAAAC aaa GAGCATAACCAACCAAACGCCTGT
Human
AAVS1 site 1 pCMV:GFP::Zeo-48 TTTAGGACGGTGCGATCCCACCCCT TTTAGGACGGTGCGATCCCACCCCT N/A CTGAGCCAGAATCGGAAGAGCCAGACGGAGGCTTTAGGACGGTGCGAT N/A
CCCTCCGTCGGGGCTTTGCCTGCTGGG
TGCCCAGCTTCCTGGCTTCCC
Table 5 - Targeting domain information for all gene targeting experiments. N/A means not applicable
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Materials and methods 
Zebrafish husbandry 
Zebrafish were maintained in Aquatic Habitats (Pentair) housing on a 14 hour 
light/10 hour dark cycle. Wild-type WIK were obtained from the Zebrafish 
International Resource Center. All experiments were carried out under approved 
protocols from Iowa State University IACUC.   
 
nMad7n cDNA cloning 
gBlocks were ordered from IDT with zebrafish codon optimized Mad7 cDNA 
sequences based on Inscripta public disclosure and the addition of dual NLS 
sequences at the 5’ and 3’ end of the cDNA (Table 3). Three gBlock dsDNA 
templates were amplified with KOD HotStart DNA polymerase (EMD Millipore) using 
primers mad7f1/mad7r1, mad7f2/mad7r2, mad7f3/mad7r3, cut with respective 
restriction enzymes, and four-part restriction cloning into NcoI/SacII cut pT3TS 
vector backbone was performed (Plasmid #46757 Addgene). Sequence of Mad7 
using primer walking and a full annotation was confirmed. 
 
Donor preparation 
Donors were prepared and purified as described previously (Wierson et al., 
2018). Homology arm design was hypothesized previous to deciphering the cut site 
and are built as follows: One arm begins 13 bp 3’ of the PAM while the other arm 
begins immediately outside of the 3’ end of the crRNA target site. See Figure 3 and 
Figure 4 for homology arm design, and Table 4 for GeneWeld homology arm oligos 
used for Golden Gate cloning. 
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Generating noto:RFP-DR48  
See Wierson Dissertation, Chapter 4 for detailed methods. 
 
Injection protocol 
Linear, purified pT3TS-nCas9n or pT3TS-nMad7n was used as template for 
in vitro transcription of capped, polyadenylated mRNA with the Ambion T3TS 
mMessage mMachine Kit. mRNA was purified using Qiagen miRNeasy Kit. The 
Cas9 universal sgRNAs were generated using cloning free sgRNA synthesis as 
described in Varshney et al., 2015 and purified using Qiagen miRNeasy Kit. All 
Mad7 pre-crRNA and crRNA was ordered as custom RNA oligos from Synthego with 
sequences described in Figure 1a. 
 
Heat shock protocol 
 Immediately after injection, embryos were placed in a 34ºC incubator for 4 
hours. At 4 hours, embryos were sorted for fertlization and moved to 28ºC incubator 
as normal. 
 
DNA isolation and PCR genotyping 
Genomic DNA for PCR was extracted by digestion of single embryos in 
50mM NaOH at 95oC for 30 minutes and neutralized by addition of 1/10th volume 
1M Tris-HCl pH 8.0. GoTaq Green was used as DNA polymerase master mix with 
the primers listed in Table 4. AmpliconEZ from GeneWiz was used for NGS 
sequencing (see below) using primers mad7noto1fEZ and mad7noto1rEZ for noto 
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target 1, mad7noto3fEZ and mad7noto3rEZ for noto target 3, and cxm7gRNA2fEZ, 
cxm7gRNA2rEZ for cx43.4 listed in Table 4. GFP+ embryo 5’ junction fragments for 
noto target 1 and target 3 were were PCR-amplified with primer notojxnf and gfp5’r 
listed in Table 8. GFP+ embryo 3’ junction fragments for noto target 3 were 
were PCR-amplified with primer GFP3’F and notojxnr listed in Table 4. All junction 
fragment products were cloned into pCR4-TOPO vector and sequenced (Invitrogen). 
 
Cloning in vitro Mad7 construct targeting AAVS1 (pMad7-AAVS1) 
Due to redundant restriction sites in the guide scaffold and Mad7 protein, the 
px601 plasmid (Addgene #61591) was digested with BsaI and NotI to first insert the 
Mad7 secondary structure and sgRNA targeting AAVS1 with mad7 sgRNA AAVS1 
top and mad7 sgRNA AAVS1 bottom (termed AAV: Mad7 AAVS1 sgRNA) (Table 3). 
Following this Mad7 as well as the Xenopus globin 5’ UTR and both N and C termini 
SV40 NLS signals were amplified from “T3TS nMadn” using PCR primers Mad7 
AgeI forward and Mad7 BamHI reverse (Table 3). The resulting 3.9kbp PCR 
fragment was cloned into an Agilent pSC Strataclone PCR cloning vector (termed 
Mad7 Strataclone) to amplify the amount of fragment with the desired restriction 
sites. Mad7 Strataclone was digested with AgeI and BamHI to isolate Mad7 with 
ends compatible with the AAV:Mad7 AAVS1 sgRNA construct. The px601 plasmid 
was likewise digested with AgeI and BamHI to remove SaCas9 and be replaced by 
Mad7. Plasmids were screened for insertion of both Mad7 as well as the AAVS1 
targeting sgRNA (pMad7-AAVS1) and grown up with Qiagen Maxiprep kit.  
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Generating knock-in cassette for AAVS1 
The 24 and 48bp homology arm CMV/GFP/Zeocin resistance knock-in cassettes 
were generated by designing PCR primers complimentary to the psiRNA-SV40 Early 
PolyA GFPzeo plasmid (Gift from Barry Lab) flanked by the 48 base pairs of 
homology likewise flanked by the donor target sequence that is identical to the 
AAVS1 Mad7 target sequence. The left 48HA forward primer AAVSI T1 L48HA and 
the right 48HA reverse primer AAVS1 T1 R48HA were used to amplify the 
CMV/GFP/Zeocin resistance cassette containing the homology arms and the donor 
target sequence (Table 4). This 2.6kbp PCR fragment was subsequently cloned into 
a Strataclone PCR cloning vector and screened for the insert. Sequence confirmed 
knock in constructs were amplified with Qiagen Maxiprep Kit and termed 
“pGFP::Zeo-48”.  
 
GeneWiz AmpliconEZ  
DNA Library Preparation and Illumina Sequencing 
DNA library preparations, sequencing reactions, and initial bioinformatics 
analysis were conducted at GENEWIZ, Inc. (South Plainfield, NJ, USA). DNA Library 
Preparation, clustering, and sequencing reagents were used throughout the process 
using NEBNext Ultra DNA Library Prep kit following the manufacturer’s 
recommendations (Illumina, San Diego, CA, USA). End repaired adapters were 
ligated after adenylation of the 3’ends followed by enrichment by limited cycle PCR. 
DNA libraries were validated on the Agilent TapeStation (Agilent Technologies, Palo 
Alto, CA, USA), and were quantified using Qubit 2.0 Fluorometer (Invitrogen, 
Carlsbad, CA) and multiplexed in equal molar mass. The pooled DNA libraries were 
129 
loaded on the Illumina instrument according to manufacturer’s instructions. The 
samples were sequenced using a 2x 250 paired-end (PE) configuration. Image 
analysis and base calling were conducted by the Illumina Control Software on the 
Illumina instrument. 
Data analysis 
The raw Illumina reads were checked for adapters and quality via FastQC. 
The raw Illumina sequence reads were trimmed of their adapters and nucleotides 
with poor quality using Trimmomatic v. 0.36. Paired sequence reads were then 
merged to form a single sequence if the forward and reverse reads were able to 
overlap. The merged reads were aligned to the reference sequence and variant 
detection was performed using GENEWIZ proprietary Amplicon-EZ program. 
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Abstract 
Genome engineering with designer nucleases induces targeted DNA double-
strand breaks (DSBs) and subsequently provides researchers the ability to program 
DNA. However, after designer nuclease induced DSBs, competition between error-
prone and error-free DNA repair pathways complicates the ability for a researcher to 
specify an outcome of interest. Using a donor molecule containing short regions of 
homology to a DSB site directs the targeted integration of exogenous DNA in many 
vertebrate cell types, including in zebrafish, pig, and human cells, using an error-free 
DNA repair process dubbed homology-mediated end joining (HMEJ). HMEJ likely 
utilizes DNA repair machinery involved in single strand annealing (SSA) or 
microhomology-mediate end joining (MMEJ), however the protein requirements for 
these pathways are not sufficiently explored in the context of precision gene 
targeting. Further, the efficiencies and precision of HMEJ need to be enhanced for 
broader application and gene therapy. To this end, we developed two genomic 
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reporters to test for the protein requirements of strand annealing in zebrafish. These 
genomic reporters will allow for the systematic overexpression and inhibition of key 
proteins involved in DNA repair pathway choice and activity in order to identify and 
prioritize methods for enhancing the precision of gene targeting. 
 
Introduction 
Genome engineering relies on designer nucleases to create targeted DNA 
double-strand breaks (DSB). Upon designer nuclease induced DSBs, cells use one 
of two general pathways to seal the break: non-homologous end joining (NHEJ) or 
homology directed DNA repair (HDR). NHEJ is the most prevalent DNA repair 
pathway in most cellular contexts (Davis and Chen 2013). HDR sub-pathways 
include homologous recombination (HR), single-strand annealing (SSA), and 
microhomology-mediated end joining (MMEJ) (Ceccaldi, Rondinelli et al. 2016). 
While HR is an error-free DNA repair pathway that results in conservation of the 
original DNA sequence, SSA and MMEJ are error-prone pathways that result in the 
deletion of intervening sequences between direct repeats used for annealing the 
ends of broken DNA.  
Biasing DNA repair towards HDR sub-pathways is notable for precision 
genome engineering to drive DNA repair outcomes with predictable patterns of gene 
disruption or more advanced edits like gene targeting, where large cassettes of DNA 
are inserted at the site of a DNA break. DNA repair pathways can be considered a 
stochastic choice based on enzyme availability during the cell cycle, architecture of 
the DNA break, and local chromatin structure (Aparicio, Baer et al. 2014). The 
mechanisms governing these pathways have largely been deciphered in yeast and 
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mammalian cell culture using fluorescent reporter assays based on the iGFP system 
developed in the Jasin lab or similar variants (Pierce, Johnson et al. 1999) (Certo, 
Ryu et al. 2011) (Gunn and Stark 2012) (Bennardo and Stark 2010). In these 
assays, the rare cutting endonuclease I-SceI is used to introduce targeted DSB in 
the coding region of a nonfunctional GFP (Colleaux, D'Auriol et al. 1988). Repair 
with a linked donor GFP fragment using HR restores GFP fluorescence. The “traffic 
light reporter” (TLR) assay and additional variants, where NHEJ at a nuclease target 
site results in RFP expression while HR at the nuclease target site results in GFP, 
have also been important in identifying the usage of DNA repair pathways in 
different contexts with different nuclease systems (Certo, Ryu et al. 2011) (Kuhar, 
Gwiazda et al. 2014).  
Fluorescent reporter assay systems are advantageous as they provide a 
direct read-out of differing DNA repair pathway utilization, often in real time, and can 
be used for small molecule screening and protein overexpression/inhibition 
experiments. All assays described to date have relied on introducing exogenous 
promoter driven cassettes either randomly into genomes or through episomal 
assays, and most have used I-SceI as the DSB inducing reagent. Additionally, most 
of these assays have been performed in cell culture systems. However, an 
organismal level iGFP-like system has been applied to studying the repair of plasmid 
DNA in zebrafish in vivo (Liu, Gong et al. 2012). In this study, the authors confirmed 
cell culture reports that inhibition of Rad51, Rad52, and ligIV decrease the 
efficiencies of HR, SSA, and NHEJ, respectively in vivo. However, this study is 
dependent on I-SceI and the data is entirely derived from episomal assays of either 
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circular or linear injected plasmid DNA. The use of I-SceI and episomal assays in 
both cell culture and in vivo create limitations in experimental application at genomic 
sites. I-SceI cannot be re-engineered to target outside its 18 bp recognition site, and 
leaves a 4 bp 5’ overhang which complicates analysis of DNA repair pathway choice 
(Pierce, Johnson et al. 1999). 
While there are reports utilizing either MMEJ or SSA for precision gene 
targeting in zebrafish (Hisano et al., 2015), the genetic mechanisms governing this 
activity for gene targeting have yet to be elucidated. In addition, the contribution of 
differing nuclease systems and their role in creating more favorable and predictable 
outcomes for MMEJ or SSA based gene targeting are not yet fully explored. To this 
end, we developed two genomic assay systems to test the genetic mechanisms of 
strand annealing and gene targeting in zebrafish at an endogenous locus, noto. The 
first assay system, RFP-DR48 (for RFP direct repeat with 48 bp of homology) is a 
predicted readout of strand annealing activity. Using this assay system, we show 
that strand annealing is a highly active DNA repair pathway in zebrafish when the 
substrates for this activity are present flanking DNA breaks, even when competition 
for MMEJ substrates is available. We also demonstrate that the DNA break inducing 
agent of choice enables strand annealing at different efficiencies, similar to previous 
reports (Kuhar, Gwiazda et al. 2014). While RFP-DR48 is a readout of chromosome 
to chromosome DNA repair, the second assay system, RFPΔ200 (for RFP 200 bp 
deletion), is a readout of exogenous DNA integration ie. gene targeting. These assay 
systems allow the systematic overexpression and inhibition of key regulators in DNA 
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repair pathway choice and will permit dissection of the DNA repair mechanisms used 
in strand annealing and gene targeting in zebrafish. 
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Figure 1 – Engineering noto:RFP-DR48. (a) Schematic showing RFP-DR48 integrated 
at noto. The NBM (yellow) contains both Cas9 and Mad7 PAMs for universal 
targeting using the underlined RNA cursor target site. Red is the engineered 
stop codon. (b) Southern blot of three noto:RFP-DR48 lines. Band intensity is 
roughly single copy based on the copy number controls in the noto probed blot 
(top). Gel shifts are present indicating precise (line 1) and linear vector 
integration (lines 2 and 3). (c) Junction fragment analysis of integrations 
showing precision at the 5’ junction. Line 1 contains a precise 3’ integration, 
while line 2 and line 3 contain differing NHEJ events. (d) Schematic of 
integrations events as determined by Southern blot and DNA sequencing 
analysis. 
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Results 
Engineering noto:RFP-DR48 
To develop the strand annealing assay RFP-DR48, RFP was broken by 
introducing a 44 bp nuclease binding module containing “Universal” target sites and 
PAM sequences for Mad7 (U-pre-crRNA) and SpCas9 (UgRNA) (Figure 1a) 
(Wierson et al., submitted, Chapter 3). Flanking the nuclease binding module, a 48 
bp direct repeat of RFP coding sequence was created. As an internal control, the 
nuclease binding module was engineered to contain a stop codon that will be 
removed only after the 48 bp direct repeat is utilized for SSA repair. A secondary 
reporter for GFP expression in the zebrafish lens was included in the targeting 
cassette for ease of identifying transgenic progeny. This cassette, dubbed RFP-DR48 
for RFP-direct repeat 48 bp homology, was integrated in frame of the coding region 
for noto using our previously reported gene targeting system GeneWeld (Figure 1a) 
(Wierson et al., 2018 submitted).  
On average across three injection experiments, 41% of injected animals were 
positive for the secondary reporter in the lens, indicative of genomic integration of 
the RFP-DR48 cassette. From these injection experiments, 18 animals raised to 
adulthood were outcrossed to look for germline transmission of the cassette. Of 
these, 2 animals transmitted alleles where RFP-DR48 was precisely integrated using 
the 5’ homology domain. F1 lines from these founders were raised to adulthood, 
outcrossed to generate lines of F2s, and Southern blot was performed to analyze the 
integration patterns on siblings of each of 3 lines from the 2 original founders. As 
predicted, single copy targeted alleles were recovered in the F2 generation (Figure 
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1b, Figure 1d). Line 1 
contains signal that is 
indicative of a concatemer, 
however junction fragment 
analysis for this line displayed 
precise integration at both 
junctions on target at noto, 
indicating the concatemer 
likely results from an off-
target integration (Figure 1c). 
Interestingly, the secondary 
reporter is inherited in 
Mendelian fashion, suggesting 
a linked concatemer. Lines 2 and 3 display Southern blot patterns indicative of a 
linear integration of the donor vector (Figure 1b, Figure 1d). Indeed, these lines 
contained precise 5’ integrations on target at noto, however the 3’ junctions were 
NHEJ events with integrations of the entire linear vector (Figure 1b and 1c). 
Because off target events and/or concatemers likely contain the NBM and will not 
allow for a single genomic DSB, line 2 was chosen for all further experiments and is 
hereafter referred to as noto:RFP-DR48.  
 
Engineering noto:RFPΔ200 
Similar experiments were performed for RFPΔ200. The NBM containing a Cas9 
UgRNA site was inserted into RFP while simultaneously deleting 200 bp of RFP 
HMEJ integration
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                    noto <--- 24 bp homology --->Vector
Precise junction - TACCGGAGCATAACCAACCAAACGTCTGTCCTTCCC
Line 1           - TACCGGAGCATAACCAACCAAACGTCTGTCCTTCCC
a
b
Figure 2
Figure 2 – Engineering noto:RFP200. (a) Schematic 
showing RFP200 integrated at noto. The NBM (yellow) 
contains a Cas9 PAM for universal targeting using the 
underlined RNA cursor target site. Red letters are the 
engineered stop codon. Green and blue brackets 
represent sequence for homology to be designed flanking 
the deleted RFP sequence. HMEJ based integration will 
restore the RFP reading frame. (b) Junction fragment 
analysis of the 5’ junction for line 1 of noto:RFP200. 
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coding sequence. Again, a stop codon was inserted upstream of the NBM that will 
be removed upon the targeting and replacement of the NBM with the 200 bp of 
coding sequence (Figure 2a). A secondary reporter for GFP expression in the 
zebrafish lens was included in the targeting cassette for ease of identifying 
transgenic progeny. This cassette was targeted using GeneWeld to the same site in 
noto as RFP-DR48. Across all injection experiments, 38% of injected animals 
displayed gamma cry:GFP in the lens and 27 F0s raised to adulthood were 
screened for germline transmission. Of these, 1 founder was identified. F2s were 
generated from this founder and contain a precise 5’ integration (Figure 2b). 
Southern blot and 3’ junction fragment analysis of this integration allele is ongoing. 
 
Future work 
Here, we describe two assay systems that will allow the interrogation of the 
genetic mechanisms of DNA repair and gene targeting. noto:RFP-DR48 allows the 
analysis of proteins and small molecules that shift DNA repair towards end resection 
and SSA or MMEJ. As demonstrated in Wierson et al., 2018 (Chapter 2), not all 
GeneWeld events are precise at the 3’ end of the targeting event. GeneWeld events 
are all analyzed in somatic tissue through the expression of a fusion reporter allele 
and there is no selection for precise targeting at the 3’ end. The design of 
noto:RFPΔ200 is such that both ends of the gene targeting event must be precise in 
order to generate a functional RFP. This assay will allow the identification of factors 
that can enhance the precision and frequency of precise alleles at both ends of an 
integration event. 
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We previously demonstrated that experiments targeting noto:RFP-DR48 with 
Cas9 mRNA and UgRNA reagents results in conversion of RFP in the notochord 
(Chapter 3). Further, an alternate nuclease system, CRISPR/Mad7, elicits strand 
annealing statistically greater than CRISPR/Cas9 in this assay. This preliminary data 
provides a baseline of efficiencies that can be used in conjunction with DNA repair 
pathway perturbations to analyze the mechanisms of strand annealing in vivo. 
Identifying key DNA repair pathway regulators that enhance strand annealing will be 
tested in noto:RFPΔ200 and GeneWeld towards enhancing integration frequency and 
precision, and our group’s predictive MMEJ outcome algorithm in order to increase 
the predictability of generating a knock-out allele of interest. We will explore a range 
of proteins using cDNA overexpression to determine their effect on strand annealing 
in noto:RFP-DR48 and on HMEJ in noto:RFPΔ200 in vivo as described below.  
Inhibition of NHEJ is a reasonable approach to enhancing strand annealing 
efficiencies. Indeed, abrogation of DNA ligase IV (ligIV) increases HDR rates in 
some systems, most notably when using single-stranded DNA molecules as gene 
targeting donors (Chu, Weber et al. 2015) (Maruyama, Dougan et al. 2015) 
(Beumer, Trautman et al. 2013). A dominant negative ligIV has been described (Wu, 
Frit et al. 2009). DN-ligIV mRNA expression in zebrafish embryos shifts DNA repair 
away from NHEJ towards MMEJ (He, Zhang et al. 2015) and decreases SSA activity 
(Liu, Gong et al. 2012), thus representing a read-out of DNA repair pathway choice. 
However, these experiments used transient plasmid-based end-joining assays as 
opposed to the chromosomal assay proposed here. noto:RFP-DR48 will provide an 
assay to confirm previous reports using DN-ligIV for end-joining in zebrafish, while 
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noto:RFPΔ200 will allow interrogation of ligIV’s requirement for controlling gene 
targeting activity. Similarly, DNA end stabilization performed by Ku70/80 is required 
for efficient NHEJ repair. Overexpression of a dominant negative form of Ku70 or 
Ku80 inhibits NHEJ and thus may increase the percentage of repair events that 
undergo strand annealing (He, Li et al. 2007) (Marangoni, Foray et al. 2000). 
Additionally, 53BP1 functions to control the extent of end resection in order to 
promote NHEJ or HR, pending the cell state and accessory factors available (Panier 
and Boulton 2014). A genetically encoded protein inhibitor of 53BP1, called i53, was 
recently described and demonstrated to improve gene targeting with plasmid donors 
and ssODNs (Canny, Moatti et al. 2018). This protein complex will be tested in both 
noto:RFP-DR48 and noto:RFPΔ200 to determine if it alters strand annealing or gene 
targeting in vivo. 
Abrogating function of proteins involved in HR, namely Rad51, can potently 
shift DNA repair towards strand annealing (Liu, Maguire et al. 2004) (Stark, Pierce et 
al. 2004). Two ATP-ase mutants of mammalian Rad51, Rad51-K133A which is 
defective in ATP binding and thus strand exchange, and Rad51-K133R which is 
defective in ATP hydrolysis but still competent for strand exchange, enhance SSA 
16- and 93-fold, respectively (Stark, Pierce et al. 2004). Overexpression of these 
Rad51 mutants will be used in both noto:RFP-DR48 and noto:RFPΔ200 to determine 
their effect on strand annealing and gene targeting in chromosomal assays. 
Additional Rad51 mutants from yeast have been shown to elevate gene targeting 
using oligonuclueotide donors. In particular, Rad51-K342E, which elevates the 
interaction of Rad51 with Rad54, enhances gene targeting up to 100-fold (Liu, 
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Maguire et al. 2004). As Rad51 and Rad54 are not required for SSA or MMEJ, 
noto:RFPΔ200 will be used for these experiments as repair with an HMEJ donor may 
indeed have overlap with the mechanisms of HR.  
Also critical to HR is the activity of the Mre11, Rad50, Nbs1 (MRN) complex 
(Lamarche, Orazio et al. 2010). Mre11, which possesses endo- and exo-nuclease 
activity, begins end resection by generating 5’ overhangs that are the substrate for 
5’-3’ end resection mediated by a multitude of factors including ExoI and CtIP 
(Shibata, Moiani et al. 2014) (Farah, Cromie et al. 2009) (Mimitou and Symington 
2009). An Mre11 double phospho-site mutant Mre11S676/678A that is not 
phosphorylated by ATM cannot mediate control of end resection by ExoI, leading to 
aberrant end resection, inhibition of HR, and elevation of SSA (Kijas, Lim et al. 
2015). Both noto:RFP-DR48 and noto:RFPΔ200 will be used with Mre11 and 
Mre11S676/678A overexpression in order to look for a shift towards strand annealing 
repair.  
The RPA heterotrimeric complex containing RPA1, RPA2, and RPA3, is 
required for protecting and stabilizing ssDNA after end resection and is hypothesized 
to prevent spontaneous ssDNA annealing, thus inhibiting MMEJ in yeast (Chen, 
Lisby et al. 2013) (Deng, Gibb et al. 2014). Yeast RPA1, encoded by rfa1, with a 
hypomorphic amino substitution D228Y, suppresses Rad52 loss during SSA (Smith, 
Zou et al. 2000). Thus, RPA1D228Y will be tested in zebrafish for its effect on repair of 
both noto:RFP-DR48 and noto:RFPΔ200. The helicase domain of polymerase theta, a 
protein required for MMEJ in zebrafish (Thyme and Schier 2016), has been shown to 
counter the activity of WT RPA by physically displacing it from ssDNA, thus 
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promoting MMEJ and inhibiting HR (Mateos-Gomez, Kent et al. 2017). 
Overexpression of Pol-theta in zebrafish may enhance the repair of both noto:RFP-
DR48 and noto:RFPΔ200 as both are designed to be repaired by strand annealing.   
 
Conclusion 
The assays and experiments described here will streamline the identification 
of factors that alter strand annealing and can be tested for their ability to enhance 
the efficiencies and precision of gene targeting experiments where large cassettes of 
DNA are to be integrated at designer nuclease cut sites. We have described a 
system, GeneWeld, that efficiently integrates reporter alleles, however not all events 
are precise and efficiencies vary from locus to locus. More complex genome edits, 
like deletion-tagging, humanizing loci, or SNP alterations require greater efficiency to 
be widely adopted. Using noto:RFP-DR48 and noto:RFPΔ200 to identify factors that 
facilitate the biasing of repair events in zebrafish embryos will be paramount to 
increasing the efficiencies of these precision genome engineering events used in the 
lab for basic research and in the clinic for therapeutics. 
RFP assay cloning Sequence
v3f ATGCCACCGGCGTTCCTAGTTCTTTAAACTGTTACAAAGTGTTTGG
v3r ATGCACTAGTTTCAATTAAGTTTGTGCCCCAGTTTGC
bactinf ACTAGTACGGACTGTTACCACTTCACGC
bactinr ATGCCGCCGGTGTAATTTATTTAGCAGTAGATAGCTATATTGTGTGAAACGC
DRr CCGCAAGCCGCTGTGGCCCGAACGCCTCCCCTAAATCACCCCTCTGATCTTGACGTT
DRf AGGGATCAAGCCTCCAGGACGGCTGC
deltar TGGTTGATGAAGGTTCTGCTGCC
deltaf TTAAGGGAGGCGTTCGGGCCACAGCGGCTTGCGGAGGGTAGTGCTGGGAGGCCAACACC
Southern blot primers
NBMf CGACATCCTGGCTACCAGCTTC
NBMr TGTCGCTTCTGCCTTCCAGG
flhSBf CAGATGCCACACTTCGCGT
flhSBr CGATGTTATACTTGCTTCTTTTTAGTTTTGTACATAT
GeneWeld oligos
flhv35aflh TGATGGGAGCGCAGAGCTGGAGACAGGAAAAGCATAACCAACCAAACGCCTGTC
flhv35bflh GAAGGACAGGCGTTTGGTTGGTTATGCTTTTCCTGTCTCCAGCTCTGCGCTCCC
flhv33aflh AAGTCCAGCTCTGCGCTCCCGCTTATTGGGCCTGTCTCCAGCTCTGCGCTCCC
flhv33bflh AGCGGGAGCGCAGAGCTGGAGACAGGCCCAATAAGCGGGAGCGCAGAGCTGGA
Table 1 - Oligos for RFP assay cloning, Southern blot, GeneWeld knock-in
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Materials and Methods 
Zebrafish husbandry 
Zebrafish were maintained in Aquatic Habitats (Pentair) housing on a 14 hour 
light/10 hour dark cycle. Wild-type WIK were obtained from the Zebrafish 
International Resource Center. All experiments were carried out under approved 
protocols from Iowa State University IACUC.   
 
Mad7 cloning 
See Chapter 3 for detailed cloning methods. 
 
RFP assay generation, injection, and line isolation 
pPRISM-V3 was PCR amplified with v3f and v3r to remove the ocean-POUT 
terminator and add SgrAI and SpeI cloning sites (Table 1). Bactin 3’ UTR was PCR 
amplified using KOD polymerase with primers bactinf and bactinr to add SgrAI and 
SpeI enzyme sites for sticky end cloning. pPRISM-V3(pout negative) amplicon and 
bactin 3’ UTR were cut with SgrAI and SpeI. After ligation with Fisher Optizyme T4 
Ligase and sequence verification to create pPRISM-V3-bactin, phosphorylated 
primers deltaf and deltar were used to simultaneously add the NBM and delete 200 
bp of RFP coding sequence using KOD polymerase (Table 1). Purified PCR product 
was ligated with Fisher Optizyme T4 Ligase and sequence confirmed. SSA-DR48 
was created by simultaneously adding the NBM and creating a direct repeat with 
phosphorylated primers DRf and DRr using pPRISM-V3-bactin with KOD 
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polymerase followed by Fisher Optizyme T4 Ligation and sequence verification. To 
target these constructs to noto, homology domains up and downstream of a genomic 
CRISPR/Cas9 target site were chosen as described in Wierson et al., 2018. 
Homology arms were added to pPRISM-V3-bactin RFP-DR48 and RFP-delta200 
using Golden Gate cloning as described in Wierson et al., 2018. The RFP cassette 
was liberated from the donor using the same noto gRNA used to cut the genome. 
Gamma-crystalin:eGFP positive embryos were sorted and raised to adulthood, 
outcrossed to generate the F1 generation, and outcrossed again to generate lines of 
F2s. 
 
Southern blot analysis  
Genomic Southern blot and copy number analysis was performed 
as described previously (McGrail et al., 2010). PCR primers used for genomic and 
donor specific probes are listed in Supplementary Table 1.  
 
Citations 
Aparicio, T., R. Baer and J. Gautier (2014). "DNA double-strand break repair 
pathway choice and cancer." DNA Repair (Amst) 19: 169-175. 
 
Bennardo, N. and J. M. Stark (2010). "ATM limits incorrect end utilization 
during non-homologous end joining of multiple chromosome breaks." PLoS Genet 
6(11): e1001194. 
 
Beumer, K. J., J. K. Trautman, K. Mukherjee and D. Carroll (2013). "Donor 
DNA Utilization During Gene Targeting with Zinc-Finger Nucleases." G3 (Bethesda) 
3(4): 657-664. 
 
Canny, M. D., N. Moatti, L. C. K. Wan, A. Fradet-Turcotte, D. Krasner, P. A. 
Mateos-Gomez, M. Zimmermann, A. Orthwein, Y. C. Juang, W. Zhang, S. M. 
Noordermeer, E. Seclen, M. D. Wilson, A. Vorobyov, M. Munro, A. Ernst, T. F. Ng, T. 
Cho, P. M. Cannon, S. S. Sidhu, F. Sicheri and D. Durocher (2018). "Inhibition of 
146 
53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 
genome-editing efficiency." Nat Biotechnol 36(1): 95-102. 
 
Ceccaldi, R., B. Rondinelli and A. D. D'Andrea (2016). "Repair Pathway 
Choices and Consequences at the Double-Strand Break." Trends Cell Biol 26(1): 52-
64. 
 
Certo, M. T., B. Y. Ryu, J. E. Annis, M. Garibov, J. Jarjour, D. J. Rawlings and 
A. M. Scharenberg (2011). "Tracking genome engineering outcome at individual 
DNA breakpoints." Nat Methods 8(8): 671-676. 
 
Chen, H., M. Lisby and L. S. Symington (2013). "RPA coordinates DNA end 
resection and prevents formation of DNA hairpins." Mol Cell 50(4): 589-600. 
 
Chu, V. T., T. Weber, B. Wefers, W. Wurst, S. Sander, K. Rajewsky and R. 
Kuhn (2015). "Increasing the efficiency of homology-directed repair for CRISPR-
Cas9-induced precise gene editing in mammalian cells." Nat Biotechnol 33(5): 543-
548. 
 
Colleaux, L., L. D'Auriol, F. Galibert and B. Dujon (1988). "Recognition and 
cleavage site of the intron-encoded omega transposase." Proc Natl Acad Sci U S A 
85(16): 6022-6026. 
 
Davis, A. J. and D. J. Chen (2013). "DNA double strand break repair via non-
homologous end-joining." Transl Cancer Res 2(3): 130-143. 
 
Deng, S. K., B. Gibb, M. J. de Almeida, E. C. Greene and L. S. Symington 
(2014). "RPA antagonizes microhomology-mediated repair of DNA double-strand 
breaks." Nat Struct Mol Biol 21(4): 405-412. 
 
Farah, J. A., G. A. Cromie and G. R. Smith (2009). "Ctp1 and Exonuclease 1, 
alternative nucleases regulated by the MRN complex, are required for efficient 
meiotic recombination." Proc Natl Acad Sci U S A 106(23): 9356-9361. 
 
Gunn, A. and J. M. Stark (2012). "I-SceI-based assays to examine distinct 
repair outcomes of mammalian chromosomal double strand breaks." Methods Mol 
Biol 920: 379-391. 
 
He, F., L. Li, D. Kim, B. Wen, X. Deng, P. H. Gutin, C. C. Ling and G. C. Li 
(2007). "Adenovirus-mediated expression of a dominant negative Ku70 fragment 
radiosensitizes human tumor cells under aerobic and hypoxic conditions." Cancer 
Res 67(2): 634-642. 
 
He, M. D., F. H. Zhang, H. L. Wang, H. P. Wang, Z. Y. Zhu and Y. H. Sun 
(2015). "Efficient ligase 3-dependent microhomology-mediated end joining repair of 
DNA double-strand breaks in zebrafish embryos." Mutat Res 780: 86-96. 
147 
 
Kijas, A. W., Y. C. Lim, E. Bolderson, K. Cerosaletti, M. Gatei, B. Jakob, F. 
Tobias, G. Taucher-Scholz, N. Gueven, G. Oakley, P. Concannon, E. Wolvetang, K. 
K. Khanna, L. Wiesmuller and M. F. Lavin (2015). "ATM-dependent phosphorylation 
of MRE11 controls extent of resection during homology directed repair by signalling 
through Exonuclease 1." Nucleic Acids Res 43(17): 8352-8367. 
 
Kuhar, R., K. S. Gwiazda, O. Humbert, T. Mandt, J. Pangallo, M. Brault, I. 
Khan, N. Maizels, D. J. Rawlings, A. M. Scharenberg and M. T. Certo (2014). "Novel 
fluorescent genome editing reporters for monitoring DNA repair pathway utilization at 
endonuclease-induced breaks." Nucleic Acids Res 42(1): e4. 
 
Lamarche, B. J., N. I. Orazio and M. D. Weitzman (2010). "The MRN complex 
in double-strand break repair and telomere maintenance." FEBS Lett 584(17): 3682-
3695. 
 
Liu, J., L. Gong, C. Chang, C. Liu, J. Peng and J. Chen (2012). "Development 
of novel visual-plus quantitative analysis systems for studying DNA double-strand 
break repairs in zebrafish." J Genet Genomics 39(9): 489-502. 
 
Liu, L., K. K. Maguire and E. B. Kmiec (2004). "Genetic re-engineering of 
Saccharomyces cerevisiae RAD51 leads to a significant increase in the frequency of 
gene repair in vivo." Nucleic Acids Res 32(7): 2093-2101. 
 
Marangoni, E., N. Foray, M. O'Driscoll, S. Douc-Rasy, J. Bernier, J. Bourhis 
and P. Jeggo (2000). "A Ku80 fragment with dominant negative activity imparts a 
radiosensitive phenotype to CHO-K1 cells." Nucleic Acids Res 28(23): 4778-4782. 
 
Maruyama, T., S. K. Dougan, M. C. Truttmann, A. M. Bilate, J. R. Ingram and 
H. L. Ploegh (2015). "Increasing the efficiency of precise genome editing with 
CRISPR-Cas9 by inhibition of nonhomologous end joining." Nat Biotechnol 33(5): 
538-542. 
 
Mateos-Gomez, P. A., T. Kent, S. K. Deng, S. McDevitt, E. Kashkina, T. M. 
Hoang, R. T. Pomerantz and A. Sfeir (2017). "The helicase domain of Poltheta 
counteracts RPA to promote alt-NHEJ." Nat Struct Mol Biol 24(12): 1116-1123. 
 
Mimitou, E. P. and L. S. Symington (2009). "DNA end resection: many 
nucleases make light work." DNA Repair (Amst) 8(9): 983-995. 
 
Panier, S. and S. J. Boulton (2014). "Double-strand break repair: 53BP1 
comes into focus." Nat Rev Mol Cell Biol 15(1): 7-18. 
 
Pierce, A. J., R. D. Johnson, L. H. Thompson and M. Jasin (1999). "XRCC3 
promotes homology-directed repair of DNA damage in mammalian cells." Genes 
Dev 13(20): 2633-2638. 
148 
 
Shibata, A., D. Moiani, A. S. Arvai, J. Perry, S. M. Harding, M. M. Genois, R. 
Maity, S. van Rossum-Fikkert, A. Kertokalio, F. Romoli, A. Ismail, E. Ismalaj, E. 
Petricci, M. J. Neale, R. G. Bristow, J. Y. Masson, C. Wyman, P. A. Jeggo and J. A. 
Tainer (2014). "DNA double-strand break repair pathway choice is directed by 
distinct MRE11 nuclease activities." Mol Cell 53(1): 7-18. 
 
Smith, J., H. Zou and R. Rothstein (2000). "Characterization of genetic 
interactions with RFA1: the role of RPA in DNA replication and telomere 
maintenance." Biochimie 82(1): 71-78. 
 
Stark, J. M., A. J. Pierce, J. Oh, A. Pastink and M. Jasin (2004). "Genetic 
steps of mammalian homologous repair with distinct mutagenic consequences." Mol 
Cell Biol 24(21): 9305-9316. 
 
Thyme, S. B. and A. F. Schier (2016). "Polq-Mediated End Joining Is 
Essential for Surviving DNA Double-Strand Breaks during Early Zebrafish 
Development." Cell Rep 15(7): 1611-1613. 
 
Wu, P. Y., P. Frit, S. Meesala, S. Dauvillier, M. Modesti, S. N. Andres, Y. 
Huang, J. Sekiguchi, P. Calsou, B. Salles and M. S. Junop (2009). "Structural and 
functional interaction between the human DNA repair proteins DNA ligase IV and 
XRCC4." Mol Cell Biol 29(11): 3163-3172. 
149 
CHAPTER 5.    CONCLUSIONS AND PERSPECTIVES 
Control of the genome was something of science fiction for nearly four 
decades after the discovery of DNA as the information that encodes life. Even then, 
introduction of exogenous DNA into the genome was low efficiency, random, 
ineffective for the precise study of defined genetics, and never mainstream for 
therapeutics. It took nearly six decades after the discovery of DNA until the advent of 
designer nucleases. Gene targeting, a term coined by Nobel Laurette Mario 
Capecchi, means any event where the genome is altered in a predictable way by 
integrating exogenous DNA into the genome. In particular, the precise targeting of 
exogenous DNA into the genome allows the ability to control gene expression, 
replace mutant alleles with wild-type alleles, or to provide cells and organisms new 
traits in agriculture or biotechnology applications. CRISPR/Cas9 has been a game-
changer in the democratization of gene targeting methods, however the methods for 
gene targeting to date have generally relied on the use of long homology arms to 
promote homologous recombination (HR) for gene targeting. In most cell types and 
in zebrafish, gene targeting using HR is not an effective method for gene targeting, 
even when using designer nucleases to stimulate DNA repair. 
 
In this thesis, zebrafish is used as an in vivo bioreactor to develop novel 
methodologies that enhance gene targeting and the ability to precisely control the 
genome. We provide a significant methodology, called GeneWeld, that promotes 
enhanced gene targeting over the state of the field. GeneWeld relies on 
simultaneous gene editing components: First, efficient targeting of the genome 
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specifies a genetic target to be engineered and second, efficient targeting of a donor 
molecule liberates a knock-in cassette containing homology to the genomic target. 
We demonstrate that CRISPR/Cas9, TALEN, and CRISPR/Mad7 can be effective 
designer nucleases for inducing GeneWeld activity at theoretically any locus of 
interest. These simultaneous nuclease-induced DNA double-strand breaks activate 
a non-HR, homology driven mechanism that promotes efficient and precise gene 
targeting. We show that GeneWeld events are up to 10x more efficient at somatic 
knock-in activity than the closest published reports. Further, GeneWeld events pass 
through the germline at rates higher than other published reports and we provide an 
in-depth analysis of germline events using Southern blots and junction fragment 
confirmation. In addition, GeneWeld is an active system in mammalian cell culture. 
We show that gene targeting using GeneWeld in porcine fibroblasts and human 
K562 cells is ~10x more efficient than gene targeting using HR in these cell types. 
We provide a detailed protocol and suite of vectors that will increase the ease and 
access that scientists have in applying this precision gene targeting method for their 
applications. Significantly, we provide a transparent report for the state of the gene 
targeting field and conclude that GeneWeld is an effective method that opens the 
door to more complex genome engineering applications and functional genomics.  
 
Though GeneWeld is effective for routine gene targeting events in order to 
create genetic fusions of fluorescent reporters, this work is not complete. Not all 
gene targeting events are precise at both ends of the integration, and some off-
target events were demonstrated by Southern blot. Additionally, the mechanisms of 
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DNA repair that drive GeneWeld are not yet identified. To this end, I developed 
genomic reporters that will allow the identification of factors that may bias strand 
annealing-based DNA repair in zebrafish. As I predict that mechanisms of a to be 
determined strand annealing DNA repair activity are driving integration of our 
GeneWeld donors, I predict an ability to enhance efficiencies and precision upon 
identification of factors that help bias DNA repair towards this pathway.  
 
Let’s not forget the powerful application of this technology towards functional 
genomics. Our group is generating additional vector suites that include secondary 
marker alleles for visual genotyping of transgenic progeny that carry a given DNA 
cassette of interest. Our group is applying GeneWeld to integrate Cre and inducible 
Cre recombinases under the control of endogenous promoters of interest. Cre driven 
by endogenous promoters will allow the tissue specific recombination of revertible 
alleles also generated using GeneWeld. This will allow precise control over a given 
gene’s activity during critical biological pathways and activities. Additionally, we are 
using GeneWeld to integrate mutant cDNAs for the study of gene function. Available 
strategies for generating single nucleotide polymorphisms (SNP) rely on 
oligonucleotide mediated repair, a strategy that is less effective than GeneWeld, and 
does not allow for visual genotyping. Thus, GeneWeld integration of these cDNA 
alleles with a secondary marker provides a system to easily study combinations of 
cDNA mutants in genetic backgrounds that can be visually identified as early as 2 
days post fertilization, removing the need for time consuming and complicated 
analysis of phenotypes that rely on PCR mediated genotyping. 
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In summary, the work presented here advances the field of gene targeting 
and precision genome modification. GeneWeld, and its continued application and 
advancement towards more complicated genome engineering techniques, is an 
effective method for driving the integration of exogenous DNA at theoretically any 
locus of interest. Its use will promote the recombination of DNA into genomes that 
will allow a next generation of functional genomics applications, agricultural 
advancement, and human therapeutic interventions.  
